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SCOPE – SCIENTISTS ON PUBLIC 
ENGAGEMENT: FROM COMMUNICATION  
TO DELIBERATION? 
This report is the outcome of a three-year research project conducted from September 2006 to August 2009 in the BIOS Centre for the Study of 
Bioscience, Biomedicine, Biotechnology and Society at the London School of Economics and Political Science. The project was funded by the 
Wellcome Trust (Society Awards: Research stream, Engaging Science public engagement grants programme: award number 080201). The 
research objective was to provide a data-led, sociological analysis of the understandings, views, perspectives, judgements and experiences of 
scientists working in the life sciences with respect to public engagement and public dialogue. 
 
BIOS is an internationally recognised centre for research on social, political and economic aspects of the life sciences and biomedicine. 
The Centre is at the forefront of contemporary sociological debate concerning cultural change in ‘the age of biology’. BIOS conducts 
empirically led, conceptually innovative research projects on a wide range of topics, from the new brain sciences to stem cell research 
and regenerative medicine. This research is conducted in close collaboration with life scientists, clinicians, policy-makers and other 
partners in the social sciences and the humanities. 
 
The Wellcome Trust is the largest charity in the UK. The Trust funds innovative biomedical research in the UK and internationally, 
spending over £600 million each year to support the brightest scientists with the best ideas. The Trust also seeks to improve 
understanding of the ways in which science and medicine have developed and how biomedical research affects people and society 
today. The Trust’s public engagement funding promotes interest, excitement and debate around science and society. 
 
ScoPE: http://www.lse.ac.uk/collections/BIOS/scope/scope.htm 
BIOS: http://www.lse.ac.uk/collections/BIOS/ 
Wellcome Trust: http://www.wellcome.ac.uk/ 
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6 
EXECUTIVE SUMMARY 
Background 
Scientists on public engagement: from communication to 
deliberation? (ScoPE), funded by the Wellcome Trust (award 
number 080201), was a three year social science research project, 
conducted in the BIOS Centre for the Study of Bioscience, 
Biomedicine, Biotechnology and Society at the London School of 
Economics and Political Science by Sarah Franklin, Kevin Burchell 
and Kerry Holden. The project was inspired by three observations 
regarding developments in official and institutional approaches to 
the relationships between science and the public. First, that 
attention to the relationships between science and the public 
remains a strong governmental and scientific commitment, 
particularly in the UK. Indeed, Science Minister Lord Drayson’s 
statement in July 2009, that the UK higher education funding 
councils will include public engagement in the 2015 Research 
Excellence Framework (REF)1, represents perhaps the most 
significant step yet in the ongoing institutionalisation of this 
agenda. Second, that policy approaches to these issues are in the 
process of reconfiguration, as evolving understandings of 
interactive, two-way public engagement and policy-oriented public 
dialogue increasingly complement pre-existing one-way models of 
science communication and public understanding of science. 
Third, that while the official, institutional elements of these 
developments have been the subject of considerable sociological 
attention, a sociological study of scientists’ perceptions of these 
developments represents a noticeable gap in the research 
literature. 
The ScoPE project 
With these observations in mind, the research objective of ScoPE 
was to provide a data-led sociological analysis of the 
understandings, views, perspectives, judgements and experiences 
                                                 
 
 
1
 In the UK, until recently, the quality of the research outputs of university 
departments has been assessed every seven years through the Research 
Assessment Exercise (RAE). This has been used to determine the future 
core funding levels of all UK universities from government. Following the 
2008 RAE, the existing system of assessment is set to be replaced by the 
Research Excellence Framework (REF). Following Lord Drayson’s 
announcement, in a development that is likely to affect the incentive 
structures for scientists and other academics, it now appears the 2015 REF 
will include some form of assessment of both public engagement and policy 
impact in addition to the existing evaluation of scholarly impact. 
of scientists – particularly those working in the life sciences – 
concerning recent developments in the ways in which relationships 
between science and the public are understood and managed, 
with particular reference to public engagement and public 
dialogue. This analysis was pursued through 30 semi-structured 
interviews with biological scientists, most of whom have 
considerable experience of public engagement, and some of 
whom have experience of public dialogue. The interviews were 
analysed according to well-established qualitative and 
interpretative methods, and were complemented by an extensive 
review of the academic, policy and practitioner literature. These 
efforts were punctuated by regular meetings and workshops 
involving a wide range of professionals active in the dialogue and 
engagement fields. 
Public culture as professional science 
The findings of the ScoPE project confirm the significance of a 
major shift or ‘sea change’ in professional scientific culture toward 
an endorsement of, and participation in, public engagement as a 
key component of scientific research and innovation. More firmly 
than in the past, public engagement emerges from the interview 
data as a matter of professional scientific commitment and as a 
valuable part of the everyday practice of professional science. 
Indeed, on the basis of the ScoPE interviews, public engagement 
skills are increasingly seen by scientists to be as important to a 
successful scientific career as scientific, clinical and teaching skills. 
From deficit to dialogue,  
from communication to deliberation 
Interviewees’ accounts of relationships between science, the 
public and public engagement were reflective, sophisticated, 
layered and nuanced. Paralleling the recent trend toward more 
positive official and institutional descriptions of science-society 
relations, interviewees’ understandings of the public and of the 
purposes of public engagement proved more generous, confident 
and enthusiastic than has been reported in the past. The ScoPE 
study found that models of unsupportive and ‘deficient’ publics are 
increasingly complemented and/or replaced by representations of 
intelligent, supportive and scientifically capable publics, particularly 
in relation to biology and medicine. Further, science’s varied 
publics were often seen by ScoPE interviewees to be in 
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possession of a broad-based social knowledge that is valuable 
because it is distinct from the more narrowly specialised and 
technical knowledge of scientific experts. 
Notably, lapses in public support for developments in science and 
medicine (GM crops, the MMR vaccine and stem cell research 
were often mentioned in this regard) were less often attributed to 
characteristics of the public itself than to the negative influence of 
mediating social actors (most prominently the media, but also 
activist groups, corporations, religious opponents of approaches 
such as human embryo research, and errant scientists). A 
measure of the complexity of the science and society relationship 
perceived by many interviewees was also reflected in their 
tendency to express empathy with – and even to share – some of 
the negative public responses to certain aspects of scientific 
research and its dissemination, particularly in the specific contexts 
with which they were professionally or personally familiar. 
On this basis, ‘lay’ publics emerged from the interview data less as 
social actors in need of reassurance about science through 
science education, but increasingly as legitimate and capable 
stakeholders or citizen-partners in the effort to determine the most 
appropriate courses for and modes of scientific and medical 
innovation in a shift we characterised as moving from deficit to 
dialogue. Thus, earlier one-way or communication-based models 
of appropriate science-society interactions aimed at improving 
public understandings of science are increasingly replaced by two-
way models based upon dialogue, deliberation, partnership 
reciprocation and exchange. In such a model, public engagement 
is understood by interviewees to fulfil multiple and more complex 
objectives, often simultaneously. It is often viewed as a means of 
democratically addressing publicly-defined priorities and improving 
the ways in which scientific research and clinical activities are 
undertaken, as well as helping to define the questions that 
scientific researchers might address. It is also viewed as a crucial 
means of counteracting the negative perceptions of science that 
are seen to be caused by malign social actors such as the media, 
and of addressing areas of particular concern, such as those 
raised by novel areas of scientific innovation. Some scientists 
described the value of public engagement exercises as a means of 
promoting science, and confirming the intrinsic excitement and 
value of scientific discovery, while others emphasised the 
importance of being seen to provide a return for public and 
charitable funding. Notably, the project also found these 
perceptions among scientists are positively reinforced by 
participation in a range of public events 
Interviewees with direct experience of policy-oriented public 
dialogue described largely positive experiences, and reported 
improved perceptions of the capabilities of non-scientists to 
understand and discuss scientific matters. At the same time, 
concerns were also expressed about the limits to public 
involvement in decision-making with respect to science, the 
representativeness of the qualitative methods of public dialogue, 
public expectations of scientific expertise in public dialogue, and 
the appropriate roles of scientists in public dialogue. 
Public engagement as a professional 
anomaly and a vocation 
A major concern of interviewees, and thus a significant finding of 
this study, is the contrast between the generally positive view 
within the scientific community of the benefits of public 
engagement, and the difficulty of accommodating such activities 
within the already-overstretched job descriptions of most working 
scientists. Thus, while strongly endorsed as valuable and 
worthwhile, the means to facilitate new public–science 
partnerships were widely acknowledged to be challenging, time-
consuming, and potentially hazardous. In sum, public engagement 
emerged from the accounts provided by the scientists interviewed 
for this study, as a professional anomaly. Public engagement is 
acknowledged to be an increasingly important aspect of the 
scientific profession, yet – at the same time, and in contrast to 
other core scientific activities such as doing science, teaching and 
clinical work – it is universally seen to be under-incentivised and 
under-rewarded, potentially detrimental to research, and 
professionally stigmatising. Paradoxically, although it is 
increasingly recognised as valuable to science in general, and as 
individually rewarding, public engagement activity is also seen to 
be potentially detrimental to a professional scientific career.  
At the same time, interviewees observed that because public 
engagement is not more fully incentivised and rewarded they 
currently have a great deal of autonomy with respect to their public 
engagement activities. The ability of teams and groups of 
scientists are able to manage their public engagement 
commitments according to their individual strengths, weaknesses, 
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preferences and schedules could be undermined by more explicit 
formal measures to require such activities. From the perspective of 
the ScoPE interviewees, a barrier to a more explicit reward 
structure is the extent to which public engagement is most 
successful when it is positively infused with the sincerity, 
commitment and goodwill that are in part the consequence of its 
current status as a voluntary, vocational, and somewhat 
exceptional activity.  
Institutionalising public engagement? 
Although the prospect of greater institutional commitment to more 
meaningful and formal incentives and rewards for public 
engagement (such as the measures recently proposed by Lord 
Drayson) was widely and sincerely shared by the interviewees, 
such changes were also viewed with some ambivalence, and 
some interviewees questioned this agenda. Interviewees 
expressed both a general concern about the value of the voluntary 
nature of current participation in public engagement and dialogue 
activities, and more specific practical questions about how to 
evaluate or ‘measure’ scientists’ contributions to such activities. 
Others expressed concern that the introduction of further systems 
of incentives and rewards might lead to obligatory targets and 
quotas that would undermine the current autonomous, voluntary 
and flexible characteristics of public engagement. As a 
consequence, interviewees expressed uncertainty about the extent 
to which existing and future incentives for public engagement, 
such as rewards through the REF or promotion structures, might 
prompt a more cynical instrumentalism, manifested as an effort to 
be seen to be engaged rather than to be engaged for its own sake. 
They also expressed a reluctance to see public engagement 
activities bureaucratised as ‘more box-ticking’ (as might be argued 
has adversely affected perceptions of research and clinical ethics 
guidelines). In addition, all of the interviewees described science 
as an already overloaded profession. In this context, some 
interviewees questioned the extent to which scientific and 
governmental institutions concerned with the promotion of 
research excellence would be motivated to encourage leading 
scientists to pursue public engagement activities in the time that 
they would otherwise commit to scientific research. 
Shared concerns 
One of the main challenges to emerge from the ScoPE study is 
thus the question of how policy-makers might resolve these 
emerging and potentially conflicting aspects of public engagement 
– or, indeed, whether it is realistic to expect to do so. In June 2009, 
fifteen stakeholders in the public engagement agenda (the ScoPE 
researchers, ScoPE interviewees, public engagement and public 
dialogue practitioners, policy actors and other social scientists) met 
to discuss an early draft of the ScoPE report. This workshop 
served to illustrate the ability of sociologically-led, qualitatively-
based research to identify a number of core concerns that are 
shared among a range of stakeholders, and its utility as a means 
of deliberating them (although it also illustrated the extent to which 
sociological research may be better at identifying key questions 
than answering them!). In the workshop, discussion focussed 
almost exclusively on the desirability, feasibility and practicality of 
both ‘measuring’ scientists’ public engagement efforts, and 
employing these measures to meaningfully and fairly incentivise 
and reward public engagement. This discussion, like the data on 
which it was based, fore-grounded the challenge of more formally 
incentivising and rewarding public engagement without introducing 
new forms of compulsion and bureaucratisation that undermine its 
current characteristics of autonomy, vocation and voluntarism. To 
meet this challenge, it was agreed that it will be necessary to 
better characterise the ways in which institutionalised public 
engagement affects the working lives of scientists, shapes choices 
about the science that does and does not get done, and 
contributes to the ways in which science, medical research and 
clinical practice are governed within an increasingly scientifically 
engaged society. 
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CHAPTER 1 INTRODUCTION 
Lord Drayson, UK Science Minister (July 2009): We 
believe that scientists have a duty – particularly when they are 
funded by taxpayers – to engage in the public arena, to 
engage in communication of the challenges and the potential 
ethical concerns about their science, and that will be included 
in the REF. 
Lord Professor Robert Winston (website, 2009): Public 
engagement with science is vital. Scientific knowledge has 
huge promise but its possible misuse means that it is 
important that society has adequate control of what is done in 
its name. 
The set of questions and concerns that formed the basis for the 
ScoPE project arose from three key observations concerning the 
roles of scientists in public engagement activities in the UK. These 
are discussed in the three sections below. 
Renewed official emphasis on relationships 
between science and the public 
The first observation is that the principle by which scientists should 
play active and wide-ranging roles in relationships between 
science and the public is now an increasingly established 
component of mainstream scientific culture in the UK2. As the pair 
of statements above illustrate, far from a passing phase or empty 
promise, the commitment of both government and senior members 
of the scientific community to real, active, meaningful and 
consequential public engagement and dialogue has become an 
increasingly prominent and important feature of what might be 
called the culture of scientific innovation. 
Examples of such activities and programmes can be found 
throughout the 20th century and, arguably, earlier (Gregory and 
Miller 1989). However, contemporary ‘official’ attention to the 
relationships between science and the public in the UK is widely 
held to have begun with the Royal Society (1985) Public 
Understanding of Science report (also often referred to as the 
Bodmer report, after its lead author, Professor Sir Walter Bodmer). 
                                                 
 
 
2
 While the UK tends to be regarded as being at the vanguard of these 
developments, similar initiatives exist in Europe and elsewhere (EC 2001, 
2005). 
The most significant change augured by this publication was the 
advent of a more concerted institutional effort to coordinate, 
promote and improve communication between science and its 
publics. The report also introduced a powerful new equation that 
has since proven to be a driving force in policy. The central thesis 
of the Bodmer report is that better public understanding of science 
promotes greater public support for science which contributes 
directly not only to successful scientific innovation but, as a 
consequence, to improved national prosperity. A kind of national 
moral purpose was seen to be served by improving the quality of 
public and private decision-making, which would thus enrich the 
life of the individual as well as the nation. To realise these gains, 
however, scientists would need to learn to communicate with the 
public, be willing to do so and indeed consider it part of their calling 
to do so effectively. 
During the late 1980s and early 1990s, largely under the rubrics of 
public understanding of science and science communication, 
Bodmer’s agenda began to become more institutionalised. Central 
to this effort was the science communication grants scheme run by 
the government-funded Committee on the Public Understanding of 
Science (see the COPUS website, COPUS 2009). At the heart of 
this initiative were scientists and the institutions in which they 
worked (as well as a burgeoning group of science communication 
professionals). Increasingly, scientists were required to describe 
their proposed public understanding of science activities in 
scientific funding bids and were encouraged to take advantage of 
targeted funding streams such as COPUS. In addition, public 
understanding of science activities were incentivised – and, for 
some scientists, rewarded – through prize and award schemes. 
The range of programmes and activities instigated under the 
banner of public understanding of science succeeded in 
encouraging scientists to undertake more such activities and, in 
providing a wealth of informative and often innovative sites, to 
promote public interaction with scientific topics. Evidence of the 
impact of these activities, for instance in increased levels of public 
understanding of science or the envisaged ensuing enthusiasm for 
science and technology, remains elusive. However, the general 
pattern of an increasing and sustained commitment to such 
activities during this period is striking. 
Attention to the relations between science and the public was both 
reinvigorated and extended in the House of Lords Science and 
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Technology Select Committee’s Science and Society report, 
published in 2000 and led by Lord Jenkin of Roding. Like the 
Bodmer report, it claimed that the understanding and application of 
science are fundamental to the fortunes of modern nations and 
that science, technology and engineering are intimately linked with 
progress across the whole range of human endeavour (House of 
Lords 2000). It similarly claimed that the applications of science 
raise, or feed into, complex ethical and social questions, which 
government and industry must handle in ways that command 
public confidence, and that many of these questions arise in the 
biosciences (for example, cited in the report are the issues raised 
by cloning, genetic testing, gene patents, assisted reproduction 
and xenotransplantation). 
The Science and Society report thus echoed the earlier Public 
Understanding of Science report in noting the potential for a lack of 
public confidence or public resistance to jeopardise or inhibit 
realisation of the benefits of scientific and technological progress. 
Thus, the report makes a pressing case for reinvigorating 
scientists’ attention to and interventions in the relationships 
between science and the public (or ‘society’, as the public now 
starts to be referred to). Further, the report identifies the period 
following the Public Understanding of Science report as one in 
which scientists have taken on board the need for activities 
concerning the public understanding of science, or ‘outreach 
activities’, particularly in potentially troubling areas such as 
bioscientific innovation. Together, these reports bookmark a 
process of change from a generally aspirational discourse – or 
even plea – for improved scientific communication to the 
beginnings of its successful institutionalisation. While precise 
quantitative measures for evaluating the impact of this change are 
unavailable, more general aspects of it are amenable to qualitative 
study, and in particular the ScoPE project focuses on the 
significance of this change within the scientific profession itself. 
From communication to deliberation?: the 
‘new mood for dialogue’ 
The reinvigoration of governmental and scientific attention to 
relationships between science and the public provides the primary 
context for the ScoPE project. However, the Science and Society 
report also sought to reframe the nature of the challenges that 
characterise these relations and, thus, the ways in which they 
should be managed. For instance, in the Science and Society 
report, pre-existing concerns regarding a lack of public knowledge 
about science are complemented by attention to a perceived lack 
of public confidence in scientific advice to government, and a 
growing recognition of the importance of acknowledging the impact 
on society of developments in science and technology. The later 
report consequently argues that public understanding of science 
should be complemented by engagement activities, in which 
dialogue between the public and science is emphasised. This shift 
can be summarised as a move away from a one-way, top–down, 
‘empty bucket’ model of ‘topping up’ public understandings of 
science in an essentially pedagogical fashion toward a two-way 
exchange model of engagement of which the primary idiom, and 
method, is dialogue. It introduced a new, post-Bodmer equation, 
according to which the public instructions to science mattered as 
much as science’s instruction of the public. Correspondingly, the 
Science and Society report issued the institutions that govern and 
regulate science with a direct challenge to develop more 
sophisticated approaches to public engagement – a challenge that 
is reflected in the ‘from communication to deliberation?’ question of 
the ScoPE project’s subtitle – by instigating a fundamental 
reconfiguration of institutional terms of reference and procedures 
in order to become more responsive to input from the diverse 
publics they serve. 
The UK institutions of science and of the governance of science 
have responded to the Science and Society report with an alacrity 
which suggests that Lord Jenkin’s widely read and influential report 
was not only persuasive but perfectly timed. Since 2000, 
developing discussions of what are now known as Science and 
Society issues have been presented in official documents and 
reports by a range of relevant institutions3 and in a succession of 
speeches by government ministers as well as prime ministers 
Tony Blair and Gordon Brown. 
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 Among others, see: Parliamentary Office of Science and Technology 
(POST) (2002, 2006); Royal Society (2001, 2004); The British Association 
for the Advancement of Science (The BA; now the British Science 
Association) (2002, 2005); HM Treasury et al (2004); Office of Science and 
Technology (2004); Royal Society and Royal Academy of Engineering 
(2004); Council for Science and Technology (2005); UK Government (2005); 
Office of Science and Innovation (2006); DIUS (2008); BIS (2009). 
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Following the report’s publication, almost every leading UK 
scientific body – both governmental and non-governmental – has 
expanded its range of programmes, funding streams, awards and 
training, and these are increasingly oriented around the terms 
‘Science and Society’, ‘Science in Society’, ‘public engagement’ 
and ‘public dialogue’.4 Indeed, these initiatives are evidence of 
what Lord Winston (recently appointed Professor of Science and 
Society at Imperial College in London) has described as a ‘sea 
change’ in the relationship between science and its publics.5 
In the period since the mid 2000s, four prominent government 
initiatives have played a leading role in bringing about, and 
furthering, the ‘sea change’ described by Lord Winston. The 
Sciencewise-Expert Resource Centre (S-ERC), established in 
2005 and with a budget of over £2 million from May 2008 to April 
2009, promotes and funds policy-oriented public dialogue by 
government departments and intermediaries 
(http://www.sciencewise-erc.org.uk/cms/). S-ERC is funded by the 
Department for Business, Innovation and Skills (BIS), is managed 
by the consultancy AEA Technology and draws upon the services 
of a varied network of commercial and non-commercial individuals 
and organisations (such as Ipsos MORI). S-ERC is perhaps 
complemented by the People and Participation.net (2009) website 
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 Conspicuous among these are the Wellcome Trust’s public engagement 
programme and media fellowships; the Royal Society’s Kohn Award for 
Excellence in Engaging the Public with Science, Michael Faraday Award for 
Science Communication, education programme and public engagement 
programme; all of the British Science Association’s work, including the 
Science in Society programme, communication award, British Science 
Festival, National Science and Engineering Week and Creativity in Science 
and Technology award; the Department for Business, Innovation and Skills’ 
Science and Society programme; NESTA’s FameLab competition; the 
Cheltenham Science Festival; the Sciencewise-Expert Resource Centre 
public dialogue programme and awards; the research council’s Science in 
Society programmes; a range of activities funded by the six Beacons for 
Public Engagement and the National Co-ordinating Centre for Public 
Engagement; and the programmes of the Royal Institution. 
5
 For an example of the science and society coalition envisaged in Lord 
Jenkin’s report in action, see the account of the successful passage of the 
revised Human Fertilisation and Embryology Bill produced by the Academy 
of Medical Sciences in collaboration with the Science Media Centre, the 
MRC and the Wellcome Trust (Watts 2009). For a possibly contrasting 
example of the policy-oriented aspects of the Science and Society agenda, 
see the government-funded GM Nation? initiative. Although considered to be 
flawed in a variety of ways, GM Nation? has nonetheless become an 
internationally totemic attempt to implement some of the ideas about policy-
oriented public participation in science and technology that were contained 
in the Science and Society report (Irwin 2006; Horlick-Jones et al 2007; 
Lezaun and Soneryd 2007; Levidow 2007. See also Irwin (2001) on the 
earlier Public Consultation on the Biosciences). 
resource (managed by Involve and Headshift and funded by the 
Department for Communities and Local Government, the Ministry 
for Justice and the Sustainable Development Commission), which 
promotes and supports public participation across public policy 
realms. 
With a budget of £9.2 million over four years, the National Co-
ordinating Centre for Public Engagement and six regional 
university-based Beacons for Public Engagement were established 
in 2008 (http://www.publicengagement.ac.uk/). Funded by the UK 
higher education funding councils, Research Councils UK and the 
Wellcome Trust, these initiatives are designed to promote, develop 
and support broad-based public engagement across the UK higher 
education sector, including among academic scientists. 
Moreover, as previewed at the outset of this chapter, in July 2009, 
Science Minister Lord Drayson committed the UK higher education 
funding councils to including public engagement in the 2015 
Research Excellence Framework (REF) (Drayson 2009). Finally, a 
revised Science and Society strategy – in which public 
engagement and public dialogue feature strongly – has been the 
topic of a consultation and ongoing further development since 
2008 (DIUS 2008; BIS 2009). 
Each of these wide-ranging and varied initiatives and programmes 
provides the institutional context within which the scientific 
community conceives and undertakes public engagement. 
Predictably, both the scale and speed of change affecting the 
scientific community have engendered both dialogue and reflection 
within its own ranks. From the perspective of professional 
scientists, the science and society agenda can be readily seen to 
raise new questions about their public, scientific and professional 
roles. For example, how should scientists consider, understand 
and respond to the impacts of their work on society and on public 
opinion? What are these ‘impacts’, and how are they defined? How 
should they communicate their science to the public, with 
attendant time pressures and potential misgivings about activities 
such as working with the news media? How should they engage in 
dialogue with the public? What input should the scientific 
community have into government initiatives to promote public 
dialogue, such as public consultation exercises or citizens’ juries? 
Does scientific expertise now require public communication skills? 
How have scientists responded to growing pressures to perform 
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new tasks in what are often experimental social contexts in which 
they may find themselves under unfamiliar scrutiny, and to perform 
new roles for which they have little or no formal training? 
 
A gap in the literature 
These were some of the key questions that informed the 
development of the ScoPE project, which is the first study to begin 
to evaluate the emergence of a new ‘two-way’ model of public 
engagement and dialogue with science from the perspective of 
scientists. The developments in the governance of relationships 
between science and the public that are discussed above have 
been accompanied by wide-ranging academic debate among 
sociologists and science studies scholars. Studies of scientists’ 
perspectives toward science communication and public 
engagement have been undertaken by or on behalf of national 
science institutions.6 Work in both of these areas is discussed in 
Chapter 2. However, a sociological study of scientists’ 
understandings of, motivations for and experiences of public 
engagement has represented a notable lacuna in the research 
literature. Indeed, while scholars are now beginning to address 
scientists’ understandings of public engagement in broad terms, no 
work has addressed these issues within the specific context of 
policy-oriented public dialogue. 
Building on a research strategy that has become increasingly 
widely used within the BIOS Centre at LSE, the institutional home 
of the ScoPE project, this study was designed to collect and 
analyse scientists’ evaluations of science communication and 
public engagement activities in a manner that exploits their 
proximity to, and close engagement with, such activities. These 
‘embedded’ understandings derived from direct experience 
comprise a valuable, but arguably under-utilised, resource for the 
evaluation of the putative shift ‘from deficit to dialogue’. We also 
used this data to inform a broader sociological analysis of changes 
in the professional culture of science, the social character of 
scientific innovation and the ‘science and society’ relation. 
                                                 
 
 
6
 See Wellcome Trust (2000) and Royal Society (2006). 
 
Defining public engagement and public 
dialogue 
The increasingly wide range of public-facing activities that have 
become prominent in the UK Science and Society approach are 
most often referred to by governmental and other institutions as 
‘public engagement’ and ‘public dialogue’. However, the 
imperatives, objectives, meanings and practices covered by these 
labels are characterised by a considerable degree of under-
definition, fluidity, parochialism, contention and overlap.7 As 
mentioned earlier, quantitative means of evaluating the efficacy of 
such initiatives remain elusive. In addition, the field is populated by 
similar terms whose meanings are subject to the same 
challenges.8 With these vagaries in mind, it is helpful to review 
briefly how these terms are understood and employed within two of 
the institutions at the centre of Science and Society efforts: the 
Department for Business, Innovation and Skills (BIS)9 and the 
National Co-ordinating Centre for Public Engagement. Both public 
engagement and public dialogue are loosely defined in DIUS’ 
updated Science and Society strategy consultation document: 
Public engagement: an umbrella term that encompasses 
many kinds of activity including science festivals, centres, 
museums, and cafes, media, consultations, feedback 
techniques, and public dialogue. Any good engagement 
activity should involve aspects of listening and interaction 
(DIUS 2008 p. 20). 
Notable in this definition is the designation of public engagement 
as an umbrella category for a wide range of communication, 
engagement and dialogue activities – in effect defining it as a 
collective noun. This is followed in the current definition of 
                                                 
 
 
7
 For instance, see the definitional endeavours of Rowe and Frewer (2005) 
and the work on the imperatives of public participation by Stirling (2008). 
8
 For example, science communication, public understanding of science, 
outreach, public participation, public consultation, public involvement, social 
appraisal, patient and public involvement, patient forums and participatory 
technology appraisal. 
9
 BIS was formed from the erstwhile Department for Innovation, Universities 
and Skills (DIUS) and Department for Business, Enterprise and Regulatory 
Reform (BERR), in June 2009. 
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DIUS/BIS terminology by a refinement of this ‘umbrella’ category to 
emphasise the importance of ‘listening and interaction’ as key 
characteristics of public engagement. This definition, then, 
designates public dialogue as a sub-category of public 
engagement. The National Co-ordinating Centre for Public 
Engagement (NCCPE) offers a draft definition of public 
engagement that it applies across academia or higher education. 
Public engagement brings research and higher education 
institutions together with the public. It generates mutual 
benefit – with all parties learning from each other through 
sharing knowledge, expertise and skills. Done well, it builds 
trust, understanding and collaboration, and increases the 
institution's relevance to, and impact on, civil society (NCCPE 
2009). 
While acknowledging elsewhere the fluidity of the notion of public 
engagement, in its definition of the term, the NCCPE also hints at 
listening and interaction through its emphasis on learning and 
sharing. At the same time, this definition also more firmly 
emphasises some of the potential institutional objectives of public 
engagement that pertain in this context: to generate mutual 
benefit, trust, understanding and relevance. 
Public Dialogue: a form of deliberative participatory 
engagement where the outcomes are used to inform decision 
making, is just one important kind of public engagement 
activity (DIUS 2008 p. 20). 
The DIUS/BIS definition of public dialogue highlights two specific 
characteristics that set it apart from other forms of public 
engagement. First, debate and deliberation are emphasised 
(usually between specific categories of public participants and 
experts of various kinds). Second, this definition of public dialogue 
emphasises a link with policy- or decision-making that is absent 
within other forms of public engagement. 
As the data presented later demonstrates in more detail, the 
ScoPE research suggests that scientists increasingly share the 
emphasis on a two-way dialogue or exchange model of 
engagement that is featured in the DIUS/BIS and NCCPE 
definitions (and, indeed, in Lord Jenkin’s Science and Society 
report). From the perspective of the scientists who were 
interviewed for the project, the two-way model can be the measure 
of a successful public engagement event. In this sense it has 
become a dominant engagement paradigm or category, and is 
also the aspect of engagement events that scientists described as 
most personally rewarding. Thus, possibly in contrast to the view – 
reflected in the DIUS/BIS definition of public dialogue – that public 
dialogue is ‘just one important kind of public engagement’, the 
ScoPE study found evidence to suggest that engagement activities 
in general are not uncommonly assessed by scientists in terms of 
how successfully they achieve the desired goal of two-way 
dialogue. The ScoPE data also shows – somewhat similarly to the 
NCCPE’s draft definition of the objective of public engagement – 
that scientists increasingly view the two-way dialogue model of 
engagement to be an essential route to productive and mutually 
beneficial coalitions and relationships between science and the 
public. 
 
Research objective and questions 
In conclusion, the research objective of the ScoPE project was to 
provide a sociological analysis of the understandings, views, 
perspectives, judgements and experiences of scientists – in 
particular scientists working in the life sciences – with respect to 
recent developments in the relations between science and the 
public, particularly how these are manifest in public engagement 
and public dialogue activities. 
Within the context of this broad research objective, four more 
specific research questions or themes can be identified: 
 Research question 1: How did interviewees characterise the 
relationships between science and the public, including the 
roles of other social actors and institutional bodies (media, 
government, activists, patients, professional organisations, 
academics, etc)? 
 Research question 2: How did interviewees understand the 
activities and objectives of public engagement and public 
dialogue, especially within the context of a putative shift ‘from 
deficit to dialogue’? 
 Research question 3: What were interviewees’ reflections on 
the challenges of public engagement in their working lives as 
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professional scientists and their changing professional role to 
encompass these activities? 
 Research question 4: What were the lessons learned from 
interviewees’ direct experiences of public dialogue? 
 
Structure of the report 
Chapter 2 provides a brief review of the scholarly and institutional 
research that is of relevance to the ScoPE project. In Chapter 3, 
the ScoPE research objectives are described in more detail, as is 
the research methodology that was employed in the study. 
Chapters 4 to 7 present the results of the research and discuss 
these findings. Chapter 4 focuses on interviewees’ discussions of 
the relationships between science and the public (Research 
question 1). In Chapter 5, interviewees’ perspectives on the 
activities and objectives of public engagement are examined 
(Research question 2). Chapter 6 is concerned with interviewees’ 
reflections on the place of public engagement within the working 
life, reward structures and career structures of the professional 
scientist (Research question 3). Chapter 7 focuses on direct 
experiences of public dialogue and interviewees’ reflections on 
public involvement in policy- and decision-making (Research 
question 4). In Chapter 8, a range of further issues that emerge 
from the data chapters are discussed, followed by a conclusion 
and summary of the major findings. 
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CHAPTER 2 RESEARCHING SCIENCE  
AND THE PUBLIC 
 
This chapter reviews some of the main reasons why social 
scientists have focused on relationships between science and the 
public, some of the main approaches to the relationships they have 
developed, and the ways in which questions about the field are 
seen to have changed. The chapter thus provides an academic 
background to the emerging shift from deficit to dialogue, which 
has become something of a cottage industry in its own right over 
the past 10 to 15 years both within and outside the UK. 
 
Science and technology as novel sites of 
contestation 
For some social theorists, scientific, technological and medical 
innovation comprise definitive spheres of social change because of 
the extent to which they elicit cultural, moral and political 
contestation (Nelkin 1992; Lindenbaum and Lock 1993; Wynne 
1996; Brown and Webster 2004). For others, these are sites of 
distinctive uncertainties that challenge conventional structural 
models of contemporary modernity by making explicit an altered 
‘order of things’ underlying social organisation (Latour 2004; Law 
1991; Callon 1987; Haraway 1997; Lock 2002; Rabinow 1996; 
Rose 2001, 2006). In his influential theory of the Risk Society, 
sociologist Ulrich Beck argues that, while late modern societies are 
increasingly dependent on science and technology, they are also, 
paradoxically, increasingly subject to the unpredictable and 
uncontrollable environmental and health risks that scientific and 
technological progress bring with them (Beck 1992, 1994). Here, 
Beck focuses particularly on various forms of pollution and 
contamination (chemical, nuclear, biological) of the natural 
environment and food systems, and climate change. At the same 
time, drawing on Anthony Giddens (1994), Beck also argues that, 
in late modernity, issues that were previously important sites of 
top–down, organised social and political action – such as left–right, 
socialism–capitalism, conservatism–liberalism and class – become 
less important in favour of what Bauman (2000) has described as 
a more ‘liquid’, or de-institutionalised, social fabric. The kinds of 
contestations that characterise debate over health and illness, new 
reproductive technologies, genetically engineered organisms, 
cloning, stem cells or the like are described by political theorists 
such as Sheila Jasanoff as essentially cultural – and thus less 
subject to the traditional orders of authority that allowed science to 
remain more independent of state politics (and vice versa) in the 
past. As she notes: 
Science and technology have been regarded for centuries as 
instruments of social progress and personal liberation. Yet, as 
scientific knowledge becomes more closely aligned with 
economic and political power, producing new expert 
elites…we can reasonably wonder whether science will lose 
its ability to serve either state or society as a source of 
impartial critical authority (Jasanoff 2005 p. 6). 
The contestations described by Jasanoff and others have direct 
implications for the meaning of democracy in ‘knowledge-led’ 
societies, in no small part because contestations over issues such 
as the MMR vaccine, GMOs, ‘designer babies’ and 
nanotechnology often directly revolve around the appropriate 
relationship between state governance and authoritative scientific 
claims. Thus it is often new sites of autonomous, bottom–up social 
and political action – which Beck calls ‘sub politics’ – that are 
increasingly the drivers in an ongoing reformulation of the ‘science 
and society’ relation (Beck 1992, 1994). 
While Beck largely concentrates on the ecological crisis in the late 
1980s and early 1990s, other sociologists have identified human 
biology, medical research practices, healthcare systems, human 
reproduction, disease and illness and developments in bioscience 
and biomedicine as similarly novel sites of autonomous, bottom–
up social and political action in the early 21st century – which 
some have called the ‘age of biology’, or what Ian Wilmut dubbed 
‘the age of biological control’ (Wilmut, Campbell and Tudge 2000). 
To encapsulate the notion of social and political change in the 
context of the new biology, the anthropologist Paul Rabinow has 
coined the term biosociality (Rabinow 1992). ‘Biosociality’ offers a 
foil to the earlier concept of ‘sociobiology’ by proposing that, 
instead of ‘natural facts’ offering a template on which human action 
can be based, modelled or understood, it is instead the process of 
technological innovation itself that is the source of new analogies 
for the human, or what some have dubbed the ‘posthuman’ 
(Hayles 1999; Fukuyama 2002). Building on the model provided by 
Rabinow, many social theorists have attempted to develop 
accounts of new social groupings based on the ability to alter 
biology. These include patient groups (Epstein 1996; Ginsburg and 
Rapp 2002), consumers of innovative biomedicine such as IVF 
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and organ transplant (Franklin and Lock 2003) and new forms of 
‘biological citizenship’ (Petryna 2002; Rose and Novas 2005). 
Social theorists have also investigated changes within the ‘cultures 
of science’ where scientific innovation takes place, offering 
accounts of the emergence of ‘biological control’ (Franklin 2007), 
the circulation of ‘bio-information’ (Parry 2004), the production of 
‘bio-value’ (Waldby and Mitchell 2006) and the emergence of 
‘biocapitalism’ (Sunder Rajan 2006) and ‘bio-prospecting’. While 
much of this work has been developed in the context of the ‘new 
genetics’, it responds to a wider set of processes through which 
the capacity of nature, biology or inheritance to limit human action 
is seen to have been superseded by technological capacities to 
alter, manipulate and redesign biological ‘facts’ (Strathern 
1992a/b). More widely, these changes associated with ‘biology’s 
big bang’ can be understood to reconstitute basic questions of 
scientific progress and technological innovation for the social 
sciences . 
Means of analysing these shifts vary. Quantitative researchers 
from a range of social scientific disciplines have been drawn to the 
task of attempting to measure or quantify relationships between 
science and the public as part of a long-standing research agenda 
that has become known as public understanding of science (PUS) 
research. Within the large-scale, quantitative, survey-based PUS 
research agenda, the contemporary emphasis is increasingly on 
long-term and internationally comparative analyses of public 
interest in science, public understanding of the facts and practices 
of science, public attitudes toward general and specific projects in 
science and technology, media coverage of science issues, and 
science communication activities (see the review by Miller 2004). 
By necessity, such studies rely upon well-developed variables and 
measurable phenomena and are hypothesis-driven research 
exercises. 
Qualitative studies, in contrast, have sought to embed the PUS 
agenda both within more specific case studies and within the 
broader social and cultural contexts that are implied in the 
foregoing material (Irwin 1995; Irwin and Wynne 1996), often by 
identifying new drivers and factors, and often by ‘discovering’ new 
hypotheses, rather than testing the validity of existing models. 
Work in this genre proposes that relationships between science 
and the lay public, including those of interest to researchers in 
PUS, are highly varied and highly dependent on the social and 
cultural contexts in which they emerge, as well as being more 
‘liquid’ and unpredictable, as depicted in the work of Beck, 
Bauman, Jasanoff and Rabinow cited earlier. Thus, these 
interpretative approaches seek to understand ‘science and society’ 
relationships through small-scale, interpretative case studies that 
often focus on contexts of uncertainty or contestation (Irwin 1995; 
Irwin and Wynne 1996; Mulkay 1997; Franklin and Roberts 2006; 
Lock 2002). 
As in any field, questions of method and evidence remain highly 
contested in the effort to understand both scientific innovation as a 
source of social change and social change as a source of scientific 
innovation. It is nonetheless the case that the social study of 
scientific innovation has become one of the most important new 
areas of contemporary British sociology, as noted in the recent 
RAE. Increasingly, many of the approaches to the production and 
consumption of scientific knowledge developed by social scientists 
rely on the analysis of qualitative data to generate new models and 
concepts, that can then be quantitatively tested (for an example 
that is also usefully comparative, see Gaskell and Bauer 2001 and 
Bauer and Gaskell 2002). At the outset, such analyses are by 
definition essentially interpretive and investigate, for example, what 
Ian Hacking calls ‘styles of reasoning’ as well as its content. These 
approaches represent something of a departure from a previous 
emphasis on scientific objectivity, neutrality and authority, 
favouring instead models of scientific knowledge and practice that 
are ‘situational’ (Haraway 1991), ‘co-produced’ (Jasanoff 2004), 
plural (Strathern 1992a/b), ‘multiple’ (Mol 2003) or ‘intersectional’ 
(Lock et al 2000). In such approaches the ‘reasoning’ that informs 
scientific practice does not derive from a single logic, but from 
many. A key aim of this report is to demonstrate this 
intersectionality in practice. Using an interrogative approach with 
scientists in semi-structured interviews, an archive of embedded 
knowledge was produced, within which intersecting logics and 
‘styles of reasoning’ or ‘styles of thought’ are found to be operating 
that demonstrate the importance of an ability to shift across 
multiple frames of reference in order to adjust to the varied 
meanings of authoritative scientific knowledge in different social 
contexts. 
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The governance of science 
As noted above, social theorists, sociologists and political theorists 
have been drawn to the study of science and technology based 
upon the observation that this is a key sector driving the 
emergence of novel modes of governance and regulation. For 
some, such as in the work of Ulrich Beck mentioned earlier, this 
shift is driven by the uncontrollable nature of contemporary science 
and technology, and the new forms of risk with which its 
uncertainty is associated. For others, changes in governance are 
rooted in new forms of social identity and affiliation that derive from 
the classificatory and disciplining effects of science, technology 
and medicine. Nikolas Rose (2001, 2006) emphasises the 
profound social and ethical implications of contemporary 
developments in bioscience and biomedicine – in genomics, 
synthetic biology, stem cell research, neuroscience and so on – 
and the extent to which these potentialities require novel forms of 
governance that he describes as part of a new ‘vital politics’ or ‘a 
politics of life itself’. Finally, for some scholars and public policy 
commentators, new modes of governance in science and 
technology are demanded by an axiomatic, democratic need for 
the governance of science to draw upon and reflect the wider 
views of the public and society, as well as those of scientific 
experts and policy imperatives (Wilsdon and Willis 2004; Stilgoe 
2007; Gavelin and Wilson 2007). 
As John Durant, George Gaskell and Martin Bauer argued in one 
of the first major comparative studies in Europe of biotechnology 
and the public sphere, ‘the biotechnological complex’ produces 
competing discourses and representations from distinct sectors of 
society (economic, political, mass media, etc) in which there is ‘no 
unified public discourse’ about bioscientific innovation, but instead 
an enormous diversity of public opinion both within and across 
European nations. The result has been a change in the process of 
industrialisation, in which public discourse has played a larger role, 
earlier on, in the processes of innovation – a shift that has involved 
significant ‘institutional learning’ as a result (Durant, Gaskell and 
Bauer 1998 p. 226). 
In this context, social scientists note that, in recent years, expert 
advisory institutions and systems have been increasingly 
complemented by a novel breed of advisory and regulatory bodies. 
These institutions have specific remits to consider the social and 
ethical implications of scientific practices and emerging 
technologies alongside matters of science, and to draw upon 
expert advice from ethicists, social scientists and other experts as 
well as scientists.10 Similar developments can also be observed 
within the context of already-existing institutions, such as the 
scientific research councils, the Royal Society and other learned 
institutions. Other social scientists have studied the inclusion of lay 
members on scientific expert panels (Stilgoe et al 2008). However, 
of more relevance here is the attention that social scientists have 
paid to the public engagement agenda that has emerged from the 
Science and Society report (House of Lords 2000). 
 
Contextualising policy-oriented public 
participation 
As indicated above, specific-issue, policy-oriented public 
participation exercises are increasingly seen to offer the possibility 
of rendering the governance of science more democratically 
accountable by delivering socially and technically robust decisions 
(indeed, this is how the DIUS defined public dialogue exercises 
earlier). However, these possibilities are also recognised to be 
limited and, at times, significantly flawed. For instance, 
government commitments to funding specific innovation strategies 
that are accompanied by high-profile commitments to dialogue and 
participation may not be enhanced by the impression of 
disingenuousness that they sometimes foster – essentially opening 
the barn door to public opinion after the horse has already bolted 
(Irwin 2006). Similarly, an institutional emphasis on ‘downstream’ 
impacts and the regulation of specific technologies neglect the 
‘upstream’ processes through which strategic decisions are initially 
made (Wilsdon and Willis 2004), reinforcing the views of critics 
who argue that the outcomes of public participation depend upon 
the institutional framing and timing of the issues and processes 
(Stirling 2008). In this regard, it has been noted that institutional 
public participation projects tend to seek out – and construct as 
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 These include the Human Fertilisation and Embryology Authority (Franklin 
and Roberts 2006), the Human Genetics Commission, the short-lived 
Agricultural Environmental Biotechnology Commission (Grove-White 2001; 
Horlick-Jones et al 2007) and the Food Standards Agency. 
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legitimate publics – public participants who have no preconceived 
views about the issue at hand, while participants with 
preconceived views are construed as representing entrenched 
interests (Reynolds and Szerszynski 2007; Schultz et al 2007). In 
addition, the extent to which such processes ‘close down’ the 
range of technological and social choices rather than ‘opening up’ 
choices and options has been noted (Stirling 2008). The resulting 
danger that institutionally led, policy-oriented public participation 
exercises may have a fait accompli flavour is one of the key 
obstacles to their success and, as a consequence, is a driver of 
consultation processes that move increasingly further ‘upstream’ in 
the process. 
 
Scientists’ understandings of the public 
This wide range of studies, along with the policy developments 
described in Chapter 1, provides the broad context for the ScoPE 
project and its objective to better understand the ways in which 
scientists talk about the public, as well as their perspectives and 
experiences with respect to public engagement. While these more 
specific issues have received less attention than many in the field, 
some studies have been undertaken into scientists’ views of these 
matters, which are worth mentioning briefly at the close of this 
review. Scientists have been invited to discuss the relationships 
between their science and the public in a number of small-scale 
studies similar to ScoPE, including those of Michael and Birke 
(1994a/b, 1995) on animal experimenters, Michael and Brown 
(2000, 2001, 2005) on xenotransplantation researchers, Cook et al 
(2004) and Burchell (2007a/b) on crop biotechnologists, and 
Davies (2008) on scientists from a range of disciplines. While it is 
not possible to draw any confident generalisations from these 
preliminary studies, some key themes to emerge are further 
developed in the ScoPE report. The first of these is the finding 
from all of the above studies that scientists readily identify different 
categories of the public and understand these sociologically as 
groups of social actors who operate in specific contexts and use 
distinct types of language and modus operandi (eg media and civil 
society groups of various types, such as NGOs or activists). 
Second, this work suggests that scientists often categorise the 
public and other social actors according to the extent to which they 
criticise or support their science. In addition, the work indicates 
that, on the basis of this distinction, scientists may rhetorically 
demarcate or separate themselves and their science from their 
critics. Here, some studies draw on Thomas Gieryn’s (1983, 1995) 
boundary work concept 
Finally, these studies most often frame scientists’ discussions of 
the public and other social actors in terms of the intent that this 
process of rhetorical demarcation and alliance-forming serves. 
More specifically, it is suggested that these rhetorical strategies 
form part of the public or political debate about science and 
technology, that they seek to create the political and social 
conditions within which authority, legitimacy, resources and 
autonomy are attracted to general scientific and medical projects 
such as xenotransplantation or agricultural biotechnology and to 
medical research approaches such as animal experimentation. 
Within this context, Michael and Brown (2000) discuss these 
rhetorical strategies of scientists and scientific institutions as a 
form of sophisticated ‘lay political science’ that both analyses and 
participates in social and political action. 
 
Scientists’ understandings and experiences 
of public engagement 
As an emerging topic of research, this issue has received only 
limited attention. Two categories of materials can be identified 
here. First, studies within which scientists have been specifically 
asked about science communication and public engagement 
(though not policy-oriented public dialogue) outside the context of 
specific processes or events: see the largely quantitative 
institutional studies by Wellcome Trust (2000), Royal Society 
(2006), the emerging qualitative institutional work associated with 
the Beacons for Public Engagement (McDaid 2008), and the more 
sociological qualitative studies by Sheppard (2007) and Parry et al 
(draft).11 This set of materials emphasises the multiple objectives 
that scientists ascribe to public engagement. For instance, the 
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 While McDaid (2008) studied attitudes toward public engagement across 
academic disciplines, from natural science to the humanities, Royal Society 
(2006) focuses on scientists and engineers, and Wellcome Trust (2000) on 
life scientists. Parry et al’s (draft) work is on stem cell scientists, and 
Sheppard’s (2007) MSc dissertation is on nanotechnologists. 
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stem cell scientists whom Parry et al (draft) interviewed spoke 
about public engagement in terms of educating the public in a 
variety of ways, securing public support for stem cell research, 
learning about public views of such research and providing space 
for debate about this research. These materials also emphasise 
the time-management challenges that public engagement 
presents, as well as the risk of professional stigma that public 
engagement can carry for scientists. In addition, the institutional 
work on this topic also raises issues that are of particular 
relevance within the context of the ScoPE project’s focus on life 
scientists. Perhaps owing to the historical relevance of science 
communication to scientists, the natural scientists in McDaid’s 
(2008) study expressed greater familiarity with the notion of public 
engagement than did academics working in the social sciences or 
humanities. In addition, the Royal Society (2006) suggests that 
scientists working in the life sciences are more involved in public 
engagement than scientists working in other scientific disciplines. 
This is perhaps due to the proximity of scientists working in the 
biological sciences to the human subject (for example as research 
subjects, in the clinic or as representatives of patient groups or 
medical research charities) or due to the extent to which 
developments in the life sciences are perceived to present social 
and ethical challenges. 
Second, there are reports by social scientists and others, who are 
often the event organisers, of a variety of specific public 
engagement events in which dialogue and deliberation between 
scientists, other experts and public participants are particularly 
emphasised (Kearnes et al 2006; Gavelin and Wilson 2007; Kerr et 
al 2007; Felt et al 2009). These materials consistently refer to the 
capacity of scientists to deliberate successfully on scientific issues 
with public participants. For instance, Kearnes et al (2006 p. 58) 
report that: 
A common set of understandings – even at times, a 
consensual language – emerged over the course of the 
afternoon, as members of the public developed a better sense 
of life in the laboratory and scientists grew to appreciate the 
legitimacy of public concern. 
However, in a variety of ways, it is also frequently lamented – from 
the perspective of these commentators, at least – that these ‘public 
concerns’ and values are easily trumped by scientific ‘facts’ within 
the context of such deliberative events; it is notable that lay 
participants are said to participate in these moves as much as 
scientist participants are (Kerr et al 2007; Felt et al 2009). In 
addition, Kearnes et al (2006) note the transformative effect that 
such events and processes can have on scientists’ views of public 
capability in discussions of complex scientific and technological 
issues. 
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CHAPTER 3 METHODS AND MATERIALS 
 
Qualitative and interpretative research 
The qualitative and interpretative tradition in social science 
research is characterised by its reliance upon a wide and rich 
variety of disciplinary backgrounds, philosophical approaches and 
practical research methods, as well as its understanding of social 
meanings as relational, contextual and, thus, contingent. While 
social science research is aimed primarily at the elucidation, 
characterisation and analysis of sociological mechanisms, causes 
and forms, it relies on the premise that all social facts are, at some 
level, interpretations. The use of social facts in social science is 
also distinctive in often yielding better questions or revised 
hypotheses rather than ‘answers’. The effect of accumulated 
sociological knowledge is thus often the depiction of change. The 
primary methods chosen for the ScoPE project – open-ended, 
semi-structured interviews, combined with an extensive review of 
relevant policy documents – represent widely used and well-
established social science approaches to contemporary social 
phenomena. The outcome of such research is often the 
identification of key themes and factors that enable nuanced, 
insightful and substantial engagement with the research topic. 
 
Research design and recruitment 
The ScoPE research design relies upon semi-structured, open-
ended interviews and a lengthy period of data analysis interpolated 
by workshops with relevant specialist professionals as well as the 
scientific community itself. The data collection process used for the 
ScoPE project differed from a survey or questionnaire-based study 
by combining predetermined topics and questions with 
spontaneous issues that emerged in the interview, or 
‘conversational interview’ as this approach is sometimes called. 
Thus, the order and manner in which research themes are 
addressed, and the attention that each theme receives, are 
determined by both the interviewee and the interviewer. In 
addition, interviewees are able to raise issues for discussion that 
are outside or complementary to the research themes conceived 
by the researchers. 
Two key criteria were used to define the research population. First, 
because the research was sponsored by the Wellcome Trust and 
carried out within BIOS, the research population was restricted to 
scientists working in the biosciences and biomedicine. Second, to 
ensure that interviewees would be able to comprehensively 
discuss their first-hand experiences of public engagement and the 
ways in which these inform their understandings, the research 
population was limited to scientists with experience of public 
engagement and, in some cases, experience of public dialogue. 
Thirty scientists were interviewed, over the period from March 
2007 to June 2008. A list of the interviewees is provided in Table 
1. Interviewees with experience of public engagement were 
purposively selected using a variety of methods. Some had 
participated in high-profile projects with a strong public dialogue or 
deliberative component (such as the Royal Society’s 
pharmacogenetics project and the Meeting of Minds project on 
developments in neuroscience12), others held advisory positions 
relating to science and society issues in governmental 
intermediaries (such as the Human Genetics Commission, the 
Human Fertilisation and Embryology Authority, the Biotechnology 
and Biology Sciences Research Council and the Medical Research 
Council). Some were associated with the Human Genetics 
Knowledge Parks, some were already known to members of the 
research team through previous research, while a number had 
been involved in the parliamentary lobbying, media and public 
debate activities associated with the passage of the revised 
Human Embryology and Fertilisation Act through parliament. Some 
interviewees were identified through general web-based 
investigations. Potential interviewees were invited by email to be 
interviewed, and interview locations and times were also agreed by 
email. 
 
                                                 
 
 
12
 The Royal Society pharmacogenetics public dialogue took place in 2005 
and involved two-and-a-half-hour sessions of discussion and debate 
between 76 members of the public and 12 experts of various kinds (in three 
groups) (http://royalsociety.org/page.asp?id=3779). Meeting of Minds 
‘European Citizens’ Deliberation on Brain Science’ also took place in 2005 
and involved 126 European citizens in very extensive debate with a range of 
experts on recent developments in the brain sciences 
(http://www.meetingmindseurope.org/uk_site.aspx?SGREF=207). 
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Name Institution 
Dr Lyle Armstrong Institute of Human Genetics, University of Newcastle 
Professor Clive Ballard Wolfson Centre for Age Related Disease, KCL 
Dr Sarah-Jayne Blakemore Institute of Cognitive Science, University College London 
Professor Sir Walter Bodmer Weatherall Institute of Molecular Medicine, University of Oxford 
Dr Chris Boyd Medical Genetics Section, University of Edinburgh 
Professor John Burn Institute of Human Genetics, University of Newcastle 
Dr Hilary Burton Public Health Genetics Foundation, Cambridge 
Professor Ian Craig Institute of Psychiatry, KCL 
Professor Dame Kay Davies MRC Functional Genomics Unit, University of Oxford 
Professor Dian Donnai School of Medicine, University of Manchester 
Professor Dylan Edwards School of Biological Sciences, University of East Anglia 
Professor Chris Frith Wellcome Trust Centre for Neuroimaging, UCL 
Dr Stephen Gentleman Division of Neurosciences and Mental Health, Imperial College London 
Dr Robin Lovell-Badge Division Developmental Genetics, National Institute for Medical Research 
Dr Stephen Minger Wolfson Centre for Age Related Diseases, KCL 
Dr Catriona Morrison Institute of Psychological Sciences, University of Leeds 
Dr Bill Newman School of Medicine, University of Manchester 
Dr Jenny Nichols Wellcome Trust Centre for Stem Cell Research, University of Cambridge 
Dr Jolanta Opacka-Juffry School of Human and Life Sciences, Roehampton University 
Dr Caroline Pennington School of Biological Sciences, University of East Anglia 
Professor Dame Julia Polak Division of Investigative Science, Imperial College London 
Professor David Porteous Medical Genetics Section, University of Edinburgh 
Professor Geraint Rees Institute of Cognitive Neuroscience, UCL 
Professor Christopher Shaw Institute of Psychiatry, KCL 
Professor Austin Smith Wellcome Trust Centre for Stem Cell Research, University of Cambridge 
Dr Glyn Stacey UK Stem Cell Bank 
Dr Alison Stewart Public Health Genetics Foundation, Cambridge 
Professor David White Institute for Food Research (now retired) 
Professor Andy Young Department of Psychology, University of York 
 
Table 1. The ScoPE interviewees. (The name of one interviewee who preferred to remain anonymous is omitted from this list.) 
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Gathering and analysing data 
Most of the interviews took place at the interviewee’s place of work 
and lasted around one hour. The interviews were preceded by a 
discussion of confidentiality and consent, and the interviewees and 
interviewers signed a consent form. The interviews were digitally 
recorded for professional transcription. The following themes were 
employed as a framework for the interviews: 
 Context 
o Relationships between the public and developments in 
science and technology 
o The value of scientific and public knowledge in policy-
making 
 Public engagement 
o The activities and objectives of public engagement 
o The challenges of public engagement 
 Public dialogue (where and as appropriate) 
o The activities and objectives of public dialogue 
o Experiences of public dialogue (motivations, roles, 
attitudes) 
o The challenges of public dialogue 
Following professional transcription, the interview transcripts were 
corrected where necessary and formatted by the research team. 
Final transcripts were provided to the interviewees so that they too 
could make corrections as appropriate. The analysis of the ScoPE 
interviews was undertaken via a lengthy and iterative process of 
reading and notation of the interview transcripts, listening to the 
interview voice files, identifying predetermined and emergent 
themes in the data, writing short commentaries on individual 
interviews or themes across the interviews, reorganising the data 
around themes, further close reading of the thematically organised 
data, developing ways of encapsulating the themes within the 
data, and writing. In analysing the data, emphasis is placed on 
identifying and interpreting the range of ideas, perspectives, 
images, metaphors and idioms that interviewees employed when 
discussing particular themes. 
The interpretative process described above was complemented by 
ongoing formal and informal discussions of the data and its 
analysis among the project team through the data-gathering, data-
analysis and report-writing period. In addition, the data analysis 
was shared with outside experts on two occasions. In September 
2007, after five interviews had been conducted, early thoughts and 
impressions were shared with and guidance was sought from two 
social science colleagues, Robert Doubleday of Cambridge 
University and Stephen Wainwright of KCL. In June 2009, a 
preliminary draft report was discussed at an immensely valuable 
workshop at LSE. This workshop was attended by 15 
stakeholders, including Sara Candy from the Wellcome Trust, the 
ScoPE team, scientist interviewees, actors from policy and 
practitioner institutions, and social scientists (see Table 2), and 
was designed to provide guidance and feedback – and, indeed, 
data – for inclusion in the final report. 
The ScoPE project was launched to academic social scientists at 
an international event entitled Constructions of Public Engagement 
with Science and Technology, as part of the BIOS Vital Politics III 
conference at London School of Economics, on Friday, 18 
September 2009. The project was launched to broader scientific, 
policy and practitioner audiences at a major event at the Royal 
Society on Wednesday, 14 October 2009. 
The ScoPE team is very grateful for all of the invaluable support 
and input that the project received from a range of individuals and 
institutions within the context of these events. Further information 
about these events can be found on the project website: 
http://www.lse.ac.uk/collections/BIOS/scope/scope.htm 
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Name Role on ScoPE Institution 
Dr Joelle Abi-Rachid   BIOS, LSE 
Dr Peter Border   Parliamentary Office of Science and Technology 
Dr Kevin Burchell ScoPE team BIOS, LSE 
Sara Candy Funder The Wellcome Trust 
Caitlin Cockerton   BIOS, LSE 
Alison Crowther   Sciencewise-Expert Resource Centre 
Dr Sarah Davies   Institute of Hazard and Risk Research, University of Durham 
Dr Robert Doubleday Advisory board Department of Geography, University of Cambridge 
Sophie Duncan   National Co-ordinating Centre for Public Engagement 
Professor Sarah Franklin Principle Investigator BIOS, LSE 
Kerry Holden ScoPE team BIOS, LSE 
Sue Hordijenko   British Science Association 
Lord Jenkin of Roding   House of Lords 
Dr Robin Lovell-Badge Interviewee National Institute for Medical Research 
Professor Geraint Rees Interviewee Wellcome Trust Centre for Neuroimaging, UCL 
Professor Brian Wynne Advisory board CESAGen, Lancaster University 
 
Table 2. Attendees of ScoPE workshop at LSE on 19 June 2009. 
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CHAPTER 4 SCIENTISTS ON: 
RELATIONSHIPS BETWEEN SCIENCE  
AND THE PUBLIC 
 
Beyond science alone 
Among the most striking findings to emerge from the interview data 
is the strength of awareness within the scientific community of the 
need for various forms of public engagement due to the open-
ended and often profound issues raised by scientific innovation – 
issues that might be described as being ‘beyond science alone’. 
Chris Frith: I think some of the things we've been doing 
recently … have implications that everybody needs to think 
about and not just the scientists. … I'm looking at the 
relationship between the mind and the brain. What determines 
why people choose one thing rather than another and then 
you get into deep philosophical questions about do we have 
free will. And then some neuroscientists take that into the 
judicial realm and say is anybody responsible for their actions, 
should the whole criminal justice system be altered because 
of what recently neuroscientists have found? … Well, I guess 
it’s the public in general that has to decide what the rules are. 
Professor Frith’s research concerns the neural basis of social 
interaction, and in this passage he describes how novel scientific 
and technological developments raise broader social challenges 
that go beyond science – ‘implications that everybody needs to 
think about’. He notes that developments in neuroscience 
concerning ‘the relationship between the mind and the brain’ raise 
profound philosophical questions, eg ‘do we have free will’. Frith 
describes an explicit transfer of scientific ideas from one social 
context to another when he refers to scientific colleagues who 
have taken findings from experimental science into the courtroom, 
where they have the capacity to affect ‘the whole criminal justice 
system’ because they could be seen to limit the possibility of 
criminal responsibility. Frith concludes that it is ‘the public in 
general’ who should ‘decide what the rules are’ about how the 
findings of neuroscientists should be interpreted in this broader 
social context. 
Frith’s view of scientific findings that are made in the lab and then 
travel to other sectors of society can be described as a 
‘downstream’ model of ‘impact’. In this view, science remains a 
separate, enclaved, specialist activity until it is ‘taken’ into another 
sector of society, such as the legal system. A different, more 
‘upstream’ model – not of ‘impact’, but of dependence – is often 
expressed by scientists working in sensitive or controversial areas 
such as stem cell research. In the following interview extract, Dr 
Stephen Minger, also a neuroscientist, articulates the view that 
public input should affect the forms and trajectories of his own 
research with human embryos. 
Stephen Minger: I think we are heavily dependent on 
interacting with the public and being responsive to what the 
public thinks about the kind of research that we do. You know, 
in every facet I think the research we do has big ethical issues 
associated with it: the use of human embryos for research, 
the creation of hybrid embryos, even our in vivo work gaining 
access to tissue samples from living human brains. 
For Minger, the novelty of the research practices and materials 
employed in stem cell research (‘the use of human embryos, the 
creation of hybrid embryos, even our in vivo work’) raise ethical 
dilemmas that are relevant to ‘the public’ beyond – or even before 
– what occurs in the scientific laboratory. Like Frith, he notes that 
these conditions require ‘interacting with the public and being 
responsive to what the public thinks’. Not unusually, but tellingly, 
Minger describes the relationship between scientists and the public 
as one of dependency – indeed, Minger describes his work as 
being ‘heavily dependent’ on public responses. As a consequence, 
he describes interaction with the public as being integral to ‘every 
facet’ of the work he does. 
 
A public that is generally supportive of 
science 
To the extent that scientists’ views of the relevance of public 
opinion appear to have become more prominent and explicit, so 
too do their comments frequently convey a general sense of 
confidence, and often optimism, about public support for science. It 
is even possible these two views comprise the ‘core’ or ‘general’ 
stance of many scientists toward public attitudes – much as there 
are well-known cases in which the reverse assumption (of 
presumed public hostility) prevails (perhaps most notably, GM in 
Europe). 
Many interviewees, including Walter Bodmer, expressed the view 
that the public is, in general, very supportive of developments in 
science, technology and medicine. 
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Walter Bodmer: I mean my general stand has been that, by 
and large, the public is extremely interested in science, 
particularly in medical science areas. And the notion that 
there’s a disaffection with science and things like that I think is 
largely wrong, … there isn’t this sort of extreme disaffection 
that sometimes even some of my colleagues talk about, but 
there are obvious concerns and that’s not unnatural. 
As the main author of the Public Understanding of Science report 
(Royal Society 1985), Professor Sir Walter Bodmer has played a 
pivotal role in the initiation of contemporary efforts to manage 
relationships between science and the public. Bodmer’s comments 
offer an important additional dimension to our assessment of the 
‘beyond science alone’ paradigm, or what we call the shift from 
deficit to dialogue. In referring to the ‘extreme disaffection that 
sometimes even some of my colleagues talk about’ as being 
‘largely wrong’, Bodmer draws a key distinction between 
representations of public views that emerge, perhaps in the media 
or simply in ‘talk’ among colleagues, and his own direct experience 
of public views, perhaps gained through his extensive work with 
medical research charities and at public events. Alongside the 
finding that scientists are strongly supportive of public engagement 
activities, the importance of scientists’ first-hand accounts of these 
activities stands out as a dominant source of their views. Bodmer 
reproduces this general pattern succinctly in his comment 
describing his opposition to the view (or ‘notion’) that there is 
widespread public ‘disaffection with science’, instead stating that 
this view is ‘largely wrong’ and identifying a generalised public 
support for and interest in science. At the same time, Bodmer 
identifies with the ‘naturalness’ of public concerns about science, 
which he further describes as ‘obvious’. 
Dian Donnai: I think it’s sometimes not as bad as people 
think it is, the things that grab the headlines are the things like 
GM-foods or Frankenstein science and animal-human 
hybrids, and all of that. And that grabs the press, but the 
press isn’t the public, and, in many ways, the public that I 
interact with, those attending hospitals, those attending 
scientific events, and those that were involved within the 
course of our research, actually, on the whole, are very pro-
science and pro-progress where there are benefits that can 
be seen. 
Bodmer’s scepticism about the notion of widespread public 
concern about science and, in particular, his observations 
regarding the malign influence of the media (‘things that grab the 
headlines’), is similarly described by Professor Dian Donnai, a 
geneticist and clinician. Donnai shares Bodmer’s view that ‘the 
press is not the public’ in a manner that underscores another 
important dimension to scientists’ awareness of ‘the public’ 
confirmed in this study; notably, that the ‘science and society’ 
relation is mediated. From her point of view (and with striking 
regularity in the interviews), this mediation is comprised both of 
actual media outlets, such as newspapers and television, but also 
of particular ‘mediagenic’ topics, most notably the GM and MMR 
debates. Like Bodmer, and in contrast to the picture that she says 
is painted by the media, Donnai describes the public she interacts 
with in the clinic, at public engagement events and in medical 
research programmes as ‘on the whole, very pro-science and pro-
progress’. At the same time, perhaps like many interviewees with 
GM in mind, Donnai adds the caveat that public support for 
developments in science are dependent on the presence of clearly 
observable benefits. 
In the same way that Stephen Minger describes his research as 
‘heavily dependent’ not only upon public responses but also upon 
his personal interaction with the public, Donnai makes a crucial 
distinction here – common to many of the ScoPE interviewees – 
between the public represented in the media and the public she 
interacts with personally. Dr Robin Lovell-Badge, a stem cell 
biologist and developmental geneticist, reiterates the points made 
by Bodmer and Donnai, while developing further analytical 
distinctions. 
Robin Lovell-Badge: …part of society seems to be rather 
anti-science and they’re the easiest to talk about in a way, 
and that worries me. But then I think most of society is 
generally supportive of science, but it depends on which 
branch of science you’re talking about, which aspects of 
science. And of course, people seem to be very happy to use 
technologies that come from science. And they often don’t 
question where they come from, but where, you know, like 
your recording devices or MP3 players or whatever. And of 
course, they’re all a product of science, initially basic research 
which has then been applied. And they’re quite happy to use 
all these things. So there seems to be quite good acceptance 
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of machines and computers, phones, whatever, but when it 
comes to biology and its applications, there seems to be more 
worry, more concern, I think I would say. 
Lovell-Badge agrees with Donnai’s and Bodmer’s view that there is 
considerable public support for developments in science, but is 
concerned that this may be overshadowed by a broadly held 
perception that the opposite is the case. It worries him that the 
anti-science view of the public is ‘easier to talk about’ – in part 
because it has become a familiar cliché. In addition, similarly to 
Donnai, though drawing on his broad-based observations rather 
than specific experiences, Lovell-Badge distinguishes between 
public acceptance of some technologies (for instance, consumer 
electronics such as MP3 players, computers and telephones) and 
public concerns about others (such as ‘biology and its 
applications’). Thus, and as has been noted in other studies of 
scientists’ views of the public, Lovell-Badge draws analytical 
distinctions within the public sphere, referring to anti-science 
sections of the public and to supportive sections of the public. This 
parsing of public debate is another feature of the interview set that 
emerges as prominent, and is discussed at greater length below. 
 
A public that is increasingly knowledgeable 
In contrast to earlier ‘deficit models’ of the public as generally 
lacking adequate knowledge about science, many interviewees 
emphasised more positive relationships between the ‘public’ and 
scientific knowledge, often expressing enthusiasm about an 
increasingly scientifically literate public. Dian Donnai offered a view 
of a situation that is ‘changing’ and of a public that is increasingly 
knowledgeable about science, in part due to the internet. 
Dian Donnai: Well, I do think [the situation] is changing and I 
do think most people are getting a much better concept of 
how their bodies work,. …. and people, actually, feel much 
more empowered now than they did before. And this is partly 
because the medical profession has changed and is much 
more willing to share information and healthcare knowledge. 
And this stems from primary care where there’s endless 
information resources …and professionals have got very 
expanded health promotion role, as well as dealing with 
illness role. In hospitals people are, you know, one sees one’s 
colleagues, who are consultants, much more involved in 
giving information to patients in a way that they can 
understand, but then, of course, there’s a huge group of 
media, multi-media, not just television and newspapers, of 
course, the internet now is people’s first place they turn when 
anything happens in their family. 
In this extract, Donnai offers a model of interactive communication 
based on her observations of how information is shared in the 
clinic. She notes that the public has greater access to information 
and is more empowered to use it, while also emphasising the 
greater willingness within the medical profession to share 
information and the promotion of such exchanges within the 
healthcare sector. Implicit in her description is a sense of 
momentum: that interaction is productive of more interaction in a 
virtuous circle in the context of healthcare and also, more widely, is 
a potential model for science communication and dialogue. 
Dr Bill Newman, like Donnai a consultant clinician and researcher 
in medical genetics, and a colleague of Donnai, similarly describes 
a process whereby access to more information builds patients’ 
confidence, enabling them to interact more knowledgeably with 
health professionals and to take more responsibility for their own 
health. On the basis of his own clinical experience, he notes that 
patients and the public are ‘becoming more sophisticated’ and 
‘much better informed’ about their conditions and about the ways 
in which they might be treated. 
Bill Newman: I think they are becoming more sophisticated, I 
think people are seeking more information and that there are 
wider sources of information clearly available to them. And 
certainly from my own clinical experience in seeing that 
patients are much better informed about their conditions, 
about the risks in the potential clinical management. … 
People will come in with cuttings from newspapers or bits off 
the internet. And so to be able to turn around and say I’m not 
aware of that or I don’t know anything about that particular 
piece of work I think is important. … I suppose I’m a little bit 
different in some ways is that I do have quite close weekly 
contact with patients and so rather than being a scientist, so I 
don’t necessarily have to go and seek that I’m sort of getting 
that through my professional role anyway. … mine’s much 
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more at that sort of clinical interface where I can have that 
dialogue within the context of a clinical consultation. 
Noting the importance of dialogue and the value of the clinical 
interface that keeps him in constant contact with patients, Newman 
reflects upon the ways in which these newly informed patients 
have changed his own practice, in particular the ways in which he 
conducts consultations. For example, he notes that informed 
patients prompt a more modest approach from him and that the 
admission of ignorance can be positively productive in the clinical 
encounter – precisely by enabling a shift from a more traditional 
model of knowledge as authority to a model of knowledge as a 
shared, plural resource that is not so much transmitted as 
exchanged. His comment that he thinks it is important to be able to 
say ‘I’m not aware of that or I don’t know anything about that 
particular piece of work’ implies that such openings enable him to 
acquire more information from patients in the pursuit of better 
clinical outcomes. Thus the exchange of knowledge – dialogue – 
becomes part of his normal practice and is mutually productive (‘I 
don’t necessarily have to go and seek that I’m sort of getting that 
through my professional role anyway’) in an important 
development of the traditional model of medical professional 
authority. 
The importance of dialogue as a context of knowledge exchange is 
complemented by its importance for knowledge translation – also a 
process many scientists and clinicians referred to as a key 
component of successful science communication. In this context, 
Dian Donnai describes a case involving a 17-year-old girl, who 
acted as her mother’s interlocutor by explaining quite complex 
medical information relating to one of the daughter’s younger 
siblings: 
Dian Donnai: We’d found a little bit of chromosome missing 
that we’d picked up with this new technology called Array 
CGH and I was explaining the very basics of what we’d found. 
We’d found a variation in the chromosome pattern too small to 
be seen down the microscope, so we had to use another 
method in the laboratory, but we picked this up and we didn’t 
really know whether it meant anything or not. We needed 
blood from the parents to try and interpret whether it meant 
anything or not and the daughter, who, I have to say, wasn’t 
that scientifically literate, was saying things to her mum that 
showed she understood what I was saying…She was 
explaining, trying to explain things to her mum, which I 
thought was quite good, and this is not uncommon. 
Here, Donnai again points to a changing or improving situation 
through dialogue, in this case where the explanation of technical 
information is mediated by the personal relationship of mother and 
daughter. Here again the anecdote works as a model of 
communication, in which Donnai implies that public understanding 
of scientific or medical information is a translational exercise. This 
is exemplified by the daughter’s understanding of the technical 
language of Donnai’s explanation – the language of CGH arrays 
and chromosome patterns – and by the daughter’s translation of 
this technical information into another language that is 
understandable to her mother. Donnai is impressed by the 
daughter’s ability to do this, observing that this is rooted in the 
daughter’s capacity – interestingly, despite not being ‘that 
scientifically literate’ – to understand and convey complex ideas 
about genetics, and she says that this is a ‘not uncommon’ feature 
of her clinical experience. 
While Donnai and Newman provide positive descriptions, 
embedded in clinical experiences, of the public as newly endowed 
with knowledge about their bodies based upon specialised 
information, Professor David Porteous – a leading medical 
geneticist, though not a clinician – places value on the public’s 
broad-based experiential knowledge. 
David Porteous: Lay publics are certainly intelligent and 
interested and informed publics. They haven’t been obviously 
exposed to the detail, the comprehensive detail, the breadth 
and depth of the experience of the expert, but, you know, if 
you go down to the pub and you ask, how do you think the 
economy’s running, well, you’ll get a strong opinion from 
every Tom, Dick and Harry and they’re not economists, but 
they, they understand ultimately, well, you know, our 
mortgage rate’s gone up. … And if you look at anything to do 
with medical advances and you forget for a moment that most 
people have got a personal history of watching an elder 
relative suffering from a degenerative disorder, and the 
effectiveness or otherwise of medical treatment. 
Porteous refers here to a high level of lay intelligence, interest and 
capability ‘across topics or issues, from the economy, to health 
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and medical advances’ that is generally observable, as he puts it, 
in the pub or among ‘every Tom, Dick or Harry’. He further 
describes this knowledge as being different to expertise because it 
is not underpinned by expert or professional education or training. 
Instead, for Porteous, this general public intelligence is 
experiential, subjective and personal. In sum, he suggests that it 
may be all too easy to underestimate common sense. 
A public that is understandably unsupportive 
in specific instances 
A public that lacks knowledge about science and scientists 
Alongside instances in which an increasingly knowledgeable public 
is identified by interviewees, occasions where a lack of public 
knowledge was evident were also noted. A lack of public 
knowledge was often identified by interviewees as a factor in 
instances of public concern and suspicion about technological 
developments. As the comments below illustrate, these depictions 
of the public as lacking in knowledge can be divided into three 
categories of ‘understandable’ confusion about scientific 
knowledge itself, the way that science works and the nature of 
scientists themselves. 
Robin Lovell-Badge: I guess, when you don’t know enough 
about a particular subject, then you can get very suspicious 
about the motives behind it, that subject, whether it’s research 
or selling something. You can be suspicious and you can be a 
little frightened of it. And that’s quite understandable. 
In his empathetic description of public suspicion of science, Robin 
Lovell-Badge identifies a link between insufficient knowledge about 
a particular issue and fear, for example concerning the underlying 
motives of the protagonists. Using an analogy between ‘research’ 
and ‘selling something’, Lovell-Badge suggests that similar 
responses occur in a range of social contexts and are 
‘understandable’ in the sense of being common, normal and 
predictable. Through use of the second-person ‘you’, he 
emphasises the everyday nature of this phenomena, suggesting 
that it is easily recognisable for what it is, namely ordinary. The 
implication here is that suspicion toward science is not necessarily 
a distinct category of fear, but is one that may exist in relation to a 
wide range of social phenomena. 
In a more complicated example of what is, or is not, 
‘understandable’, Dr Sarah-Jayne Blakemore, a researcher in 
social cognitive processes in people with autism, draws upon her 
own research expertise and her experiences as a parent to 
comment upon the public furore that was caused by Dr Andrew 
Wakefield’s controversial speculation regarding a possible link 
between the MMR vaccine and autism. In the comments below, 
Blakemore moves the discussion from public knowledge of the 
content of science to public knowledge about the methods of 
scientific and medical research, and clinical trials. In the central 
section of these comments, she emphasises the difficulties of 
understanding the ‘seeming contradictions in scientific fact’ that 
result from the potentially counterintuitive appearance of scientific 
methods, such as replication, to ‘people who do not really 
understand the scientific process’. 
Sarah-Jayne Blakemore: There’s not a very good 
understanding of what science involves, the classic things like 
replication, the fact that things aren’t necessarily replicable 
and so you can get these seeming contradictions in scientific 
fact, and that’s very difficult to understand if you’re not a 
scientist because people think of science as producing facts. 
But of course it doesn’t. It’s all wrapped up in statistics and 
probability and replicability. So that makes it inherently a bit 
untrustworthy. You shouldn’t trust a scientific fact until it’s 
replicated many, many, many times and even then it’s never a 
fact. It’s just a hypothesis being supported. … I suppose the 
one I’m most interested in is, or know most about, is the MMR 
and autism idea and controversy. Basically that was defined 
by the fact that people don’t really understand the scientific 
process. And I say this as someone who, because I’ve got 
two small children, had to think hard about the MMR vaccine. 
So even as a scientist, I still am affected by reading those 
front page news stories about science. So basically the whole 
MMR story, one person, one paper reports a link between 
MMR and autism in a very, very small number of children. 
And even then, a link is just a correlation. You can’t say 
anything about causality with no mechanism or no idea of how 
the MMR can cause autism. But obviously this is a big deal 
and it comes at a time when people think that autism is really 
on the increase. Even that’s very questionable, probably the 
prevalence for autism has increased, ie the awareness of it, 
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but maybe not the incidence, the actual rate of autism. The 
incidence has not increased that much, that’s what the latest 
evidence suggests. But anyway, people want to explain this 
apparent increase in autism. So the MMR is a nice theory, 
they want something like that. If there has been an increase, 
then presumably that’s environmentally caused and they want 
something in the environment that is tangible and that you can 
kind of imagine causing autism, and the MMR played that role 
for a lot of people. 
Here, Blakemore’s emphasis on method suggests a model of 
contextual ‘understanding’. A ‘link’ or ‘correlation’ in one context 
may not be relevant in another – indeed, it may be the opposite – 
which inevitably generates misunderstanding. Based upon her 
expertise as a scientist specialising in autism, while also a mother 
of young children and familiar with the concerns of other mothers, 
Blakemore can readily identify a range of scientific, medical and 
clinical research practices and principles that she and other 
interviewees believe are particularly poorly understood by the 
public because their interpretation requires switching between very 
different contexts of interpretation – eg childcare and laboratory 
science. From a scientists’ point of view, she points out, scientific 
facts should always be treated with scepticism – indeed as 
‘inherently untrustworthy’ – which is exactly the opposite of how 
they are interpreted by the media. It is easily understandable why 
this discrepancy is difficult to manage: as Blakemore notes, ‘even 
as a scientist I still am affected by reading those front page news 
stories about science’. Moreover, the range of basic concepts and 
methods in science that mean different – or opposite – things 
outside of science is numerous. In addition to ‘fact’, these include 
replication, the associated difference between single studies and 
scientific consensus, the difference between small- and large-scale 
research designs, issues of increased diagnosis versus increased 
prevalence, and the difference between correlation and causality, 
sampling and representation, and statistical probability and 
significance. Significantly, the source of misunderstanding is also 
precisely identified not only at the level of method rather than 
knowledge, but at the level of very specific methods that lie at the 
heart of risk calculation. From this perspective, although public 
misunderstandings of science may be problematic, they are not 
seen to be a distinct category of illiteracy or ‘deficit’. Indeed, as 
Wynne (2006) has argued, public misunderstandings of science in 
the description offered by Blakemore are depicted as part of the 
ordinary struggle any intelligent person would have in making 
sense of a specialist professional language. 
Blakemore’s comments are also notable because they illustrate 
the view, expressed by a number of interviewees, that scientists 
are themselves members of the public and experience science as 
members of the public. Thus, as a mother of two young children – 
and despite her expertise with respect to autism and the scientific 
method, and notwithstanding her evident investigations of the 
scientific literature relating to the MMR vaccine – Blakemore 
reports that she was affected by the media coverage of the 
controversy and had to think carefully about the MMR vaccine with 
respect to her own children. Here, Blakemore echoes Lovell-
Badge’s earlier assertion that scientists are prone to respond in 
similar ways to other members of society, for example as worried 
parents, and that to this extent public responses are not a separate 
category of social experience. 
In other comments on public misunderstandings with respect to 
science, some interviewees expressed concern about negative 
and inaccurate public perceptions of scientists themselves, most 
often associated with the cultural stereotype of the scientific boffin 
(also expressed as the hare-brained or absent-minded professor) 
who responds to motivations and acts in ways that are outside 
social norms. Although explicit and direct links between these 
perceptions and lack of support for science were not drawn by the 
interviewees, some did appear to feel that public responses to 
certain scientific projects are often framed by these negative public 
perceptions of scientists. In addition, these comments reveal 
scientists’ discomfort concerning their own identity, status or role 
within society. Notably, positive cultural stereotypes of scientists 
and clinicians – perhaps as being dedicated to science, medicine, 
patients or progress – are largely absent from interviewees’ 
discussions of their perceptions of public perceptions of 
themselves. 
Catriona Morrison: I think the public perceives scientists as 
being these kind of crazy boffins who dream up experiments 
and aren’t working for the public good. 
In this comment, Dr Catriona Morrison, an experimental 
psychologist, associates the boffin stereotype with acting outside 
of the public good. She invokes a public perception that scientists 
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are perhaps working on projects that are not prioritised by the 
public, that might even harm the public or that are driven by other 
interests, perhaps scientists’ self-interests or obsessions. The 
theme of separateness in scientists’ perceptions of public 
perceptions of scientists is also emphasised by a stem cell 
scientist (who wishes to remain anonymous). 
Interviewer: You mentioned misconceptions of science and I 
just wondered, can you characterise those misconceptions? 
Interviewee: Well, boffins and scientists with their wild hair 
and their lab coats, and just sort of being obsessed by doing 
science and not understanding that they have to fit into the 
community. And being something separate, a separate breed 
almost. ... I suppose they have seen on the telly, there’ve 
been some quite strange scientists and kids will look at them 
and think, well, I don’t want to turn out like that, maybe, I don’t 
know. 
For this interviewee, along with visual cues – such as wild hair and 
lab coats (others referred to white coats, high foreheads and social 
awkwardness) – the perceived public stereotype of the scientific 
boffin raises issues of strangeness and isolation from society, ‘a 
separate breed almost’. More notably, perhaps, in direct 
contradiction of the views expressed by Chris Frith and Stephen 
Minger at the outset of this chapter that matters of science are now 
‘beyond science alone’, the interviewee suggests that the public 
may perceive that scientists do not understand the extent to which 
they have to operate within the norms, expectations and 
permissions of society or the community. In addition, in common 
with other interviewees, this scientist comments on the roots of 
such public misperceptions in popular culture such as television. 
Drawing on his own familial experience, Dr Stephen Minger, also a 
stem cell scientist, also describes the discomforting sense that the 
public perceives that scientists behave in ways that transgress 
social norms and permissions. 
Stephen Minger: So, for example, my own family for years 
has been saying, you really just want to clone people, don't 
you? And no matter how hard I try to convince them that that's 
not really what we want to do, I think they're, kind of, 
convinced deep down inside that I'm probably doing 
something I shouldn't be. 
For Minger, the suspicion that his family believes that he wishes to 
transgress social – and, quite possibly, Minger family – norms by 
cloning people appears intractable: ‘no matter how hard I try to 
convince them’. Thus, the sense that the public has suspicions 
about who scientists really are and what they are really doing 
struck some interviewees as deeply held and widespread sources 
of potential distancing between ‘science and society’. As Minger 
notes, this suspicion may even include the possibility that 
scientists are unwilling to admit even to themselves the full 
implications of their work. 
 
A public that is negatively mediated by the media 
Prominent in many interviewees’ comments are a range of malign 
social actors who mediate relationships between science and the 
public in ways that may – intentionally or unintentionally – disrupt 
the more generally observable public support for scientific, 
technological and medical developments that was discussed 
earlier. This point is succinctly made by David Porteous. 
Interviewer: It sounds as if you’re describing a generally 
positive relationship, yet one that on occasions becomes a 
little bit problematic and that’s often to do with media, 
pressure groups. 
David Porteous: Yes, the intermediaries, it’s the 
intermediaries. 
In many instances, interviewees identified very direct relationships 
between the representation of science by intermediaries and the 
public. In others, more complex relationships are described in 
which the culture of science is sometimes implicated. 
Without doubt, and despite the widely well-regarded efforts of the 
Science Media Centre that were discussed earlier, the most 
prominent of these malign mediating actors in the interviewees’ 
minds is the news media. All interviewees portrayed a news media 
that misrepresents science in a range of ways – from 
exaggeration, sensationalisation and dramatisation to hype, 
oversimplification (dumbing-down) and distortion. In some cases, 
interviewees even responded to a question about relationships 
between science and the public entirely in terms of the press 
corps. 
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Interviewer: The first issue that we wanted to unravel a little 
bit is your views about the state of relationships between 
science and technology, and the public, in quite general 
terms. 
Andy Young: We do think it's a huge issue. I think the mass 
media represents science very badly. Most journalists are 
technically illiterate, and they don't seem to understand the 
difference between good science and rubbish. … Especially 
on the BBC, the dumbing-down of their science programmes 
has been appalling. 
Interviewer: Okay. And on the public side, or societal side, 
what do you think the results of this issue are? 
Andy Young: The results are that people believe things that 
are factually not true. They won't have their kids immunised, 
etc. There clearly is a lot of scaremongering going on. 
Although invited to respond in ‘general terms’, Professor Andy 
Young, a neuropsychologist and experimental psychologist, 
answered a question about science and its publics with a specific 
attack on the media, in which he describes ‘a lot of 
scaremongering’, ‘dumbing-down’ and technical illiteracy or 
incompetence on the part of journalists, which inevitably leads to 
the misrepresentation of science. In a familiar perception that is 
common among the interviewees, Young draws a direct link 
between misrepresentations in the media and what the public 
believes, with perceived costly results in terms of public behaviour, 
for example with respect to vaccination and other unstated 
matters. 
Other interviewees drew attention to the ways in which the media 
sensationalises scientific and medical issues. For instance, Dr 
Stephen Gentleman, an experimental neuropathologist 
specialising in Alzheimer’s disease, drew attention to the 
relationship between sensationalising hype in the media about 
scientific discoveries and medical breakthroughs and ‘disaffection 
with science’ among patients and the general public as a result of 
its perceived unreliability: 
Stephen Gentleman: I think one of the big problems is the 
press portrayal of science, it tends to be very sensationalised. 
In my own field, Alzheimer’s disease, unfortunately there’s a 
new cure every week in one or the other of the newspapers, 
which really just causes a lot of grief and I think people who 
are affected by these diseases just become disaffected and 
causes general disaffection with science. 
Other interviewees focused on the media tendency to exaggerate 
any problems that are produced by scientific, technological and 
medical research and developments. 
Sarah-Jayne Blakemore: Do you remember those six people 
who had a really bad reaction in that clinical trial? There are 
millions of people who go through clinical trials each year who 
don’t have any effects. But when they do have a bad effect, it 
makes front page news for many, many weeks, not 
surprisingly. But that over-represents what can go wrong in 
science. I think it’s very tied up in the media representation as 
well. But I’m not blaming the media. I mean the media just 
publish what we want to read, [laughs] what sells papers. But 
you can get the impression that a lot goes wrong in science, 
there’s a lot of dodgy stuff. But that’s just because that’s what 
makes the news [laughs]. 
Thus, Sarah-Jayne Blakemore employs the case of a disastrous 
clinical trial at Northwick Park Hospital, north-west London, in 2006 
to illustrate her view that negative stories are disproportionately 
emphasised in the media. However, while she suggests that this 
phenomena creates a public impression that ‘a lot goes wrong in 
science’, she also suggests that the behaviour of the media is not 
surprising and therefore the media should not be blamed. While 
not necessarily implying empathy toward such media strategies, 
Blakemore’s comments illustrate an understanding of media 
culture, its specific demands and an appreciation that what is 
‘newsworthy’ is not necessarily either representative or accurate 
(perhaps also implying that this is common knowledge and that 
people do not always believe what they read in the papers). Such 
examples of scientists’ understanding of the ways in which the 
media works are widespread in the data. Other aspects of media 
culture which – while not necessarily celebrated – were recognised 
by many interviewees were the media’s desire for balance within 
the reporting of a story even when considerable scientific 
consensus exists, and the ever-present potential for science 
stories to be reported or edited by non-science journalists. 
While interviewees recognised the obligation of the media to 
achieve balance between competing perspectives, Dr Glyn Stacey, 
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the Director of the UK Stem Cell Bank also noted some significant 
disadvantages to scientists of this tendency to equate certainty 
based on religious conviction with the inevitable uncertainties of 
technically complex areas of scientific research. 
Glyn Stacey: Very often you’ll see, arguments from both 
sides but the thing is that the argument from say a pro-life 
perspective is very clear, ideological and that’s just, this is just 
the position, this is what I believe, it’s a belief. Whereas the 
balance to that is the scientists who are saying, well you 
never know, this could be right and that could be right, maybe 
this could happen and maybe not. … They will qualify 
because that is the nature of their work, they will qualify 
whatever they say. So you’ve got someone who’s very clear 
and knows exactly what they think and, because it’s a belief, 
whereas somebody who’s dealing with technical issues and 
science, and knows that you can’t say this is definite and 
nothing is 100 per cent. And so I’ve always perceived that the 
public are going to get a view on what’s going on there but it 
may be not quite correct because you’re comparing apples 
and pears in the arguments that are being made. 
In discussing the question of balance, Stacey contrasts  the 
unequivocal manner in which pro-life commentators present their 
arguments, which are rooted in religious conviction, and the more 
equivocal or qualified communication style of scientists, which is 
rooted in the scepticism integral and doubt integral to their 
scientific training. From Stacey’s perspective, this contrast in styles 
– unequivocal versus equivocal – has the potential to create a 
false impression in the minds of the public, and indeed to 
undermine the ability of scientific fact to be considered reliable, 
stable or factual. This is one of a number of ways in which 
scientists’ awareness of the extent to which, while compelling in 
scientific contexts, scientific ways of knowing and communicating 
are easily rendered less adequate in mainstream public culture. 
In many interviewees’ observations, such understandings were 
reflected in discussions of particular strategies developed through 
experience or training for coping with the demands of the media. 
Clive Ballard: When you're sort of working through the 
medium with journalists, they're trying to make the story 
interesting or exciting, and once you've done that work for a 
while, you realise that you've got to give them something 
that's a story, otherwise it's not going to work. So I think the 
challenge is often to try and sort of make a story that's not 
scientifically inaccurate, and is interesting, but conveys a 
reasonable amount of the factual material that you want to 
convey. 
In this comment, for instance, Professor Clive Ballard, who 
specialises in dementia, underscores the value of his long-
standing experience of working with the media in achieving 
desirable outcomes. In addition, he emphasises the importance of 
understanding the needs of the journalist (an ‘interesting or 
exciting’ story) and meeting these in conjunction with the 
objectives of the scientist (to not be ‘scientifically inaccurate’ and to 
convey ‘factual material’). 
 
A public that is negatively mediated by other  
malign social actors 
Alongside the media, interviewees mentioned three other 
categories of prominent social actors that negatively mediate in 
relationships between science and the public. As illustrated by the 
comments of David Porteous, prominent among these is a range 
of civil society groups, variously described by interviewees as 
activists, lobbyists and pressure groups that are opposed to 
specific scientific projects or practices such as animal research, 
stem cell research or agricultural biotechnology. In common with 
previous research, such groups were described by some 
interviewees as representing an anti-science, anti-rational or 
emotional perspective, often rooted in religious or political 
ideology. 
David Porteous: I am conscious of the fact that the power of 
lobby groups has also increased dramatically; they’re very 
vocal, committed lobbyists. Usually, although broadly 
speaking, of a Luddite nature and anti-science nature, are 
able to halt the progress of research in a way which I don’t 
think matches or adequately reflects true public opinion. 
Like other interviewees, Porteous here expresses a partially 
negative, ambivalent view of activist groups who, while vocal and 
committed, may be able to restrict scientific progress in a manner 
that is not strictly representative of the views of the wider public 
(‘true public opinion’). Mixed together in this view of so-called ‘anti-
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science’ lobbyists is the recognition that such groups comprise one 
of science’s most vocal public audiences and are part of the 
dialogue, but with a worrying power to halt the progress of 
research in a manner that has ‘increased dramatically’. 
Other interviewees emphasised the malign influence of 
corporations as mediators between science and the public – most 
notably Monsanto, the agricultural biotechnology firm – and a 
range of pharmaceutical companies that were repeatedly cited in 
this regard. However, while most interviewees understood the 
malign mediation of civil society groups as deliberate and did not 
share the positive perceptions of these groups that the 
interviewees attributed to the public, the negative impacts of 
corporations were seen as inadvertent, and interviewees largely 
shared the apparently negative public perceptions of these 
corporations. 
Robin Lovell-Badge: Monsanto started damaging the whole 
field by marketing things in an aggressive way without telling 
people that it was genetically modified. And then this whole 
complex issue of, for example, they were selling seeds which 
were, you could grow whatever crop from, but then the 
farmers couldn’t take seeds from those because, essentially, 
they were sterile – yeah, terminator gene and all that. 
Like many scientists and politicians, particularly in the UK, Lovell-
Badge views the actions of Monsanto as having had a direct 
negative impact on public perceptions not only of agricultural 
biotechnology but the ‘whole field’ of biomedicine and bioscience. 
Like many scientists, he also draws a distinction between the 
antagonism directed at Monsanto for its marketing strategy (selling 
products to people without telling them they were GM) and its 
science (genetically engineered crops), which was confused by 
association with terminology such as ‘terminator gene’ and its link 
to intellectual property protection. 
The final prominent category of malign actors that interviewees 
cited as negatively mediating in relationships between science and 
the public is that of scientists and clinicians who commit 
conspicuous acts of malpractice or error. The well-known incidents 
relating to Alder Hey Children’s Hospital, Bristol Royal Infirmary, 
Northwick Park Hospital, Hwang Woo-Suk, Arpad Putzai and 
Andrew Wakefield were variously mentioned by interviewees as 
causes of lapses in public support for projects in science, 
technology and medicine. In this context, drawing on cases within 
his own field, Dr Stephen Gentleman laments the impacts of two 
specific sites of controversy – in this case, regarding the retention 
of human materials by pathologists – on public perceptions of 
pathology. 
Stephen Gentleman: Sure, I mean there are cases, 
obviously, in the recent past of bad eggs in the scientific field. 
We’ve had, again in my own field, there’s been various 
pathological problems in terms of Alder Hay, Bristol, and that 
has put an unfortunate slant on pathology which is a vital 
discipline but perhaps is seen as something a little bit 
unnatural, so we have to redress that in terms of the PR for 
pathology. 
In this case the combination of a specific field’s ‘unnaturalness’ 
with the inappropriate conduct of specific individuals is seen to 
have created a situation in need of redress. Here, the malign 
intermediaries disrupting public confidence in science may 
originate within its own ranks. Other interviewees also described 
the possibility that negative public perceptions of science, 
technology and medicine may be partly rooted in aspects of 
scientific culture or in individual scientists. 
Hilary Burton: I think there’s a danger of too much hype. … I 
think a lot of it comes from the scientists and then I think a lot 
of it actually comes possibly from the media as well … It’s 
stated quite often really that in some ways scientists have to 
hype the potential advantages that are going to come from 
their work, in order to get them funded. And so then that gets, 
I think, picked up by the media, and by the public. 
Dr Hilary Burton, a consultant in public health medicine, identifies a 
process of exaggeration or hype of the promise of medical 
research that is both familiar to scientists and recognised as a 
source of potential ‘danger’. This process begins with the 
requirement by funders of medical and scientific research that 
researchers identify potential benefits of their research, an 
incentive to which researchers inevitably respond in a future-
oriented bidding war in which the currency is therapeutic promise. 
Dr Stephen Gentleman identifies a different aspect of this network 
of hype that appears to have its source in established aspects of 
scientific culture. 
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Stephen Gentleman: And, of course, in the science press, all 
breakthroughs are trumpeted and one of the big ones in stem 
cells was the South Korean scientist who claimed to have 
cloned human cells and it turned out he’d falsified the results. 
Sadly, you can see to some extent what might have pushed 
him towards that, in no way excusing it, but the pressure to 
publish within the scientific community, to maintain a profile, 
to maintain your job, is quite strong, and, as I say, while I can 
see why it might have happened, I don’t condone it, it is a 
problem. The expectations are there to produce all the time in 
a society that’s going faster and faster. 
Here, Gentleman refers to the famous falsification of scientific 
research results by the South Korean stem cell scientist, Hwang 
Woo-Suk, through the early 2000s. While merely implying the 
impact of public views in this comment, like Burton, Gentleman 
identifies a link between the trumpeting of scientific results in the 
media and the exaggeration – and, in this case, wholesale 
falsification – of results by Hwang. More notably, Gentleman 
explicitly links Hwang’s actions to pressure from within the culture 
of science, or the scientific community, to publish and produce in 
order to maintain and advance a scientific career. 
 
Summary 
The study found that interviewees provided largely positive, 
complex and nuanced accounts of relationships between science 
and the public, from a wide range of perspectives and across 
many different contexts. These accounts were replete with 
analytical distinctions between different manifestations of science, 
different categories of publics, different categories of actors within 
society, different categories of actors within these categories, and 
scientists’ own experience-based understandings of relationships 
between science and the public. 
In examining scientist interviewees’ discussions of the 
relationships between science and the public, a noticeable theme 
is the extent to which scientific, technological and medical issues 
are now considered to be subject to public opinion, debate, 
scrutiny and permission. In addition, although contrary cases are 
readily identified by scientists, the public is described as being 
generally supportive of developments in science, technology and 
medicine. Interviewees often evoked an increasingly 
knowledgeable and capable public, in both specific and general 
contexts, and were depicted as active knowledge-seekers who 
could improve the professional practice of medical scientists 
through dialogue such as that undertaken at the clinical interface. 
However, the interviewees also provided a range of accounts of 
why lapses in public support for scientific and technological 
projects continue to occur and cause damage to both science and 
society. While inadequate public understandings of science and 
scientists were often mentioned in this regard, interviewees also 
often emphasised the roles of a range of other malign mediating 
social actors (including the media, civil society groups, 
corporations and errant scientists, clinicians or researchers). It is 
highly notable that scientists often understood – and sometimes 
even empathised with – the reasons behind these perceived 
misunderstandings of the public and misrepresentations of 
science. In some cases, the roots of such misunderstandings and 
misrepresentations were sometimes traced to roots within the 
culture of science itself. 
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CHAPTER 5 SCIENTISTS ON: THE  
ACTIVITIES AND OBJECTIVES OF  
PUBLIC ENGAGEMENT 
 
The activities of public engagement and 
public dialogue 
As illustrated in the three comments below, ‘public engagement’ is 
generally understood by interviewees as an umbrella term for a 
wide variety of activities that are undertaken by scientists. This is 
reflected in the extent to which some interviewees employed the 
term ‘public engagement’ interchangeably or synonymously with 
other terms such as ‘public understanding of science’, ‘science 
communication’, ‘science education’ and ‘outreach’. As the 
following extracts demonstrate, the findings of this study confirmed 
a simultaneously wider and more nuanced view of public 
engagement, accompanied by sensitivity in some cases about the 
use of the term. 
As Sarah-Jayne Blakemore indicated in response to a request by 
the interviewer to list her public engagement activities, these vary 
widely and require several different types of communication skills. 
Sarah-Jayne Blakemore: So, any kind of media work, but 
also giving public lectures. … Ah, writing a book that’s 
accessible to non-specialists, giving talks in schools, working 
with policy makers, also with people in parliament or 
whatever. 
In common with most interviewees, the first activity that Blakemore 
mentions as a public engagement activity is media work. This was 
frequently described by interviewees as an important reactive and 
proactive activity, including news and documentary work with 
newspapers, magazines, radio and TV at local and national levels. 
Most interviewees also cited participation events at which public 
speaking is emphasised as an important part of their public 
engagement activities. This category of public engagement activity 
includes events described as public talks or lectures, which might 
be understood to consist of relatively little interaction. However, it 
also includes public debates, discussions, Question Time 
scenarios or Café Scientifiques, in which actual interaction, or 
dialogue, with members of the public play a larger role. Many such 
engagements are one-offs, while others are part of larger events, 
such as science festivals. Public engagement work in schools, and 
with children and young people, was also regularly cited by 
interviewees, including work with teachers and pupils in schools 
and colleges or with parents and parent groups. 
Kay Davies: Public engagement might include visiting 
schools, talking at science festivals, going to parent groups 
and try to understand what medical advances can do for their 
particular genetic conditions, going on the radio. 
Since many of the interviewees are funded by medical research 
charities and patient groups, work with these organisations 
comprises a key area of public engagement and outreach for many 
of them. Thus, as indicated in the above comment by Kay Davies, 
who works on the genetic bases of Duchenne muscular dystrophy, 
speaking at events organised by patient and carer groups and 
medical research charities is an important form of public 
engagement both for scientists and their funders. 
Dylan Edwards: We also have a local cancer charity that 
works very closely with us. So, they and ourselves want to get 
exposure to the public, so they know that there is work going 
on here, it helps with fund raisings and things. The last 
Tuesday of every month, we have an open day and, and the 
public comes in usually in groups of about a dozen or so, and 
we show them what’s going on in the afternoon. And both 
Caroline and I go off and make talks. 
Public engagement links with medical research charities are also 
stressed in this extract from an interview with Professor Dylan 
Edwards, a geneticist working on cancer. In common with many 
interviewees, Edwards also cites ‘open lab’ events, in which both 
adults and children are invited to visit a scientific laboratory, as an 
important aspect of public engagement. Other activities less 
frequently described by interviewees as forms of public 
engagement include work with politicians, civil servants, lobbyists, 
regulators, policy-makers and government officials; sci-art 
collaborations and other cultural events such as museum exhibits, 
film festivals and book fairs; and work with science centres and 
science festivals, such as those mentioned above. Finally, some 
interviewees discussed their clinical and research activities (as 
well as their teaching, which might be applicable in broader areas 
of science) as forms of public engagement.13 
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 Notably, although some interviewees included references to their 
teaching and other academic work, such as public lectures, in lists of their 
public engagement activities, none cited their involvement in social science 
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While interviewees’ understandings of the activities of public 
engagement include participation in a wide range of events and 
interactions, these also remain limited to relatively formal contexts, 
almost all of which are planned in advance and occur outside 
scientists’ normal working environments. Scientists’ interactions 
with the media are the major exception to this, and it is notable that 
interviewees expressed more concern about the media than any 
other area of public outreach (see the discussion in Chapter 6). 
In somewhat paradoxical contrast to the increasingly varied types 
of activities described under the public engagement umbrella, this 
study also found evidence of awareness of a need for increased 
precision in the use of the terms ‘public engagement’ or ‘dialogue’ 
as opposed to previously popular terms. As Professor Austin 
Smith, a stem cell scientist, noted in his interview, ‘public 
engagement’ has the additional significance of being an alternative 
to, or successor version of, ‘public education’, the use of which has 
become indexical of a now outdated and stigmatised category. 
Austin Smith: Now it seems to be considered politically 
incorrect to talk about public education. 
Smith’s observation that it is now politically incorrect to refer to 
‘public education’ not only confirms that this has become a 
negatively charged term of reference, but also signifies a broader 
shift. A more succinct summation of the ‘sea change’ 
encompassed by the shift from deficit to dialogue would be difficult 
to find. Through such comments, public engagement emerges as 
an activity that not only complements but replaces a former 
paradigm. His observation is consistent with the wider findings of 
the ScoPE project that ‘public engagement’ has undergone a 
transformation as part of an evolving value system within the 
scientific community, in which a breach has opened up between 
former deficit models and emerging dialogue paradigms. This is 
precisely the shift at the policy-level discussed in Chapter 1 – from 
the model of communication and education as one-way ‘input’ to 
the model of engagement and dialogue, alongside communication 
and education, as a two-way system of exchange and reciprocity. 
                                                                                
 
 
research, despite the fact that a good deal of such research involving 
scientists, such as the ScoPE study, is directly concerned with public 
engagement and often funded under public engagement rubrics. 
While explicit reference to this policy trajectory by interviewees 
was rare in the interviews (and the topic was not raised by the 
interviewers), David Porteous offered the following account of 
where science ‘went badly wrong in the early days of so-called 
public understanding of science’: 
David Porteous: Where I think we went badly wrong was in 
the early days of so-called public understanding of science in 
the 80s, when there was a strong feeling that there was a 
revolution taking place in the biosciences, and particularly in 
relation to genetics and medicine. And there was this sense 
that if only we taught the public how to understand science, 
they would appreciate what we were doing. Personally, I think 
that that was such a misguided approach to take; what we 
want to do is to find ways in which we can engage with the 
public and really they’re multiple publics. And, I think, that 
recognising that and knowing you need to be available to 
answer questions, as opposed to answer the questions you 
think the public might be interested in. 
Porteous’s observations, like those of Smith previously, helpfully 
condense some of the key components of the shift from deficit to 
dialogue among scientists that we attempt to characterise more 
fully in this report. Among the many important features of 
Porteous’s observations are the relationships he establishes 
between the sense of revolutionary zeal among scientists about 
the promises of biomedicine, the ‘misguided’ effort to teach the 
public to understand its importance, and the subsequent failure to 
comprehend the social character of interaction not with ‘the’ public, 
but with many publics. Essentially a corrective observation, 
Porteous’s brief account of what went ‘badly wrong…in the 80s’ 
directly pinpoints a failure to appreciate the two-way nature of 
relationships between science and public, and a subsequent 
learning process here marked by a distinctive before and after. 
This view, however, was not universally shared, and despite 
awareness of the deficits of the so-called deficit model, some 
scientists were equally wary of ‘throwing it out completely’. 
Alison Stewart: I suppose the only thing that immediately 
comes to mind is the discussion about what people call the 
knowledge deficit model of public engagement or involvement 
or whatever. The idea that if only people knew more about it, 
all these worries would go away. I don’t really know how that 
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debate is developing at the moment. I haven’t read a lot about 
it in recent years but it seemed to me that that went way out 
fashion, we weren’t allowed to think that way. But I don’t think 
you can throw it out completely, I really don’t. … I think that 
you can’t get anywhere having a sensible discussion unless 
people are up to speed, at least to some extent, about the 
science. And I just think it’s going to be a big problem. How 
are people going to evaluate things, critically, if they just don’t 
know enough science to be able to do that. You have to 
understand a bit of basic cell biology to understand, for 
example, what cloning is. And I think very few people have 
that. 
Like Smith and Porteous, Dr Alison Stewart, a specialist in public 
health genetics, suggests that certain modes of thinking about or 
acting on relationships between science and the public, such the 
deficit model, have become unfashionable or even unacceptable. 
Perhaps less explicitly than Porteous, Stewart also illustrates that 
she supports the development of novel modes of public 
engagement in which discussion and critical evaluation are 
emphasised. However, Stewart also suggests that, while 
remaining sceptical of the deficit model assumption that greater 
public understanding will necessarily deliver fewer public concerns, 
it is a mistake to reject the idea that enhanced public 
understanding of science – getting people ‘up to speed’ -- is not 
part of a ‘sensible’ discussion about science, nor that the absence 
of adequate scientific literacy is not still ‘a big problem’ . 
Although explicit comments such as those by Porteous, Smith and 
Stewart were rare, interviewees’ awareness of the issues raised in 
policy circles by the ongoing emergence of public engagement as 
an important and increasingly widespread institutional and policy 
commitment is frequently evident in less direct comments 
throughout the data. Indeed, this sense of shared concerns among 
policy actors and scientists – for instance with respect to 
evaluation and reward – was palpable at the ScoPE workshop in 
June 2009, at which policy actors and interviewees met with social 
scientists and ScoPE researchers to discuss a preliminary draft of 
this final report. 
In contrast to the familiarity of the term ‘public engagement’, 
interviewees were relatively unfamiliar with ‘public dialogue’, the 
expression that is most often used within UK institutions of science 
governance to denote structured deliberative discussions between 
scientists and members of the public with specific policy contexts 
in mind. Indeed, although approximately half of the interviewees 
had participated in such processes, these events were not always 
instinctively categorised by those interviewees under a separate 
category of ‘public dialogue’. Instead, the term ‘public dialogue’ 
was understood by interviewees in the ordinary sense of 
‘dialogue’, as in conversation or discussion, involving a ‘two-way’ 
process, exchange or interaction. 
Interviewer: What does public dialogue mean then, for you, 
Catriona? 
Catriona Morrison: That suggests some kind of discussion 
about what scientists might engage in, research-wise. I’m just 
thinking that public dialogue is more about a sort of two way 
process. Actually, Meeting of Minds is public dialogue. 
The experimental psychologist Dr Catriona Morrison was 
interviewed for the ScoPE project because she had participated in 
the Meeting of Minds project, subtitled ‘European Citizens’ 
Deliberation on Brain Science’. In her initial thoughts, Morrison 
illustrates several aspects of many similar comments by other 
interviewees, or even a more general process of social evolution 
from engagement to engagement-as-dialogue. Initially, Morrison 
engages with the term ‘public dialogue’ on the basis of the 
meaning of the word ‘dialogue’, as opposed to a specific type of 
engagement activity (eg a Public Dialogue event). She suggests 
that this might be a discussion in which scientists learn about the 
public’s views, ‘research-wise’. Latterly – as her thoughts develop 
– Morrison emphasises that public dialogue is distinguished by a 
‘two way process’. Considering the matter still further, Morrison 
defines public dialogue in terms of her own experience of a 
specific activity, the Meeting of Minds project. Her third sentence – 
‘Actually, Meeting of Minds is a public dialogue’ – concretises the 
meanings of the first two parts of her definition – ‘some kind of 
discussion...scientists engage in’ that is also a ‘two way process’ – 
that, in any event, she has herself participated in. Here again, the 
importance of first-hand experiences of engagement activities is 
shown not only to reinforce their value, but to reshape their 
definition in the minds of individual scientists. 
 
  
 
38 
The objectives of public engagement and 
public dialogue: getting science done 
While important in their own right, many interviewees described 
the value of public engagement and public dialogue activities as 
part of the more generalised goal of promoting scientific progress. 
In this sense, the importance of such activities could be seen as 
part of the broader sense of science as a vocation often driven by 
a strong sense of moral purpose and obligation.14 In accounts of 
their reasons for participating in such activities, interviewees 
typically described a range of interwoven objectives, imperatives or 
interests embedded in an ethos of promoting science, and the 
benefits of scientific research. 
Kay Davies: The pharmacogenetics dialogue had two 
purposes. It served to educate that small section of people in 
pharmacogenetics. It was also a survey to see how 
acceptable that type of technology was likely to be, so it was a 
consultation if you like. … In addition, it served to promote 
science in the public eye because we’re making policy in 
partnership rather than on our own. 
This multiplicity of objectives is reflected in the above comment by 
Kay Davies, who participated in the Royal Society 
pharmacogenetics public dialogue project. Here, Davies responds 
to a query about the objective of that project. Although she 
suggests the project had a ‘dual purpose’, Davies here identifies 
five separate objectives. First, she identifies a communication or 
education objective, albeit among a ‘small section of people’, with 
respect to pharmacogenetics. Second, she suggests that the 
project was designed to test-drive the public ‘acceptability’ of 
pharmacogenetics, and, third, through use of the term 
‘consultation’, she implies that public views may be taken into 
account in the development of pharmacogenetics technologies. 
Notably, through use of the word ‘really’ here, Davies indicates that 
these are perhaps the stated institutional objectives of the 
exercise, while the other objectives are perhaps tacit, unstated or 
personal. Outside of the specifics of pharmacogenetics, Davies 
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 As Max Weber famously argued in his influential essay, ‘Science as  
Vocation’, the distinguishing fate of science, and thus scientific work, is that 
it is ‘chained to the course of progress’, thus also stating the progress is its 
central value, as well as its instrumental purpose (Weber 1968:137). 
then identifies one or two further objectives that serve science 
more broadly. Thus, as her fourth objective, Davies suggests that 
public dialogue helps to promote science ‘in the public eye’. 
Finally, through her observation that this is the case because 
‘we’re making policy in partnership rather than on our own’, Davies 
evokes a fifth objective related to the ideals of participatory 
democracy. 
Notably, and in common with many of the interviewees’ comments 
on this issue, Davies’ understands the objectives of public 
engagement to be embedded within the context both of a specific 
area of scientific research and the promotion of science in general. 
Thus, within the context of pharmacogenetics, a therapeutic 
approach still in its infancy and not widely known among the 
general public, public engagement is used for educative, test-
driving and consultative purposes as part of a wider process of 
innovation in the governance of science. In the sections that follow, 
these objectives and others are examined in more detail. 
 
Putting the record straight 
It will be recalled from Chapter 4 that many interviewees perceive 
a social terrain that is to some extent populated by individuals who 
do not understand scientific and medical issues or the way science 
works, often because of the intentional or unintentional 
dissemination of misinformation by a range of social actors (such 
as the media or certain activist groups). With these social 
conditions in their minds, many interviewees spoke about public 
engagement and public dialogue in terms of improving public 
understanding with respect to a wide range of issues relating to 
science, technology and medicine. The notion of putting the record 
straight emerges for interviewees as an important objective of both 
public engagement and public dialogue. 
Chris Frith: First of all, I think it's very important that people 
like me, who are actually doing the experiments, should 
interact with the public. … Because if I don't tell them what I'm 
doing, somebody else will. … And may not get it quite right. 
Here, Frith suggests that it is ‘very important’ for scientists – or 
‘people like me, who are actually doing the experiments’, as he 
puts it – to ‘interact with the public’ with the explicit objective of 
pre-empting the dissemination of misinformation by other social 
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actors. Dian Donnai describes this ‘bit of work that needs doing’ as 
the management of public expectation. 
Dian Donnai: So the actual clinical utility of that sort of 
knowledge is probably going to take awhile to actually come 
through, and yet the announcements are there: a gene for 
Alzheimer’s, a gene for diabetes, a gene for this, a gene for 
that, and, actually, that’s another bit of work that needs doing, 
is managing the public, whatever the public is, managing the 
public expectation. 
In this comment on her general objectives in public engagement, 
Donnai again draws upon her experience as a clinical geneticist to 
focus on the problem of hype, often associated with genetics 
research, that was discussed in the previous chapter. In particular, 
she draws attention to the unrealistic public expectations that are 
created by the lengthy time lag between public ‘announcements’ of 
the identification of specific genes and the realisation of the 
‘clinical utility of that sort of knowledge’. In the following interview 
extract, Robin Lovell-Badge similarly draws attention to the use of 
public engagement to counter public misunderstandings of 
controversial research areas, such as stem cell science, and 
contentious medical interventions, such as the MMR vaccine. 
Robin Lovell-Badge: Again to, just to try and make them 
appreciate what science is about. Why scientists will never 
say, this is impossible, this is absolutely going to work, 
because we can’t. We can’t, science never deals in absolutes 
in that way. We always have to be a little hesitant, which can 
be misinterpreted. We’ll never say something’s impossible, 
even if we think it’s very, very, very difficult. We can’t say it’s 
impossible because we are always being surprised by new 
things. And that itself is something that, so, if you ask a 
scientist, is MMR dangerous or is it perfectly safe? Well, we’ll 
say, it’s probably not dangerous, and yes, we think it’s very 
safe. But they’re never going to say, yes it’s absolutely 100 
per cent safe, because you never know, right? But the risks 
are incredibly minute that it’s going to be unsafe. So [public 
engagement] is getting across things like that, how scientists 
think and work. It’s getting across why, some might say, we 
have adult stem cells; why aren’t you doing this work on 
adults? Why do you want to work on embryonic stem cells, 
which means destroying embryos, and why can’t you do it on 
adult stem cells? It’s because often they have picked up half-
truths on what’s possible with adult cells, and so again, they 
can’t make up their minds about technology if they don’t 
understand it. Now, we are, so we’re trying to be proactive in 
making sure that they understand particular areas of science. 
In this comment, in which he responds to a question about his 
objectives at public meetings, Lovell-Badge (like Blakemore 
earlier) first cites a number of misconceptions that he feels the 
public may have with respect to ‘what science is about’ or ‘how 
scientists think and work’. To make these points, and reiterating 
upon themes that have already been discussed, Lovell-Badge 
draws upon the contemporary scientific and medical controversy 
relating to the MMR vaccine, arguing that part of the explanation 
for the controversy lies in the public misinterpretation that arises 
when scientists are ‘hesitant’ rather than speaking in ‘absolutes’. 
With these concerns in mind, Lovell-Badge then states that one of 
his objectives at public meetings ‘is getting across things like that, 
how scientists think and work’. Drawing upon his own experience 
in the context of public understanding of stem cell research, he 
focuses on public misunderstandings relating to ‘half truths on 
what’s possible with adult cells’, indicating that his objective in 
public meetings is to respond to and correct such 
misunderstandings. As he puts it, ‘we’re trying to be proactive in 
making sure that they understand particular areas of science’. 
Other interviewees discussed public engagement in terms of 
responding to the potential for the public to have faith in therapies 
that they themselves consider to be dubious. 
Stephen Minger: You know, they'll call me up and say, I just 
saw this clinic in Barbados, it's doing X, Y, and Z. Should I go 
there? And it's, like, no, of course not, you know. Why do you 
think it's in Barbados or in Tijuana or in India and not here. 
So, I mean, I think they are susceptible to hype in many 
respects, and also susceptible to people who sell snake oil. 
But I think [public engagement] is one thing I do that I think is 
really crucial, and I do it as often as I can. 
Here, Stephen Minger discusses a particular objective of his public 
engagement work with patient groups. More specifically, he notes 
that the individuals that he meets in such interactions can be 
‘susceptible to hype’ and to ‘people who sell snake oil’, in the form 
of dubious therapies that are not available in the UK, thus 
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reinforcing his view that public engagement ‘is really crucial’ and 
that he does it as often as he can. Dr Caroline Pennington, a 
researcher specialising in the genetics of cancer, makes a similar 
point in the extract below about the value of the ‘open lab’ events 
that she and her colleagues undertake, and also raises the issue 
of ‘alternative medicine’. She describes the value of ‘open lab’ 
visits in direct proportion to her annoyance about ‘bad science, and 
the bad way it’s reported’, noting that ‘taking people around the 
lab’ provides her with the opportunity to put the record straight, or 
to ‘redress that a little bit’ by emphasising the untested claims 
about alternative medicine. 
Caroline Pennington: The other reason I think that I enjoy 
doing that is because it does really annoy me about the bad 
science, and the bad way it’s reported. And taking people 
around and explaining things is a way to redress that a little 
bit. So, you know, the alternative medicine side of things, 
when things haven’t been rigorously tested, and people ask 
us about that a lot when they come and look around the lab. 
And then I can explain why we wouldn’t have faith in it, and 
why it hasn’t been tested, and the scientific experiments you 
might have to do to test these things. 
Chris Frith also makes this point within the context of his 
experience of the Meeting of Minds deliberative event on brain 
science. 
Interviewer: Why did you get involved? Why did you say 
yes? 
Chris Frith: I'm more and more interested in talking about my 
work to more general audiences. And also, in this particular 
case, I thought it was important, as I was saying before, that 
there are a lot of misapprehensions about what brain imaging 
can actually do and I wanted to find out whether people really 
did have funny ideas and try and correct them. 
In response to a question about his motivations for participating in 
the Meeting of Minds event, Frith describes multiple goals, 
including the correction of ‘misapprehensions about what brain 
imaging can actually do’. However, in the two-way spirit of 
dialogue and deliberation, Frith also confirms that, at the same 
time, he hopes to learn something himself, in this case ‘whether 
people really did have funny ideas’ about brain science. Thus, in 
what emerges as a pattern of responses in the data set, an 
important source of the two-way value of public dialogue and 
engagement is not only to provide a context to apply pre-emptive 
corrective strategies, but to check – or test – if these are indeed 
necessary. 
Finally, a number of interviewees’ accounts of the imperatives of 
public engagement are embedded within their sense, as discussed 
in the previous chapter, that the public often has misconceptions of 
the value of science and scientists. Thus, many scientist 
interviewees described part of the value of public engagement 
events in terms of the opportunity to convey the sheer excitement 
and satisfaction that can be derived from scientific enquiry. Thus, 
for example, Stephen Minger emphasises the importance of 
providing inspiration to students as part of the effort to increase the 
public appreciation of science as a vocation, through public 
outreach to schools: 
Stephen Minger: It's, A) I want the students to understand 
what we do scientifically. But, B) I also want them to see that 
science is, is great. You know, that it's exciting, it's 
challenging, it's fun, it's cool. It's not geeky. You know, you 
can be a geek and be cool. You know, you're trying to inspire 
the next group of scientists. 
In his comment, Minger asserts that understanding science is 
about not just understanding how science is done, or the social 
value of science, but also the pleasure and pride scientists’ take in 
their activities, and their sense of pursuing a career that is fun, 
exciting, challenging and even ‘cool’. Reversing the stereotype of 
science as ‘geeky’ to celebrate science as ‘cool’ both 
acknowledges its negative perception as ‘uncool’ and seeks to 
challenge this. 
 
Building public support and  
securing funding 
As noted earlier, many of the interviewees identified the objective 
of public engagement as instrumental in building public support for 
– and public appreciation of the value of – specific and general 
scientific and medical projects. 
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John Burn: So basically, I think the message is, if you meet 
the public in an intelligent and sensible way, tell them what 
you are doing and why you are doing it, and as long as what 
you are doing is reasonable, then the British public is 
supportive. 
Professor John Burn is a senior clinical geneticist at the Centre for 
Life in Newcastle. In this comment, he provides a succinct 
rationale for public engagement activities that also describes an 
underlying principle of exchange: in exchange for meeting the 
public in an intelligent and sensible way and providing a 
reasonable explanation of what you are doing, the British public 
will support your research. Notably, although this explanation turns 
on the provision of a ‘reasonable’ account of a scientist’s activity, it 
also relies on basic social models of courtesy and politeness. 
Implied in his comment are three primary deficiencies that can lead 
this exchange to fail, namely treating the public as unintelligent, 
not meeting with the public, or failing to provide a reasonable 
explanation of one’s research. Also noticeable in what is clearly a 
two-way model is its symmetry, summarised by the word 
‘sensible’: if one party is sensible, the other is likely to be also. 
For Dr Lyle Armstrong, a colleague of Burn, and one of the two UK 
scientists to be granted a licence to conduct hybrid embryo 
research, due emphasis must also be placed on explanations of 
what scientists are not doing. As Armstrong’s account illustrates 
below, the sense for interviewees that public engagement is as 
much about explaining what scientists are ‘not trying to’ do as it is 
about explaining what scientists ‘are actually trying to do’ is 
particularly relevant in some areas. Once again, Armstrong draws 
a direct link between scientists taking time to meet with the public 
and give reasonable explanations of their science, and the public 
support that is needed to pursue their research. 
Lyle Armstrong: Once we explain to people what we are 
actually trying to do, and that we’re not trying to make some 
kind of weird chimera animal, which is half cow and half 
human, then people, once they have understood the concepts 
behind it, are often very supportive. 
Evident in such comments are not only the social logics of 
exchange (in exchange for courtesy, good reason and good sense, 
the public will show goodwill), but an explicit recognition of science 
as being, in some respects, the subordinate partner in a 
relationship often characterised as the opposite (in which science 
is the more powerful of the ‘Science and Society’ pair). As Austin 
Smith’s comments below also indicate, this evolved understanding 
of the need for continuous interaction with the public 
acknowledges a recognition of indebtedness (science is 
dependent on the public) and that of an animated and contested 
social context in which scientists cannot afford to take public 
support for granted. 
Austin Smith: But I think the thing that really makes a 
difference for, at least for myself, and I think it’s true for many 
scientists, is that we are aware now that we are dependent on 
public funding whether that’s from the government or from 
charities, and that that makes us vulnerable to public opinion. 
The public opinion is volatile, easily misled; we’ve seen that 
with views about animal research and we’ve seen that with 
views about genetic modification. Which is not to say the 
public don’t have legitimate concerns, just as with embryo 
research, but scientists have to get out and articulate what 
we’re trying to do, and why it’s good and why it’s for the 
benefit of society, because it’s clear if we don’t, there’s plenty 
of other people who’ll stand up and say this is evil, monster-
creating stuff. 
Significantly, like Burn and Armstrong, Smith conducts research 
with embryonic stem cells. In his comment, Smith argues that 
‘scientists have to get out and articulate’ the benefits of embryonic 
stem cell research so that misleading information about the 
research is not left to occupy centre stage and so that the 
legitimate concerns of the public can be addressed by the scientific 
community itself. 
Other interviewees discussed the relationship between public 
engagement and funding within the context of their work on 
specific diseases and conditions, and their resulting relationships 
with medical research charities and patient groups. 
Clive Ballard: But I suppose doing that work for the 
Alzheimer's Society, it's not just about public information, a lot 
of it's about promoting awareness of Alzheimer's disease 
specifically, and also of the organisation specifically. As a 
charity, they’re clearly reliant on public interest, public 
support, public donations, so it's important that the public are 
aware of the organisation and what they do. 
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Clive Ballard holds a university post and is Director of Research of 
the medical research charity and patients’ organisation, the 
Alzheimer’s Society. Initially, once again, Ballard alludes to the 
core objective of public engagement as a means of conveying 
information about the work done by the Alzheimer’s Society. He 
then describes public engagement as a means of raising 
awareness of the disease and the organisation with the objective 
of securing the ‘public interest, public support, public donations’ 
that support his research and the other activities of the 
organisation. This therefore positions his scientific activity not only 
as part of society but as part of a social fabric in which patient 
groups and charities play a beneficial mediating role in the 
promotion of scientific progress.15 
Here, Stephen Gentleman, who also works on dementia and has 
strong links to the Alzheimer’s Society, discusses the relationship 
between public engagement and funding in slightly different terms. 
Interviewer: Is this an aspect of developing programmes that 
are funded? 
Stephen Gentleman: Yes, obviously funding is part of what 
you’re at in trying to raise the profile and if you put in the grant 
application that you’ve been part of these consultation bodies 
or whatever, that you have some insight into the real 
problems. You’ve engaged, you’ve found out that there’s a 
problem, and you’ve had some public engagement. I think 
that really helps. 
Here, Gentleman states that he conducts public engagement partly 
to ‘raise the profile’ of his work among funders, adding that his 
public engagement activities are helpful in preparing grant 
proposals (the rising importance of public engagement activities in 
grant applications is discussed in more detail in the following 
chapter). At the same time, however, he stresses the importance 
of public engagement work to the scientific quality of his grant 
proposals, emphasising that it gives him ‘insight into the real 
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 The charitable organisation working in support of reproductive 
biomedicine and embryo research, the Progress Educational Trust, both 
provides a good example of the type of ‘mediating constellation’ of social 
actors that can be highly effective in promoting scientific research, and 
embodies in its name what Max Weber (1968) described as the defining 
social value of scientific activity. 
problems’ that people experience. It is worth adding here in 
relation to many of the comments presented above that several 
different senses of ‘translation’ can be seen to be at work in this 
and other similar contexts mentioned by interviewees. The 
translation by the scientist of his or her work serves to facilitate its 
progress, while the translation by patients to researchers of their 
needs may improve the design of scientific research. Both of these 
translation processes, in turn, may contribute to the current sense 
of scientific translation as the process whereby basic scientific 
discovery is ‘translated’ into applications that directly benefit 
patients and other users. Indeed, at the heart of the translational 
promise (for example from the perspective of HM Treasury) is a 
two-way, or reciprocal, ‘virtuous circle’, in which public support for, 
and investment in, basic science research will provide a ‘return’ of 
health and wealth benefits for all. 
The suggestion that something like a model of this type is in the 
minds of many of the interviewees, according to their descriptions 
of engagement, is supported both directly and indirectly from the 
ScoPE data. Approximately three-quarters of the interviewees 
explicitly described a sense of reciprocal obligation for the funding 
that they receive, be it from medical research charities, patient 
groups, private philanthropy or public funds. As is discussed in 
more detail in the following sections, consequently, many of the 
interviewees also viewed public engagement as a means of 
reciprocation to these funding organisations and to the individuals 
who contribute to these funds, as well as to the general public. 
 
Reciprocating to patients and carers:  
the ‘virtuous circle’ model 
Chris Boyd: It’s a kind of virtuous circle, in our case, in that 
we are funded directly by the CF [cystic fibrosis] Trust, and so 
it’s our obligation I believe, particularly to engage with CF 
patients and their families, and other supporters of the CF 
Trust. … So, that the virtuous circle is the fact that, that by 
doing that, we hopefully encourage people to continue 
donating to the CF Trust, which funds our work, so it’s, not a 
completely selfless exercise. 
Dr Chris Boyd leads a group working on cystic fibrosis (CF), and 
much of his work is funded by the national charity the CF Trust. In 
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his comment, Boyd uses the expression ‘virtuous circle’ to 
describe the reciprocal nature of his and his colleagues’ 
relationship with the CF Trust: since the CF Trust provides 
research funding, the researchers who benefit from this funding 
have a reciprocal ‘obligation’ ‘to engage’ with a range of actors 
associated with the CF Trust, including those directly affected by 
the disease, and individuals who have raised money for the Trust. 
At the same time – and, here, Boyd’s comment resembles some of 
those discussed in the previous section – he notes that this public 
engagement work serves the simultaneous purpose of 
‘encouraging people’ to donate to the CF Trust. Thus, Boyd’s 
‘virtuous circle’ is completed: he works to enhance the efforts of 
the CF Trust, which in turn works to support his research on behalf 
of its members and all those who might benefit from improved 
treatments or even a partial cure. Importantly, Boyd acknowledges 
the benefits that accrue to him directly as a result of his 
involvement, noting that ‘it’s not a completely selfless exercise’. 
Many interviewees’ reflections on their funding relationships are 
suffused with the language of obligation, duty or responsibility. 
Professor Dylan Edwards receives funding from a local cancer 
research charity called The Big C. In the following extract, 
Edwards makes a similar point to Boyd, explicitly stating that he 
and his colleagues have ‘a duty and a responsibility’ to The Big C 
because it generously provides research funding. As Professor 
Edwards goes on to say, part of this duty or responsibility takes the 
form of providing feedback through public engagement. 
Dylan Edwards: Yes, I think we do have a duty and a 
responsibility to [The Big C]. We certainly get some funding 
from them. They’ve been generous in supporting us, and I 
think, we have a responsibility, and that relates also into 
giving them feedback when a project is completed. 
Here, as in a number of the examples provided in this and other 
chapters, what is noticeable from a sociological point of view is 
that the sense of duty as an individual or team to pursue research 
is embedded within a larger sense of producing social benefits for 
others – and indeed the frequency of explicit descriptions of a 
sense of duty to do so. Such comments strongly underscore the 
proximity of scientists’ commitments to public engagement work as 
an expression of their vocation, or ‘calling’, as scientists. 
In her comments on this issue, Professor Kay Davies, who works 
on Duchenne muscular dystrophy (DMD) and spinal muscular 
atrophy (SMA), explicitly extends this sense of ‘duty’ to informing 
the larger community of patients and carers affected by these 
conditions about relevant scientific progress in her field. 
Kay Davies: I go to the Parent Project UK for DMD every 
year and tell them what I perceive to be the scientific 
progress. Internationally, I go to the Parent Project of the 
Spinal Muscular Atrophy Group in the USA in two weeks time. 
Interviewer: And why do you do that? 
Kay Davies: Because the parents provide some of the 
funding, but not all of it, and I just feel that we have a duty to 
tell them what’s going on. 
Interviewer: Right, do you find that it helps your work? 
Kay Davies: Not necessarily, I think it helps them so I’ve 
always done it. 
Initially, Davies mentions that she attends the annual Parent 
Project meetings of the medical research charities and groups that 
relate to her areas of research, and she specifically states that she 
does this to inform parents about the relevant scientific progress. 
In response to the interviewer’s question about why she does this, 
Davies then explains that, since ‘the parents provide some of the 
funding’, she feels that she has a reciprocal ‘duty to tell them 
what’s going on’. Thereafter, in response to the interviewer’s 
question about whether this benefits her own work, Davies 
responds that it does not ‘necessarily’ (perhaps suggesting the 
benefits are not direct), noting instead that she undertakes this 
form of public engagement because it helps the parents. 
 
Reciprocating to society: being democratic 
Other interviewees discussed the objectives of public engagement, 
and particularly public dialogue, as part of a wider set of reciprocal 
and democratic relationships with society within which decision-
making is shared or undertaken in partnership with the public – 
again, as in the following comment, using the idiom of a circle to 
convey a two-way process. 
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Jolanta Opacka-Juffry: So, this is a full circle. So, our first 
interest is to inform the public for the public’s sake because 
they deserve it, they need it, they want it, they are interested. 
They pay their taxes. They should know what happens with 
the money. And additionally, being well informed, they may 
play a better role when it comes to these kinds of 
contributions. 
In this account, Dr Jolanta Opacka-Juffry, a neurobiologist, speaks 
of the multiple and interwoven objectives that emerge in many 
interviewees’ descriptions of public engagement and public 
dialogue. Initially, within the context of funding from public taxation, 
Opacka-Juffry employs the same ‘circle’ metaphor as Boyd to 
evoke a reciprocal relationship with the public and the obligations 
that this places on both institutions and scientists. More 
specifically, Opacka-Juffry asserts that public engagement, or 
informing the public, is the right thing to do because the public 
provides funding for science through taxation; as she puts it, ‘they 
deserve it…They pay their taxes. They should know what happens 
with the money’. Here, however, Opacka-Juffry also evokes two 
further linked objectives. First, she asserts that public engagement 
also has the objective of creating scientifically ‘well informed’ 
individuals and, second, as a result of this, that public engagement 
has the objective of creating individuals who are better able to 
substantively contribute to decisions about science – in sum to 
‘play a better role’. 
Like Opacka-Juffry, Professor Geraint Rees, a cognitive 
neuroscientist who participated in one of the Meeting of Minds 
events, comments on the notion of an obligation to reciprocate the 
benefits of receiving public funding. Like other interviewees, and 
as we have seen earlier, Rees also explicitly extends this model of 
reciprocity beyond an individual set of obligations on the part of 
scientists to a broader, more inclusive obligation on the part of 
institutions (to which scientists might also contribute), all within the 
context of Western liberal democracy. 
Geraint Rees: Most research is publicly funded, there is a 
public responsibility therefore to at least take into account, or 
feed into the processes, the views of those people who are 
doing the funding. I think that’s just part of the political 
compact of Western society. …that’s how society works. … 
political representatives are elected…to make decisions which 
include decisions about how much funding to give the MRC, 
how much funding to give the NHS, how much funding to give 
BBSRC, and so on. So, I think it’s axiomatic to have public 
involvement in that kind of case. … The public has a right, 
and there is a need for the public to be involved in decision 
making, whether it’s about GM foods or stem cell research or 
in vitro fertilisation. 
Rees’s starting point in this comment is his assertion that most 
scientific research is publicly funded. He then places this belief 
within readily available conceptions of Western, liberal democracy 
in which institutional ‘responsibilities’, ‘public rights’ and pluralism 
are emphasised. This, according to Rees, confers a very obvious 
(‘it is axiomatic’) ‘right’ on the ‘the public’ ‘to be involved in 
decision-making’ concerning funding priorities, as well as a 
‘responsibility’ on the institutions of scientific governance to 
respond to broadly defined social or public priorities. This, Rees 
argues, is ‘part of the political compact of Western society’, it is 
‘how society works’. 
However, although such reciprocal, democratic intents for public 
engagement and, particularly, public dialogue were identified by 
many interviewees, these comments were also in tension with a 
number of concerns about involving the public in policy- and 
decision-making. Here, Rees continues his comment on public 
involvement in policy- and decision-making. 
Geraint Rees: The problems, of course, come about because 
the public are, by definition, not a professional body and don’t 
necessarily make decisions about prioritisation on the basis of 
the same types of information as professionals would be 
making. …There’s a hospital just down the street called Great 
Ormond Street which, of course, is incredibly well funded by 
charities…because children who are vulnerable and on 
intensive care units, everyone, of course, naturally wants to 
give money. But, old ladies with mental health problems living 
in a community, weeing on their beds, are not such a popular 
topic and schizophrenics living rough on the streets of London 
are even less vulnerable. Now, their healthcare priority on 
needs may or may not be equal, it’s obviously a contentious 
issue how to measure them, but the point is obvious that 
sentimentality in that case, if you like, would vastly swing 
public priorities in favour of premature babies over vulnerable 
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young schizophrenics living rough. …And, also, of course, 
there’s different time scales. You know public opinions like 
that can change quite rapidly over short time scales, whereas 
often research takes place over much longer time scales, you 
know, 50-year time scales. So, there are all these kind of 
tensions that, I guess, you’ve got to devise a system that 
provides checks and balances. 
As part of this sophisticated account of what might be described as 
the politics of social reciprocity (or some problems with the virtuous 
circle), Rees raises two concerns about public involvement in 
decision-making with respect to healthcare issues. First, he points 
out that the priorities of the general public may be driven by 
sentimentality, and that this may lead the public to prioritise and 
support certain groups, such as children, over others, such as the 
elderly or homeless people with mental health problems. Second, 
he adds that the public can be fickle and that its priorities can 
change rapidly in ways that are incompatible with the timeframes 
of scientific research. Like many of the interviewees, Rees is 
reflective here, to the point of thinking in explicitly sociological 
terms about the paradoxical manner in which inequality and social 
exclusion can be reinforced by patterns of charitable giving. He 
recognises that these concerns are inherent to the democratic 
ideals that he earlier elucidates, and he argues that these tensions 
need to be managed through ‘checks and balances’ that require 
professional oversight. 
Such tensions and intense reflection are very differently evident in 
the comments of Dr Catriona Morrison, an experimental 
psychologist who participated in another of the Meeting of Minds 
events, as she makes a slightly different point about the 
ambiguities of public involvement in decisions about the future 
directions of scientific research. 
Interviewer: You mentioned that one objective of the public 
dialogue might be to gather public views about what research 
should be done. How does that strike you? 
Catriona Morrison: I don’t really like to think about that. I 
think the public are so ill-informed. I would be very frightened 
that the public really have much kind of involvement. …It’s 
incredibly arrogant to say, but I just think that they wouldn’t 
understand the value of a lot of what we do. It’s a terrible thing 
to say, actually; I’m just kind of thinking, what on earth am I 
saying here? The public didn’t understand my science and 
therefore they’ve got no entitlement to comment on it, almost. 
It’s not really what I think, but I don’t really know what I think 
about it. I just think they just don’t understand enough to 
comment. 
The substantive question in Morrison’s highly self-reflective 
comment is, if the public are ‘ill-informed’ and ‘don’t understand 
enough’ about the value of the science that she and her 
colleagues do to meaningfully contribute to decisions about the 
research, what are the implications of this? Does this mean, 
perhaps, that upstream public engagement would necessarily 
involve ill-informed public vetoes of valuable scientific projects? 
These tensions are very evident in the spoken form of Morrison’s 
comment, which is also notable for the extent to which she actively 
reflects on, and twice rescinds, her own comments as she is 
making them. Describing her own perspective as ‘incredibly 
arrogant’ and ‘terrible’, she asks herself ‘what on earth am I saying 
here?’ and then restates her view in order to examine it again. Her 
recognition of, and attempts to reconcile, the tension between her 
obvious commitment to public involvement in scientific decision-
making and her concerns about public ignorance are palpable in 
both her self-interrupted speech and her conclusion that ‘It’s not 
really what I think, but I don’t really know what I think about it. I just 
think they just don’t understand enough to comment’. As a spoken 
response, this is literally equivocal – speaking in more than one 
voice. Morrison’s ambivalence – one of the modern hallmarks of 
professional decision-making in contexts of uncertainty – is 
nonetheless an eloquent articulation of tensions that are clearly 
widely shared and, arguably, highly ‘sensible’. 
 
Improving science, improving scientists:  
‘a vision of a bigger picture’ 
Whereas the previous two sections have explored the many 
reasons for public engagement and public dialogue being the 
subject of both praise and critical reflection by scientists, the 
following section focuses on scientists’ discussions of how public 
perspectives might contribute to an altered definition of polity in the 
form of public science. 
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Interviewer: I’m wondering, what does the public bring to 
policy? 
Jolanta Opacka-Juffry: Well, the public brings a vision of a 
bigger picture. The public, as I understand it, sees the 
landscape maybe without the details on it. Details are below 
their resolution level but they see the bigger landscape. 
Whereas the research community very often sees the details 
very sharply, has a focus on the details and often forgets 
about the landscape. That’s how I see it and that’s why public 
input is needed to keep that large landscape in mind. 
In her response to a question concerning the value of public views 
or perspectives with respect to the governance of science, 
technology and medicine, Jolanta Opacka-Juffry uses the terms 
‘the bigger picture’ and ‘the bigger landscape’ to describe public 
views as knowledge. At the heart of her claim, and in common with 
the aforementioned views of sociologists such as Brian Wynne and 
Alan Irwin, is the assertion that the public offers a distinctive and 
valuable vision from which scientists, clinicians and institutions can 
learn. In her legitimisation of public knowledge, Opacka-Juffry 
emphasises that science is one – but not the only – way of 
knowing or seeing and thus must be complemented by other ways 
of knowing, ‘maybe without the details on it’. Indeed, from this 
perspective, the micro-resolution of scientific knowing renders it 
somewhat narrow and parochial, and the very distinctive ability to 
see detail is seen to blinker its gaze. Thus, Opacka-Juffry argues 
that, for both scientists and the general public, what they know is 
related to what they do not know. Because scientists, or ‘the 
research community’, focus on the details, the bigger picture or the 
landscape can be obscured or ‘forgotten’. 
The idiom of ‘adjusting focus’ is similarly used by David Porteous 
in his comments on the value of public perspectives within the 
context of scientific projects. 
Interviewer: Does it improve the science? 
David Porteous: I think it improves the science in the sense 
that it adjusts the focus of the science. … So that has 
unquestionably been the case in our Generation of Scotland 
population study where we involved ourselves in a series of 
public engagements and MORI polls and questionnaires and 
set ourselves up to be questioned and queried about the 
whole idea and to tease out all of the possible ethical issues. 
And that certainly informed the study design … our sort of 
fundamental approaches and context. … We’re absolutely 
convinced that the project is stronger and better for having 
done that serious public engagement early on in the process. 
And not as a sop to funders or to the publics but as a 
fundamental component part, and that was something I was 
very firmly of the opinion should be built in right at the 
beginning. 
The Generation Scotland study has the aim of understanding the 
genetic component of diseases among the Scottish population 
(http://www.generationscotland.org/). Here, Porteous comments on 
the extent to which he believes that an early series of public 
engagement activities made the ‘fundamental’ scientific aspects of 
this project ‘stronger and better’. For example, he suggests that 
public engagement was able to adjust ‘the focus of the science’, 
informing the design and ‘fundamental approaches’ of a scientific 
study and ‘teas[ing] out all of the possible ethical issues’. Once 
again, scientists’ knowledge or perspectives alone emerge as 
potentially narrow and parochial, while the public is the site of 
meaningful ethical insights that have fundamental scientific 
relevance. Notably, at the end of his comment, Porteous 
distinguishes between doing public engagement as a ‘sop to the 
funders or to the publics’ and as a ‘fundamental component’ of a 
scientific project. Implicit in Porteous’s comment is an 
acknowledgement of, and a scepticism toward, the idea that public 
engagement is merely a tick-box exercise for scientists that is 
undertaken without sincerity. This issue is discussed in greater 
detail in the next chapter. 
For her part, an interviewee who wished to remain anonymous 
turned her attention to the value of public perspectives and 
knowledge within the context of the determination of national 
science-funding priorities. 
Well, I don’t know, but maybe they bring some kind of 
balanced perspective from a standing back point of view. So, 
whereas scientists have become very involved in their 
research, and it’s the be all and end all, and they can see, 
because they’ve worked on it for many years, the potential 
benefit, let’s say, or advances that could be made in that field. 
The public can give a more balanced view of whether the 
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advances in that field are actually what the country needs at 
this time. Or, whether it would be better to put our resource 
into funding something else like, for example, an alternative to 
carbon fossil fuels or something like that. 
In this comment, the interviewee echoes Opacka-Juffry’s emphasis 
on the highly detailed and expert knowledge of scientists; as the 
above interviewee puts it, scientists ‘become very involved in their 
research’, ‘it’s the be all and end all’ and ‘they’ve worked on it for 
many years’. She goes on to imply that with this expertise comes a 
potential ‘lack of balance’ – a narrowed subjectivity or a bias with 
respect to the broader social or national desirability, necessity and 
efficacy of their own research. She thus invokes a model of 
objectivity comprised not of one specialist perspective, but of a 
civic polity, in which diverse perspectives are mixed together to 
produce a more carefully evaluated outcome. This stands in 
contrast to the objectivity and neutrality with which scientists are 
commonly imbued, which, in this view, is reversed to alignment 
with a single perspective, and is thus diminished in power. Here 
again, as in Opacka-Juffry’s comment, the public is able to take 
this balanced view precisely because they have not ‘worked on it 
for many years’. This positive role of the public as both different 
from scientists and broader in outlook has a corollary in the view of 
the public as being more grounded or ‘down to earth’. 
Stephen Gentleman: They do tend to bring some scientists 
down to earth, to a more basic level, where they may have got 
a little bit esoteric and blue sky, and they bring it right back 
down to earth like what’s this going to do for my husband, etc. 
… I think the lay voice is the voice of reason in some ways. I 
mean you can get carried away with your own research and 
not be able to apply it to the real world particularly. … Actually 
it really helps when you go back to the lab and realise there’s 
a real reason for doing this that may not always be apparent 
when you’re just stuck in the lab. 
Stephen Gentleman is a laboratory-based pathologist with no 
clinical responsibilities; as he put it in interview, he ‘looks at brains 
all day but not people’. In the above comment, Gentleman 
compellingly explains the value of patient and carer input in his 
work, through the lens of his experience of working with lay 
members on Alzheimer’s Society panels. Notably, Gentleman 
draws a strong distinction – or, to put this another way, identifies a 
significant gap – between patient and clinician, or lay concerns and 
those of scientists. For Gentleman, again in contrast to a view of 
the public as lacking knowledge or as having less knowledge, lay 
concerns articulate ‘the voice of reason’ precisely because they 
are at ‘a more basic level’ and more personal (‘what’s it going to do 
for my husband’), reflecting the ‘real world’. By contrast, 
Gentleman suggests that the concerns of scientists have the 
potential to become ‘esoteric and blue sky’, ‘carried away’ and, by 
implication, detached from the ‘real world’. Thus, for Gentleman, 
scientific perspectives on their own are valuable, but are 
insufficient in and of themselves to the task of enabling science to 
respond to the ‘real lives’ of patients and their carers. Thus, 
returning to the theme of translation mentioned earlier, the 
objective of public engagement is to close the gap between basic 
scientific research and the concerns that emerge from patients’ 
lived experiences in pursuit of an improved, more patient-focused 
science. Thus, in Gentleman’s case, it is his interactions with 
patients and carers that have served to remind him of the ‘real 
reason for doing’ his research, leading to changes in his research 
goals and the design of his experiments. Indeed, many scientists 
gave ‘upstream’ examples of this kind, often based on a sense of 
personal conversion. 
The final remark in this section does not represent a broadly 
observable theme in the data. Nonetheless while it is a further 
example of the ways in which public engagement might improve 
science, it is also a striking endorsement of the emerging 
significance of public engagement to notions of what it means to 
be a professional scientist (discussed in greater detail in the 
following chapter): 
Geraint Rees: One way in which I sometimes see public 
engagement is as an extension of communication skills of 
science in general. I see writing a paper as a continuum with 
all the public engagement activities. Science doesn’t exist 
unless it’s published, that’s my personal viewpoint, and so to 
that extent, I see public engagement as part of the 
professional development activity. You need to learn to be a 
more effective communicator that feeds back into professional 
communication. I’m not sure that’s always picked up on as 
either a promoter or a positive reason to do public 
engagement for scientists. … I mean, writing papers is a 
fundamental skill. There are different sorts of papers you 
  
 
48 
write, and high impact papers, such as published in journals 
like Nature and Science are shorter, more condensed, more 
abbreviated versions of the longer papers. Generally 
speaking, it’s relatively easy to construct a long paper, which 
has a very stereotype format, and you just transit through the 
findings, and transit through the discussion and say, that’s 
fine and off we go. Short format papers, which I guess some 
of us around the table have been lucky enough to be involved 
in writing, are a harder sell. They’re harder to construct. It’s 
not just the quality of the science and the scientific findings, 
it’s how you communicate them and put together a coherent 
and straightforward argument that can be understood by a 
general audience, because these journals are not specialist 
journals in the jargon. They’re generalist journals appealing to 
a wide variety of readers, and so some of the skills, I think, 
that you need to construct that kind of argument, logic, the 
language you need to deploy are not dissimilar to the way in 
which I certainly think about preparing the public nature, how 
to employ and simplify and omit unimportant details to the 
main scientific story, to communicate to the masses. 
Here, in a comment made at the ScoPE workshop on 19 June 
2009, Rees makes a strong case for the role of public engagement 
in enhancing his professional abilities as a scientist, strongly 
echoing the translational motif evoked earlier. Thus, translating 
scientific and technical forms of language and argument into forms 
that are understandable to the public also has relevance to his own 
professional scientific communication and his professional 
advancement, and vice versa. In describing argument and the use 
of language and logic, as well as emphasising the importance of 
incorporating feedback as an essential skill, he depicts a 
continuum of communication in which listening is as important as 
speaking or writing. 
 
Inspiring and delivering the future scientific 
labour force 
As discussed earlier in this chapter, activities with children and 
young people – whether in the lab, at schools and colleges, in 
museums or at science festivals – are central to the interviewees’ 
understandings of public engagement. While these specific 
activities have a variety of objectives for the interviewees, they are 
always related to inspiring and exciting young people and 
somehow contributing to the delivery of the future scientific labour 
force. 
David White: At one level, it’s the excitement of science. 
Let’s take one thing we did, this was part of a wider range of 
activities in a large public area in Norwich called The Forum. 
We ran something which was, how tall can you build a jelly? 
Now, it turns out that you can’t build a jelly more than about 
four inches tall however you try. And so, who was going to 
build the tallest jelly? So, what has that got to do with food? 
Well, it had a little bit to do with food structure. But it had quite 
a lot to do with getting people interested and asking questions 
that were related to science. Now was that information, or was 
that excitement? I would say that the information content was 
little, four inches of jelly. But getting people to think about 
why, and getting people to think of the science is another way, 
is another thing. 
Many of the interviewees spoke of the importance of enthusing, 
exciting and inspiring young people (and adults) with respect to 
science, technology and medicine. Although he has now retired, at 
the time of the interview, Professor David White was Director of 
the Institute of Food Research. In this comment, White again 
speaks to the multiple objectives that scientists evoke in the 
context of public engagement. Using the example of his ‘how tall 
can you build a jelly’ event, White’s question ‘was that information, 
or was that excitement?’ points to the often indistinguishable 
nature of these imperatives in the minds of scientists and their own 
awareness of this multiplicity. In the specific context of school 
children and young people, such desires to enthuse, excite and 
inspire were very often associated with the objective of delivering 
the future scientific labour force. 
Lyle Armstrong: I mean our university tries to get us involved 
in these things, because they want to recruit new potential 
students, in the future. They want children in schools these 
days, to look upon science as a worthy pursuit, something 
that’s interesting and is a lot better than doing media studies, 
or sport, or something, and Britain certainly needs more 
scientists. 
Here, Dr Lyle Armstrong discusses this objective within the context 
of visits to local schools. At the end of his comment, Armstrong 
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defines the problem: ‘Britain certainly needs more scientists’. 
Within this context, then, for Armstrong, activities with children and 
young people serve the larger scientific goal because they are 
designed to ‘recruit new potential students, in the future’. As 
Armstrong and other interviewees suggest, this is generally seen 
to be achieved by encouraging children to view science as a 
pursuit that is both ‘worthy’ and ‘interesting’. In addition, Armstrong 
evokes an image of an open and competitive study and labour 
market in which science must compete with other study and career 
options such as media or sport. 
Pushing science through parliament 
Working with parliamentarians and policy-makers was not among 
the activities that were most often cited by interviewees as a form 
of public engagement. However, among those who did, this 
dimension of public engagement was vitally important. Lyle 
Armstrong, Robin Lovell-Badge, Stephen Minger, Chris Shaw and 
Austin Smith were among those who had contributed to scientists’ 
considerable efforts in the years leading up to the successful 
passage through the UK parliament of the revised Human 
Fertilisation and Embryology Act in 2008–9. Although the range of 
relevant issues broadened as the bill passed through parliament, 
these scientists’ efforts were focused on ensuring that scientific 
research using stem cells derived from a particular form of 
human/animal hybrid embryo was permitted under the terms of the 
Act. As one of the two UK scientists to have been granted a 
licence to undertake such research, Dr Stephen Minger took a 
prominent role in scientists’ activities in this regard. Minger offers 
this account of the parliamentary work after the successful 
passage of the bill: 
Stephen Minger: So I think my involvement with parliament, 
which I also view as public engagement has been really 
important. You know, at this reception last evening, basically I 
was told by several members of parliament that ‘if you guys 
hadn't fought for the issue, you wouldn't have gotten it’. You 
know, that the government was determined at that time, and 
18 months ago, to ban this research. … And, I mean, it was a 
tremendous thing that collectively we did together with other 
scientists and with patient charity organisations and with the 
media to push this through. So I think going in and briefing 
ministers and MPs is really crucial, particularly when the 
science is pretty tough, as this was. 
As Minger states, scientists worked on this issue in collaboration 
with patient groups, science journalists, press relations experts, 
social scientists, lawyers and members of parliament (MPs). They 
devoted considerable amounts of time to briefing ministers, MPs, 
civil servants and the media, as well as meeting with opponents of 
stem cell research and conducting public engagement activities. 
Indeed, the night before Lovell-Badge was interviewed for the 
ScoPE project, he had been at Westminster until midnight drafting 
the proposed legislation with government lawyers. As Minger 
noted, ‘the government was determined…to ban this research’ and 
it was necessary to ‘push this [science] through’ parliament. The 
successful outcome, he emphasised, was ‘a tremendous thing that 
collectively we did together’ (for other perspectives on this 
coalition, see Watts 2009). For many scientists, such collective 
efforts, through which a political battle will be won or lost, with the 
result that particular lines of research may be banned, are 
reminders that public engagement can make a dramatic difference. 
Lyle Armstrong: It was an interesting exercise, that’s 
certainly true, and it took me to areas of British society that I 
would never have ordinarily expected to have gone, not as a 
scientist. But I think it was a very valuable exercise, because 
essentially the government seems to have changed its mind. 
Dr Lyle Armstrong is the other scientist to have been granted a 
licence to conduct hybrid embryo research in the UK, and here he 
reflects on his experiences of what he describes as a novel and 
unexpected set of activities that took scientists into a range of 
novel social contexts or ‘areas of British society’. Through this 
novel form of public engagement, scientists become overt 
advocates and lobbyists on behalf of their science, and in doing so 
must become hybrids themselves – part politician, part advocate, 
part sociologist and part biologist. 
 
‘Knowledge is power’: enabling the public 
Earlier in this chapter, scientists’ desire to educate the public or put 
the record straight through public engagement was discussed. For 
many of the interviewees, this objective is seen as a route to the 
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subsidiary objective of enabling the public or facilitating action by 
the public. 
Interviewer: So pushing that a bit further, why is it important 
for the public to know the value? 
Catriona Morrison: Because, well, knowledge is power. 
Knowledge is, you know, a good thing. It has to be good to be 
aware; knowledge gives you choices and opportunities. 
In her emphasis on the enabling potential of knowledge in general, 
Catriona Morrison restates the Baconian maxim that ‘knowledge is 
power’ and suggests that the public is enabled by knowledge or 
awareness because it brings with it ‘choices and opportunities’. 
Science becomes knowledge and thus a means to an end, or a 
route to action, for a public that is envisaged here as an active 
user of scientific knowledge. For her part, Dr Sarah-Jayne 
Blakemore identifies two specific ways in which scientific 
understanding empowers the public. 
Sarah-Jayne Blakemore: Another reason why public 
engagement in science is important is so that people have 
more understanding on which to base decisions like, do I give 
my child the MMR? It’s just really crucial that they understand. 
… And also to have a say in science itself. To have a say in 
what science is done. 
As previously mentioned, Blakemore works on social cognitive 
development and processes, and specialises in autism. Here, as in 
her earlier comments, her description of public engagement is 
embedded in concrete examples drawn from her first-hand 
experience; as an example of the kinds of decisions she is talking 
about, Blakemore draws upon her own work on autism through her 
reference to enabling the public to make decisions regarding the 
much-discussed MMR vaccine. In these comments, she further 
illustrates the ready manner in which interviewees ascribed 
multiple interwoven objectives to public engagement. Initially, she 
emphasises the value of enhancing the public’s understanding of 
science so that they can ‘base decisions’ on this knowledge – 
decisions such as whether or not to vaccinate their children. In the 
second form of public action envisaged by Blakemore, like 
Opacka-Juffry, she connects this understanding of science to a 
wider vision of polity – in which it is scientific understanding that 
enables citizens ‘to have a say in what science is done’. Here, 
Blakemore evokes a model of what might be described as 
scientific citizenship, in which parenting decisions are linked to 
scientific understanding in a manner that also enables greater civic 
participation in decisions about scientific research. Underlying this 
model is the basic equation of scientific understanding with 
empowerment articulated above by Morrison. 
 
Testing science and gauging public opinion: 
‘the vibe coming back’ 
At the outset of this chapter, the range of objectives that Kay 
Davies ascribed to the Royal Society pharmacogenetics public 
dialogue project were discussed, including her suggestion that 
such events offered the opportunity to test the public acceptability 
of pharmacogenetics technologies and to learn from public 
responses. This theme was also mentioned by other interviewees 
who had similarly experienced public engagement and public 
dialogue as a valuable means to gauge public responses to 
science – what John Burn referred to as ‘the vibe coming back’. 
John Burn: The value [of the vibe coming back] is that when 
you end up in those three-minute debates on News at Ten, 
and [a prominent spokesperson against stem cell research] 
says that what I am doing is immoral and illegal, as (s)he did 
on one evening occasion, I simply said, it’s not illegal, it’s not 
immoral, it is perfectly reasonable, and people support it … I 
was confident because I had tested it in conversations with 
real people. 
In this account, Burn reflects on the value of testing the public 
acceptability of stem cell research through public engagement or, 
as he puts it, ‘conversations with real people’. For Burn, such 
conversations increase his confidence that ‘people support’ stem 
cell research, and thus aid him in fending off challenging 
opponents in the context of interviews on national television. For 
Burn, the truths – or the ‘vibes coming back’ – that emerge from 
first-hand experience of public engagement reinforce his maxim, 
described earlier, that if scientists take the time to meet with the 
public, to answer their questions, to acknowledge their concerns 
and to give a reasonable explanation of what they are doing and 
why, the British public will be supportive in return. Here, he 
amplifies this maxim by adding that the close proximity of a 
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conversational engagement has an added bonus of boosting his 
confidence and resolve to defend science against opponents. 
Again demonstrating the two-way model that in so many of the 
interviewees’ comments emerges as paradigmatic, he is able to 
respond succinctly and confidently to an opponent of his work who 
accuses him on News at Ten of conducting research that is 
immoral and illegal: ‘I simply said, it’s not illegal, it’s not immoral, it 
is perfectly reasonable, and people support it … I was confident 
because I had tested it in conversations with real people’. 
That the value of being in touch with public concerns about 
controversial areas of scientific research was repeatedly 
mentioned, particularly by stem cell scientists, is not surprising 
given the time period of the study. Sociologically, these comments 
are notable not only for their content (that listening carefully to 
people’s concerns can both assist your credibility and your ability 
to represent them), but, once again, because of their implications 
for the role of the professional scientist and, in particular, the 
scientist’s sense of vocation. In the following extract, Robin Lovell-
Badge looks ahead to one of the many public engagement 
exercises in which he and other scientists participated during the 
public and parliamentary debate of the new Human Fertilisation 
and Embryology Act: 
Robin Lovell-Badge: On Saturday I’m doing this focus group 
of 40 people in London and we’ll take them through the 
science of stem cells. ... I think it’s very important to 
understand what the social concerns are and what people are 
worried about, why they’re worried about what they’re worried 
about, who they trust, what sort of arguments will convince. 
The transition we describe as the ‘shift from deficit to dialogue’ is 
here both illustrated and given an important corollary. Anticipating 
an event with a familiar format, Lovell-Badge describes his 
forthcoming role as a traditional pedagogical performance, of sorts, 
in which he will ‘take them through the science of stem cells’ by 
presenting an overview of the basic scientific facts. After 
completion of this mini-lecture, discussion will ensue, and here he 
expects to change gears, no longer giving out information but 
instead hearing about concerns and in particular ‘worries’: ‘what 
the social concerns are and what people are worried about, why 
they’re worried about what they’re worried about’. In this context 
the role of the scientist is significantly transformed from 
experimentalist, knowledgeable authority or published author to 
something much more pastoral, personable and caring. The shift 
from deficit to dialogue is thus accompanied by a shift from 
scientific reason to public reasonableness, and from distant 
rational authority to proximate discursive exchange, in which 
affective qualities figure prominently. That Lovell-Badge is not 
simply ‘giving out’ but is receiving something in return is evident in 
his references to trust and persuasion. As both his and Burn’s 
comments illustrate, the value of such exchanges lies in their 
ability not only to reveal what people know but to explore how they 
feel and, at another level, what they want. Successful public 
engagement, like most successful social exchanges, are not only 
two-way but at some level also symmetrical. It is thus through the 
exchange of concerns that the value of public engagement is 
increased. 
 
Personal reward and curiosity 
Continuing the theme of what ‘comes back’ from public 
engagement and conversations, many of the interviewees 
described such events as personally rewarding – in some cases 
for reasons they did not initially appreciate or for reasons that 
differed from what they might have assumed before taking part. 
Interviewer: Well, that’s really interesting, Austin, because it 
sounds as if you’re saying that there’s pretty much nothing 
that a non-scientist can say to you that will have any value to 
you as a scientist. Is that putting it too strongly? 
Austin Smith: I’m just tying to think, is there any reason why I 
would reject that statement, and it’s probably essentially 
correct. But that is a different thing from whether I personally 
might get any reward from speaking with the general public. It 
actually is very rewarding to do these things. When people 
say, thank you for making that clear, now I understand this, or 
you talk to patients’ groups with Parkinson’s say, and they 
say, we just want to know somebody is working on the 
problem. So that makes you feel good, but it doesn’t change 
your basic scientific approach, that’s already set. 
Austin Smith’s comments here are notable in two respects. He 
notes that he finds it rewarding when people tell him that he has 
enhanced their understanding or that they are pleased to know 
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that he is ‘working on the problem’, for example Parkinson’s 
disease. In addition, like Kay Davies earlier, he includes in his 
description a recognition that direct contact with scientists working 
on problems related to disease can be of value in and of itself for 
patients who are suffering as well as for their carers. Unlike 
Stephen Gentleman’s comments earlier, Smith is firm in his 
assertion that no amount of contact with patients is likely to affect 
his basic research design, which Smith describes as ‘already set’. 
A sense of reciprocity nonetheless infuses his sense of being 
rewarded and his appreciation of being thanked. 
For Dr Jolanta Opacka-Juffry, public engagement is ‘hugely 
rewarding’ in ways that evoke the pleasure of sociality and human 
connection in and of itself. 
Jolanta Opacka-Juffry: It’s hugely rewarding. It’s that kind of 
pleasure which you can derive from a conversation with a, 
say, randomly met stranger of perhaps a different cultural 
background and suddenly you realise that you’re clicking and 
you understand each other. 
For Opacka-Juffry, reward comes from the emergence of shared 
or mutual understanding, a realisation, as she puts it, that ‘you’re 
clicking and you understand each other’ despite other social 
barriers and uncertainties that might impede such a connection. 
Thus, she implies, part of the reward lies in the sense of 
overcoming obstacles. 
Within the specific context of more formally structured public 
dialogue events, personal curiosity was sometimes mentioned as a 
motivation for participation. 
Bill Newman: Not having been involved in that type of 
situation before where there was that type of patient forum 
designed in that way, I was really quite interested to see how 
would it work, what the structure would be, how the 
conversation would be facilitated. So I think it was more my 
own sort of curiosity to see. 
In the above comment, Dr Bill Newman responds to the 
interviewer’s query about why he agreed to participate in the Royal 
Society pharmacogenetics public dialogue by stating that he was 
personally curious about, or ‘really quite interested’ in, a variety of 
rather practical or methodological aspects of the process or event. 
Professor Geraint Rees makes a similar point – he was curious, 
‘intrigued’, and he wanted ‘to find out more’ – in his response to 
the interviewer’s question about his motivations for taking part in 
the Meeting of Minds public deliberation on brain science. 
Geraint Rees: Curiosity, an altruistic and somewhat foolish 
desire to help out somebody who wants a panellist. Yeah, 
curiosity, intrigue, just it seemed like an odd thing so I was 
intrigued to find out more. 
In their discussions of their own personal curiosity, both Newman 
and Rees notably reveal the high levels of autonomy that scientists 
currently enjoy with respect to their public engagement activities. 
This is a key theme in the next chapter on the role of public 
engagement in the working lives of professional scientists. 
 
Summary 
Interviewees were familiar with the term ‘public engagement’ and 
understood it to describe a wide variety of activities that are 
undertaken for a wide range of purposes and sponsored by 
various sectors. The existence of a distinctive activity known as 
‘public dialogue’ was less familiar to interviewees and was most 
often understood as a characteristic of an activity and only 
sometimes as a specific activity.  
The in-depth analysis of interviewees’ perceptions of public 
engagement and dialogue activities presented in this chapter 
confirms the importance of the two-way dialogic model within the 
scientific profession. Descriptions of the benefits of public 
engagement included those to science in general, individual 
scientists, patients and their carers, students and young people, 
‘the public at large’ and ‘society as a whole’. Many of the 
interviewees’ perceptions of the value of public engagement were 
based on first-hand experience of it, often accompanied by a 
‘conversion narrative’ of sorts, in which interviewees described 
unexpected enthusiasm for this type of activity in spite of its 
potential limitations, time-consuming nature and unconventional 
demands. Interviewees discussed public engagement as a means 
of accessing the highly valuable substantive contributions that the 
public can make to identifying scientific priorities, improving 
scientific projects, positively refocusing scientific objectives and 
improving clinical practice. Further, public engagement was often 
discussed as ‘the right thing to do’; here, highly reciprocal 
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relationships with patient groups, medical research charities and 
society in general were evoked by interviewees. 
The purposes that the interviewees attributed to public 
engagement are often best understood within the social context of 
the specific form of science, research practice, medical application 
or technology that they specialise in. For instance, scientists 
working in controversial areas such as stem cell research often 
emphasised the contribution that public engagement makes to 
ensuring the social conditions within which their research is 
possible. Often at the same time, scientists working on specific 
diseases or conditions also emphasised the importance of public 
engagement within the context of a reciprocal relationship with 
relevant patient groups and medical research charities. At other 
times, these objectives were rooted in broad-based issues relating 
to relationships between science and the public in general. 
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CHAPTER 6 SCIENTISTS ON:  
PUBLIC ENGAGEMENT AND THE 
PROFESSIONAL SCIENTIST 
 
Introduction 
When asked, many interviewees were straightforward in  
confirming that they now consider public engagement to be an 
important aspect of their role as a professional scientist. 
Interviewer: So, would you say that by now public 
engagement is part of what it means to be a scientist? 
Stephen Gentleman: Yes. 
Interviewer: It’s an aspect of the profession? 
Stephen Gentleman: Absolutely. 
The suggestion that public engagement has become an 
established component of many scientists’ professional lives as 
part of a ‘sea change’ in professional scientific culture, arguably 
over a relatively short period, is clearly reflected in Stephen 
Gentleman’s succinct, firm and positive – yet not atypical – 
responses to the interviewer’s enquiries about whether public 
engagement is now an aspect of the scientific profession. Indeed, 
many interviewees, including John Burn, suggested that public 
engagement skills – or communication, as he puts it – are as 
important an aspect of scientists’ professional repertoire as 
scientific, clinical and administrative skills. 
John Burn: Sometimes we have had debates about whether 
it is more important to be a good communicator, or a good 
scientist, or a good clinician, and I just felt like saying, well 
which of the four wheels on your car is the most important 
one? Actually, if your car’s not going to fall over, you need a 
good communicator, a good scientist, a good clinician, and a 
good administrator, and if you can do all four, you have a 
good car, and it will roll, but if you lose any of them, then you 
will have a problem. I’d rather not have to compare them, but 
would simply argue you need all the capacities and you pick 
people who can do it all. 
Through likening these skill sets to the wheels of a car (other 
interviewees also emphasised teaching in this regard), Burn 
makes a powerful case for the centrality of public engagement in 
terms of what it means to be a contemporary professional scientist. 
In this account, and those of many other interviewees, public 
engagement is confirmed to be a core aspect of professional 
science. 
At the same time, all of the interviewees described a number of 
underlying challenges, contradictions or tensions regarding the 
place of public engagement in the professional working lives of 
scientists. 
Geraint Rees: I think scientists are increasingly, as a group, 
interested in engaging with the public and wider society, but 
face a number of barriers -- primarily that engagement with 
the public is not necessarily helpful to their professional 
advancement, and indeed, there can be disincentives that 
engagement can be harmful to their professional 
advancement. 
Initially, Rees make a similar point to Gentleman in his observation 
that ‘scientists are increasingly interested in engaging with the 
public’. However, he immediately alludes to ‘a number of barriers’ 
to public engagement by scientists, noting that public engagement 
is ‘not necessarily helpful’ to scientists or can be ‘harmful to their 
professional advancement’. In so doing, Rees captures a basic 
contradiction that runs through many of the interviewees’ 
discussions of the current place of public engagement in the 
professional lives of scientists: while public engagement is 
becoming an increasingly important aspect of scientists’ 
professional lives, it retains an ambiguous role in the systems of 
incentives, rewards and priorities that govern professional scientific 
advancement, and it brings its own professional challenges. 
Perhaps in part for this reason, all of the interviewees noted the 
general desirability of more formal structures for the institutional 
incentivisation, assessment and reward of public engagement 
activities by scientists. However, such a development was also 
seen by most of the scientists to bring with it a range of troubling 
tensions and problems. 
Chris Boyd: I can see the attraction of including [public 
engagement] as part of professional assessment or at least a 
mark of esteem to use the best word. But what I would find 
difficult about it is how would you measure it. If there was a 
quota system, it would be a disaster because [scientists] 
would fill the quota, but they wouldn’t necessarily be engaged 
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to do it. So as soon as you make it a compulsion like that, you 
get the problem of people meeting their targets but not 
necessarily engaging with it. So I’m going to reserve 
judgement on that, I’m not going to come down either way on 
that. It’s an attractive idea, and there should be 
encouragement for people to engage, but the point is I’m not 
sure whether it should be a part of their professional 
assessment. 
In common with all of the interviewees, Chris Boyd initially 
confirms that he sees the benefits of more meaningfully assessing 
and rewarding public engagement. However, both at the beginning 
and the end of his comment, Boyd draws a distinction between 
informal modes of incentivisation – for example, as ‘a mark of 
esteem’ or through ‘encouragement’ – and formal modes of 
assessment, as ‘part of their professional assessment’. In common 
with many interviewees, Boyd identifies practical obstacles to the 
measurement of public engagement activities and describes 
significant drawbacks to the formal professional assessment of 
public engagement through ‘quotas’, ‘targets’ and ‘compulsion’. 
Thus, Boyd underscores the presence of a troubling tension, and a 
sense that something important might be lost, at the heart of 
otherwise understandable desires to formalise the assessment of 
public engagement activities. Boyd associates such measures with 
a loss of sincerity: ‘as soon as you make it a compulsion like that, 
you get the problem of people meeting their targets but not 
necessarily engaging with it’. These issues are explored in more 
detail in the following sections. 
 
Rewards, incentives and lip service 
For all of the interviewees, the key reason that public engagement 
is not necessarily helpful to scientists’ ‘professional advancement’, 
as Geraint Rees put it, is the ambiguous place of public 
engagement in the current reward and incentive structures that 
direct the priorities of scientists. 
Sarah-Jayne Blakemore: More and more scientists are 
willing and encouraged to engage with the public which must 
help a lot. I mean, now on grant applications and that kind of 
thing, there’s a whole huge space for your public engagement 
activities and if you’re doing none it doesn’t look very good. 
So people are definitely encouraged. … I don’t think it’s just 
lip service anymore. I think really people do actually, 
reviewers comment on how much you do this and that kind of 
thing. In their reviews of your grant application and I think it 
makes a difference. I don’t know but I think on a whole it 
probably does. And yet there are all these problems because 
it doesn’t count as part of the RAE, public engagement 
doesn’t factor in there at all. 
Many interviewees, like Blakemore, complained that public 
engagement is not meaningfully rewarded within scientific reward 
and career structures the way that other scientific activities are 
(such as research and publishing, professional activities and, 
where appropriate, teaching and clinical activities). Existing 
incentives for public engagement, such as those developed by 
research councils and funding bodies, were the subject of mixed 
assessments. For instance, interviewees noted that they are now 
routinely required to discuss the ways in which patients’ and 
carers’ perspectives and experiences have informed their scientific 
research questions in biomedical grant funding proposals. 
Similarly, many noted that they are required to document the 
public engagement activities that will be undertaken as part of the 
planned research. Further, they observed that reviewers now 
comment on these issues when they review grant funding 
proposals. Interviewees also reported that scientists are 
encouraged to participate in public engagement activities by their 
institutions and that various forms of support are available for 
these activities. However, the general impression from the 
interview data as a whole is of an uncertain, mixed and developing 
scenario in which there is concern among scientists about the 
influence and sincerity of these incentives and, in particular, about 
the implications of their further institutionalisation (including 
through the Research Excellence Framework).16 
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 To reiterate, in the UK, until recently, the quality of the research outputs 
of university departments has been assessed every seven years through the 
Research Assessment Exercise (RAE), which is used to determine future 
core funding levels of all UK universities from government. Following the 
2008 RAE, the existing system of assessment is set to be replaced by the 
Research Excellence Framework (REF). Following an announcement by the 
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While acknowledging that public engagement is now part of the 
scientific profession, and nominally a component of its formal 
reward structure as part of funding and promotion decisions, 
Austin Smith raised a concern that public engagement is 
nonetheless not taken as seriously by institutions as it should be. 
Indeed, he suggests it is ‘completely discounted’ within both 
scientific grant funding systems and institutional appraisal or 
promotion criteria: 
Austin Smith: What you’ll find is the funding bodies and the 
universities will say, oh, that’s great, and then when it comes 
to your next grant application or particularly your promotion 
application with the university, [public engagement] is just 
completely discounted. 
Bill Newman: I’m afraid to say I think a lot of scientists pay lip 
service, they see that the application form says there needs to 
be public engagement, they tick it and say, oh, we’ve spoken 
to so and so from this group. And that will be the sum total of 
their public engagement until they write their report and then 
they get on the phone and get some feedback. … It’s 
relatively new so there’s always going to be a lag period. I 
think people are generally getting better. And I think that it’s 
higher up the agenda and you do get more of a sense that 
people are starting to talk about it. 
Bill Newman reflects a similar concern in his use of the term ‘lip 
service’ to describe the apparent insincerity of many scientists with 
respect to public engagement. In the above comment, Newman 
also evokes a negative image of public engagement as a tick-box 
exercise or as an afterthought that scientists go along with but do 
not take seriously. In reflecting on the relative novelty of public 
engagement, Newman then acknowledges an inevitable ‘time lag’ 
or delayed reaction and identifies a more positive, evolving 
scenario characterised by improvement over time, noting that 
‘people are generally getting better’, ‘it’s higher up the agenda’ and 
‘people are starting to talk about it’. However, Dian Donnai, a 
                                                                                
 
 
Science Minister Lord Drayson, it now appears the 2015 REF will include 
some form of assessment of both public engagement and policy impact in 
addition to the existing evaluation of scholarly impact. 
colleague of Newman, takes a more equivocal or ambiguous view 
of the emergence of institutional incentives for public engagement. 
While acknowledging increasing recognition among scientists of 
the importance of meaningful public engagement statements in 
grant applications, she remains of the view that many scientists 
remain naïve about what this might mean in practice and about the 
importance of public engagement. 
Dian Donnai: If you look at any grant application form, 
nowadays, in biomedical sciences, there is always a section 
for how you engaged the public, and it’s a very naïve person 
these days, who just puts down, I have asked the patients, 
who’ve come to my clinic, whether they think this is an 
important study. That won’t tick the box, so I do think that 
people are recognising that to get the grants they need to do 
the research they want to do, that public engagement is a 
factor. So, I think that is emerging in the scientific 
consciousness and I think that is important. I still think, 
because a lot of people are quite naïve about, what public 
engagement means, and I think just asking a few patients in 
the clinic whether they think it’s a good thing. 
Geraint Rees raises the possibility that lip service is also paid to 
public engagement in the context of grant funding review panels. 
Despite the fact that grant reviewers routinely comment on 
scientific researchers’ plans for public engagement, Rees suggests 
that these plans do not figure in the deliberations of review panels, 
even in the face of ‘two equally scientifically valid projects’. Thus, 
Rees points to an apparent contradiction between institutional 
commitments to the importance of public engagement and the 
provision of meaningful rewards for public engagement through 
institutional funding systems. 
Geraint Rees: Then most review panels look at [statements 
about public engagement in grant proposals] and think, oh 
good, yes, that’s fine. I don’t know, but I perceive that lip 
service is sometimes paid to that aspect of it. I don’t think I 
can think of a single example from my professional reviewing 
where in a critical funding decision, people say, well, let’s look 
at the public engagement and use that to decide whether to 
fund these two equally scientifically valid projects, let’s fund 
the one that’s got better public engagement. 
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The picture created by these comments is one in which many 
interviewees express an uncertainty, or sometimes scepticism, 
toward the sincerity of institutional incentives for public 
engagement. Instead, interviewees’ incentives or motivations for 
public engagement appear to be derived from their own personal 
commitment to the objectives discussed in the previous chapter. 
This theme is further developed in the next section. 
 
The ‘80-hour week’, the scientific day job  
and voluntary public engagement 
Almost as one, interviewees also associated public engagement 
with the overwhelming time commitment they feel they are obliged 
to – and, indeed, prepared to – make in order to pursue a 
successful scientific career. 
To achieve reasonable success as a scientist is something 
like an 80-hour week, minimum, I think. Just trying to keep 
your head above water with teaching, research grants, 
research papers, and various commitments on public panels, 
like research council panels or one of the funding bodies. It’s 
a committed job being a scientist, it’s a vocation job, really, 
rather than a nine to five type job. 
Here, in response to a question about the professional implications 
of public engagement, an interviewee who preferred to remain 
anonymous answers in terms of the rigorous commitments of her 
profession. Observing that it is not possible to conduct a scientific 
career within the bounds of a normal working day or week, she 
suggests that science is not a ‘nine-to-five job’, instead requiring 
an ‘80-hour week, minimum’. The interviewee goes on to list the 
long-standing core professional priorities of scientists; as well as 
the research, teaching and professional activities that she 
mentions, clinical work must be added in the case of many of the 
interviewees. This, then, is the already overloaded ‘80-hour week’ 
into which the interviewees perceive that public engagement has 
more recently entered. 
Thus, as previously noted, public engagement emerges as an 
anomalous activity; it is an increasingly important aspect of the 
scientific profession yet remains outside the incentive and reward 
systems that inform scientists’ core priorities and responsibilities. 
As a result, public engagement is seen by scientists as an activity 
that is additional to the scientist’s already overloaded day job. 
Within this context, a scientific career emerges as ‘a vocation job’, 
requiring exceptional commitment. As Robin Lovell-Badge notes, 
the time spent on public engagement and media work is always 
time that might have been spent doing something else and, in 
particular, addressing the core responsibilities of scientists to their 
lab and their research. 
Interviewer: Is [public engagement] something that you 
consider, at least by this stage, to be part of your professional 
role as a scientist? 
Robin Lovell-Badge: Yes I do, for myself. … It clashes in 
some ways with what we do, my day job, which is to do 
science and research, publishing and all that. So if I spend 
lots of my time talking to the media and dealing with these 
debates and all this other stuff, then it detracts from the time I 
can spend dealing with my own research and my lab and 
what I care about. 
Initially, in this comment, Lovell-Badge confirms that he considers 
public engagement has now become part of his professional role 
as a scientist. However, he immediately qualifies this by adding ‘for 
myself’, indicating that this is a personal choice and not for 
everyone, which he follows with an explanation that public 
engagement ‘clashes in some ways’ with what he describes as his 
‘day job, which is to do science and research, publishing and all 
that’ and is thus potentially to the detriment of his core research 
priorities. 
As previously mentioned, Clive Ballard specialises in dementia and 
holds research posts at the Alzheimer’s Society medical research 
charity and at King’s College London (KCL). Here, he begins to 
address what public engagement is, if it is not part of the ‘day job’. 
Interviewer: I'm wondering to what extent at this point you 
see public engagement as part of the professional role of a 
scientist, perhaps either for you or in general. 
Clive Ballard: Well, for me, it certainly is within my role in the 
Alzheimer's Society I guess. Within my role at King’s, I do feel 
personally a responsibility to do that, but I mean, the kind of 
events that are set up or organised in that context are far 
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fewer, so it's a much smaller call on time. … I think most 
people have been quite supportive of those kinds of events 
when they've happened, but it’s not a key priority, it's not in 
anyone's job plan. It's something that people are doing out of 
goodwill, and probably they're quite happy to do it, but it's 
almost like a voluntary additional thing rather than a core 
responsibility. 
Interviewer: And does that imply particular problems or 
challenges? 
Clive Ballard: Well, I think it probably does. I think it means 
that if that goodwill doesn't exist, then it's not going go 
happen, and their appraisal isn't going to be affected by not 
doing it. And I think also that, if something's given a very low 
priority, then if the chips are down, then that's exactly what it 
will have, a low priority. 
Ballard here introduces an important distinction between the 
prominent place of public engagement in his Alzheimer’s Society 
work and the more minor role that it plays in his KCL work. He 
reiterates the observation that scientists’ public engagement 
activities are not institutionally rewarded within contexts of 
appraisal and promotion, claiming that if a scientist has not 
participated in such activities, ‘their appraisal isn’t going to be 
affected by not doing it’. He concludes that public engagement is 
not a ‘key priority’ or ‘core responsibility’ for scientists and that 
public engagement will often make way for other activities that are 
key priorities. Notwithstanding this, Ballard reports that public 
engagement is something that people are ‘quite happy to do’. In 
commenting that public engagement is ‘almost like a voluntary 
additional thing’ that scientists do ‘out of goodwill’, he is 
suggesting, like the earlier anonymous interviewee, that public 
engagement activities point to the ‘vocational’ character of a 
scientific career. 
Dr Sarah-Jayne Blakemore explicitly mentions voluntarism in her 
account of doing public engagement ‘almost as a favour’ in some 
circumstances: 
Sarah-Jayne Blakemore: You do public engagement on a 
sort of voluntary basis, you do it as much as you want but it 
does also really eat into your research time. So I get a bit 
worried when I’ve published a paper that I know is going to 
have media interest. I do a lot of research on adolescence 
and if we’ve just published a paper saying something about 
the teenage brain, the next two weeks I’m just going to be on 
the phone to the media, and that’s fine because I like doing it, 
but it means that a lot of my time in the office is not going to 
be working, doing my research. And, you do feel a bit like 
you’re doing it as a favour almost because it’s not rewarded in 
the same way that publishing papers is on the RAE and by 
your head of department. I happen to be in this institute which 
does really encourage it. But I know of other people around 
the country who say they’re basically told not to do it because 
it’s a waste of time. 
In Blakemore’s account here, as in Ballard’s, public engagement is 
undertaken on a voluntary basis or as a favour. Yet, public 
engagement also takes up a considerable amount of time (and 
here Blakemore reiterates Lovell-Badge’s emphasis on talking to 
journalists) that is seen as time away from research. However, 
notably, public engagement also emerges as an activity that is 
characterised by a considerable degree of autonomy; as 
Blakemore puts it, ‘you do it as much as you want’. The idea of 
public engagement as an additional voluntary activity or a favour is 
important because it reinforces the notions about reciprocation and 
altruism that were discussed in the previous chapter. Equally 
importantly, it evokes public engagement as a matter of scientists’ 
own personal choice, autonomy and motivation (rather than an 
obligation) and thus as an activity to which participating scientists 
may be expected to bring commitment, enthusiasm and passion. 
This can be seen to inform the concerns, raised earlier by Chris 
Boyd and discussed further in the next section, about obliging 
scientists to participate in public engagement through the 
introduction of formal metrics. 
Within the context of their commitment to public engagement and 
their acknowledgement that public engagement is not a priority for 
scientists, many interviewees offered personal accounts of how 
they manage or reconcile core scientific activities and public 
engagement. In this example, Austin Smith describes the – 
apparently largely autonomous – ways in which scientists judge 
and select public engagement activities on the basis of informal 
assessments of their value. 
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Austin Smith: Next Tuesday, I’m going to Norwich, so that’ll 
take most of the day, to give a 45 minute lecture to school 
teachers. And I was sitting and looking at my schedule 
yesterday thinking, I could do with this like a hole in the head. 
But then I thought, well, no, I chose to do this because it is 
actually quite a useful thing to do, because I’m talking to a lot 
of teachers. I question whether it’s so useful for me to go at 
an individual school. 
Like Lovell-Badge earlier, Smith here describes a future public 
engagement activity to which he has committed, a lecture to a 
large group of school teachers in Norwich that will take up ‘most of 
the day’. Noting that he has a very full schedule, Smith reflects that 
he initially regretted having made this commitment; as he vividly 
puts it, ‘I could do with this like a hole in the head’. He reiterates 
Lovell-Badge’s concerns about spending time on public 
engagement activities that could instead be dedicated to core 
scientific activities. In his description of how he re-evaluated this 
negative perspective, he emphasises that the decision was his 
own choice (he is not doing it because he has been forced to), and 
in turn, the voluntarism of his choice is affirmed by his reasoning: it 
‘is actually quite a useful thing to do’. He further reflects on his 
assessment of the value of the activity from a different perspective 
when he says that he will be speaking to ‘a lot of teachers’, thus 
maximising the potential impact of the activity, as opposed to 
speaking to small numbers of teachers ‘at an individual school’. In 
his account, then, it is individual choice based on personal 
assessments of the value of public engagement activities that 
stands out, ultimately prevailing in reminding Smith why he has 
made the right decision despite its considerable inconvenience. 
Other interviewees appeared to be more sanguine about the 
additional time pressures presented by public engagement. 
Interviewer: Does the time demand present challenges? 
Caroline Pennington: No, I don’t feel as if it does. I feel it fits 
in quite easily with what we do. Sometimes it’s a challenge 
when I want to be going home at the end of the day, and 
there’s people coming round in the evening, but it’s not that 
often. 
Dylan Edwards: I don’t think so. I mean, in science you don’t 
go into it necessarily for a typical nine to five working day. 
Here, in a joint interview, Caroline Pennington and Dylan Edwards 
suggest that the time demands of public engagement do not 
present overwhelming challenges. Admitting, however, that it is 
‘sometimes a challenge’, both interviewees acknowledge the extra 
demands, and thus hours, required for a career in science, where 
in any case one would not expect a ‘typical nine-to-five working 
day’. 
 
Metrics and compulsion: killing the goose 
that laid the golden egg? 
As noted at the outset of this chapter, all of the interviewees 
suggested that public engagement activities should be more 
explicitly rewarded through structures within their own institutions 
and within funding institutions, and they cited a number of ways in 
which this might be achieved. The most significant of these was 
the development of metrics to inform the assessment, 
measurement and reward of scientists’ public engagement 
activities. One of the interview questions used in data collection for 
this study raised the possibility of including public engagement in 
the next RAE (what will be, the REF). While broadly supportive of 
such a development, the interviewees raised a number of 
concerns about strengthening the incentives for scientists to 
undertake public engagement in these ways. 
Interviewer: If public engagement could be factored into 
whatever new system replaces the current RAE, I wonder 
how that strikes you? 
Caroline Pennington: Maybe that would be a little bit unfair 
because some on the physics side of things, how difficult 
would that be? Is it easier for some groups than for others to, 
to factor that in? And you know, as we were saying, people 
initially come to us and show interest because they’ve had 
cancer, or a relative has had cancer, and so we’re in a very 
good position to think that would be an excellent idea. But if 
you work in a more obscure area of science, that could be 
really quite difficult, couldn’t it? 
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In this comment, Caroline Pennington raises a concern about 
equity, suggesting that universal metrics and rewards for public 
engagement ‘would be a little bit unfair’ because public 
engagement is ‘easier for some groups than for others’. She 
argues that public engagement is relatively easy with respect to 
her work on cancer because the public has interest in such work 
based upon personal experience of the disease. For other areas, 
such as physics, which is ‘more obscure’, public engagement 
would be less easy. Thus, science as whole might not benefit from 
including public engagement in its evaluation procedures. 
Other interviewees raising the problems of compulsion, given 
scientists’ variable aptitude for public engagement, noted that 
some scientists have better communication skills than others and 
that some scientists are more comfortable in the novel social 
contexts of public engagement than others. Since these comments 
focus on interviewees’ judgements of the personal capabilities of 
colleagues, they are presented anonymously. 
I’m not that comfortable with [public engagement], I prefer [my 
colleague] to do that sort of thing, he’s much better at it than I 
am. 
Similarly, in the following comment, the interviewee states that a 
colleague ‘is a brilliant scientist’ but ‘is not terribly good in that sort 
of [public] environment’. With this in mind, the interviewee states 
that he and his colleagues share the task of public engagement to 
achieve the best outcome: ‘it works better if he gives me a few 
slides and I do the talking’. 
Last night it would have been more sensible for [my 
colleague] to stand up but, although [he] is a brilliant scientist, 
he grew up [overseas] and he is a bit shy, and he is not 
terribly good in that sort of [public] environment. Therefore it 
works better if he gives me a few slides and I do the talking. 
In both of these cases, public engagement once again emerges as 
a matter of autonomous choice and decision-making for individual 
scientists and groups of scientists. On the basis of this autonomy, 
public engagement commitments can be managed individually and 
within laboratory and research groups on the basis of aptitude and 
preference as well as – recalling Austin Smith’s discussion of his 
public engagement commitment in Norwich – availability. Some 
interviewees expressed concern that, in a context of universal 
metrics and rewards for public engagement by scientists, such 
individual and group autonomy would be curtailed by the resulting 
obligations and compulsion that would be created. If scientists 
were obliged to conduct public engagement regardless of their 
aptitude or preference, the quality of public engagement could be 
diminished even if such measures increased its quantity. 
Geraint Rees: If you really wanted to drive public 
engagement you would do something quite crude. You’d 
announce you were measuring each scientist’s public 
engagement activity on a scale of 1–5. You would then 
announce that any borderline funding decisions would use 
that score to decide, and then sure as eggs are eggs every 
scientist would do public engagement. It might not be the right 
way to drive quality but it would certainly drive quantity and 
would drive a focus on it. 
As Geraint Rees observes, public engagement could readily be 
incentivised using a simple assessment metric to inform funding 
decisions. However, mirroring the concern expressed earlier, Rees 
fears that, while such an approach might ensure a greater quantity 
of public engagement, compulsion could compromise quality. 
Alternatively, Rees suggests that the autonomy and volunteerism 
on which current approaches to public engagement by scientists 
are dependent also serve to protect the integrity of both scientists 
and their public engagement activities – again suggesting the 
importance of their link to the vocational qualities of the scientific 
profession. 
Kay Davies: A more formal system of reward wouldn’t bother 
me personally because it’s part of my nature but I think it 
might be difficult for some people because they don’t naturally 
communicate. … Just thinking of some of the brightest 
scientists, I don’t think some of them communicate very well 
at all. … So I think it would probably be better and fairer to 
assess public engagement at an institutional level. 
Recognising these challenges, Kay Davies suggests that public 
engagement might be best assessed and rewarded at the 
institutional level. In particular, Davies suggests that this approach 
would preserve some of the discretionary aspects of public 
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engagement and would avoid penalising individuals who ‘don’t 
naturally communicate’. 
A reference point for the potential costs of a more formal system of 
public engagement, and of the loss of autonomy that is implied by 
metrics and rewards, was the RAE. 
Clive Ballard: For example, the publication based [RAE] 
system doesn’t offer [scientists] any latitude, and I think that’s, 
certainly in our area [dementia], that’s been a big problem. So 
I think in principle I could see advantages of it [a more formal 
system], but I think what I wouldn’t want to see is some sort of 
arbitrary metric which hadn’t been well field-tested put into 
place that becomes a criteria that’s a barrier rather than 
something that enables. 
In describing the RAE as a system that ‘doesn’t offer [scientists] 
any latitude’, Ballard argues that such systems of incentives and 
rewards can create conditions in which the actions of scientists are 
over-directed and constrained. In a similar way to Chris Boyd, 
then, Ballard reveals a fundamental ambivalence toward the 
proposal that public engagement should be subject to a universal 
reward system: he can see that this brings ‘advantages’ ‘in 
principle’, yet he is concerned that such systems can also act as ‘a 
barrier rather than something that enables’. In particular, through 
his reference to the importance of field-testing, Ballard suggests 
that reward systems can produce consequences that are 
unforeseen and unintended by the implementing institutions.17 
Delivering public engagement in order to be seen to be delivering 
public engagement might, according to such arguments, evacuate 
the exercise by changing its purpose to the fulfilment of externally 
imposed requirements rather than the expression of internally 
generated motivations to participate in engagement activities for 
their own sake because they bring their own rewards. 
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 Ballard’s argument here is reminiscent of Michael Power’s compelling 
analysis of the ways in which the emergence of a private and public ‘audit 
culture’ has served to reduce rather than enhance transparency and 
accountability (Power 1997). 
Public engagement and professional stigma 
When it was put to them directly, a number of interviewees 
rejected the notion that scientists’ participation in public 
engagement brings with it the risk of professional stigma or 
opprobrium. 
Chris Boyd: I don’t think there’s generally a negative 
perception, in fact I think in general people are glad that there 
are people in the profession who are willing and able to do 
that. … I don’t think it something that is perceived as negative, 
in fact, I think it’s probably perceived as a positive thing by 
fellow scientists. 
Other interviewees reported that they are familiar with the view 
among other unspecified scientists that public engagement is often 
not well perceived by scientific peers. 
Robin Lovell-Badge: I’m not sure whether I really experience 
it myself, but I’ve been told by others that their colleagues can 
often look on it, this guy’s a media tart. … And whether it’s 
jealousy or whether they really think that your goals are not 
about science but about self-promotion, I really do not do 
[public engagement] for self-promotion. So anyway, there may 
be some jealousy sometimes, or there’s this feeling that you 
can’t be a serious scientist if you spend all your time doing 
this. 
As mentioned earlier, Lovell-Badge has been involved in public 
engagement activities since the early 1990s and has had a public 
profile in public debates about animal research and stem cell 
research over much of that period. More recently, he was one of 
the scientists most involved with the new UK Human Fertilisation 
and Embryology Act. Lovell-Badge readily identifies two key 
elements associated with the notion that excessive participation in 
public engagement might compromise a researcher’s scientific 
credentials. First, that scientists who pay great attention to public 
engagement are said to have objectives that are not consistent 
with the norms of science. For instance, such scientists might be 
accused of sacrificing scientific principles – including modesty, 
communalism and factual accuracy – because they are seeking 
fame or satisfying their egos, promoting their own interests or 
seeking commercial gain; as Lovell-Badge puts it, ‘your goals are 
not about science but about self-promotion’. This pejorative view – 
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particularly of working with the media – is condensed into the 
expression ‘media tart’ (other interviewees used the expressions 
‘media whore’ and ‘prostituting yourself to the media machine’ in 
the same way). Second, Lovell-Badge refers to the view – from 
which he distances himself – that public engagement is an activity 
that might compromise scientists’ attention to their science; as he 
puts it, ‘this feeling that you can’t be a serious scientist if you 
spend all your time doing this [public engagement]’. Geraint Rees 
reflects on the latter point at what he describes as the ‘macro 
level’, or highly public level. 
Geraint Rees: So, the macro level would be people who are 
very successful at public engagement and are highly visible 
figures that are scientists, so we’re thinking [three highly 
prominent scientists] or someone like that, I think [such 
figures] are sometimes regarded by their peers, perhaps 
unjustifiably, as slightly flaky. As people who didn’t 
necessarily make it and have pursued an alternative career 
pathway. And that’s, as I say, not always justified but I think 
it’s a perception, you’re the Big Brother psychologist, you’re 
doing something a bit flaky even if that is doing something 
positive in terms of engaging with the public and science. 
Like Lovell-Badge, Rees distances himself from the perspective 
that he describes. However, Rees identifies three ‘highly visible’ 
scientists, who are anonymised here. Thereafter, Rees suggests 
that there is a ‘perception’ among other unspecified scientific 
‘peers’ that such scientists may have turned to the ‘slightly flaky’ 
discipline of public engagement because they ‘didn’t necessarily 
make it’ as scientists. Thus Rees candidly encapsulates the central 
tension that is revealed in interviewees’ discussions of the 
potential stigma of public engagement: scientists may be ‘doing 
something positive in terms of engaging with the public’, yet peers 
may still perceive that those who do so are ‘a bit flaky’ or, worse, 
have pursued an ‘alternative career pathway’ because they are 
inadequate as scientists. 
 
The challenges of non-scientific  
social contexts 
A consistent finding in the data is the concern expressed by almost 
all of the interviewees about the challenges of undertaking 
professional scientific work outside recognisably scientific spaces 
(such as laboratories, clinics, universities and scientific and policy 
meetings) and their reluctance to venture into the range of non-
scientific spaces that are associated with public engagement (such 
as public meetings, media encounters and school classrooms). In 
these discussions, such spaces emerge as potentially unfamiliar, 
unpredictable and difficult to control, and scientist interviewees 
often described feelings of discomfort, exposure and vulnerability. 
David Porteous: I know that a lot of colleagues are very 
reluctant for the reason that they find it very difficult to 
translate the technical language of their science into 
something that’s bite-sized and understandable, but not 
distorted. They think, oh, they’ve got to really know that I put 5 
mls into the tube and I cooked it for two hours before I got the 
reaction to work. So, no, no, no, you don’t need to do that; but 
that’s quite tricky. 
Here, David Porteous comments on the communication challenge 
that is experienced by his colleagues when they undertake public 
engagement.18 Describing these difficulties in terms of translation 
from the ‘technical language’ or the jargon of science to a ‘bite-
sized’ language that is understandable to a lay audience, Porteous 
notes that achievement of this language runs the risk of distorting 
the science, perhaps through omission of qualifying and cautious 
‘ifs and buts’ (as Dylan Edwards put it) that would be important to a 
scientific or medical audience. Porteous himself then provides an 
example of the technical ‘ifs and buts’ that he considers to be 
inappropriate in communication with a lay audience, though he 
notes that achieving the balance between simplicity and 
complexity is ‘quite tricky’ for scientists. For Professor Ian Craig, a 
molecular geneticist, this challenge is compounded by the fact that 
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 Notably, this was a particularly strong theme in the discussions with 
interviewees who do not have clinical responsibilities. 
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different lay groups demand a different ‘pitch’ or ‘level’ of 
complexity or simplicity: 
Ian Craig: Well, the challenges with any audience of knowing 
at what kind of level you’re going to have to pitch something, 
which obviously depends upon which section of the public 
you’re going to be talking about. If you’re talking to people 
whose children have muscular dystrophy, you don’t have to 
describe it or anything relating to the condition, but they may 
not know about the muscular dystrophy gene and how big it is 
and how difficult it is to get hold of and other molecular 
details. So, it’s always about having to make a decision 
concerning the level of pitching it and the possibility you’re 
going to lose people so they’re going to get turned off and that 
kind of concern. 
In this comment, Craig implicitly differentiates between engaging 
with a group of ‘people whose children have muscular dystrophy’, 
who understand the condition but not necessarily the genetics of 
the condition, and engaging with a more general group who may 
understand neither. The pitfalls of misjudging the appropriate level 
of simplicity or complexity – in particular the dangers of pitching an 
interaction at a level that is too complex – are the ‘possibility you’re 
going to lose people’ or that ‘they’re going to get turned off’. 
A number of interviewees, though again – notably – none who 
have clinical responsibilities, also reflected on the problematic or 
uncomfortable nature of the forms of personal contact with 
individual members of the public that can arise out of public 
engagement activities – for example instances in which individuals 
request advice and help with respect to their own or their loved 
ones’ medical conditions. 
Caroline Pennington: So, one of the things that I’ve had 
happen a couple of times, is that people will email me after 
they’ve had a meeting, and they want you to write back to 
them, and you have to be so careful what you say, and I find 
that a little bit difficult sometimes. Because, you know, your 
words can then be taken out of context and you’ve actually 
written something, and I find that a bit difficult. 
Caroline Pennington is a medical geneticist working on cancer but 
without clinical responsibilities. Here, she describes the difficulty 
that such situations cause for her as a scientist and her concern 
about advising individuals given the ways in which her written 
words might be interpreted – a concern that is at once specific and 
practical and amenable to generalisation as a symptom of the role 
confusion so often depicted by scientists in the context of public 
engagement. Other interviewees described a sense of exposure or 
vulnerability in public engagement contexts, often in terms of 
negative expressions of personal discomfort, terror, feelings of 
being tainted and encountering unfamiliar difficulties and problems. 
A number of interviewees commented on the aggressive and 
sometimes violent approaches of activist groups that campaign 
against specific areas and methods of biomedical research – most 
notably animal research. 
Chris Boyd: Many of my colleagues are reluctant to put their 
heads above the parapet, because if they are involved directly 
or indirectly with animal experimentation, they think they may 
be putting themselves or their families at risk. So, that has to 
be taken into account. And actually that’s an extreme example 
of the hostility I mentioned earlier that can actually have the 
effect of silencing people who would otherwise be quite happy 
to present their research. 
Here, Boyd draws on his own and his colleagues’ experiences as 
scientists who use animal models in their research, confirming the 
risk that such work can become subject to extreme hostility and 
occasional violence from animal rights protestors. Notably, this 
sense of hostility and threat in Boyd’s account is both heightened 
and linked to public engagement by his use of the expression 
‘reluctant to put their heads above the parapet’. A military term, a 
‘parapet’ is a protective wall at the front of a trench, and although 
idiomatic, this figure of speech makes reference to war. Pointing 
out the chilling effect of such threats on the establishment of a 
more open public sphere for science and debate about scientific 
innovation, Boyd suggests that, as a result of such threats, 
scientists are ‘silenced’ when they would ‘otherwise be quite happy 
to present their research’ in the form of public engagement. 
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Youth and experience 
In their discussions of the place of public engagement in the 
professional working lives of scientists, interviewees often returned 
to two issues relating to youth and experience. When asked, many 
interviewees assessed the importance of public engagement to 
PhD and early career scientists in much the same terms as for 
more senior scientists. Indeed, a number of interviewees stressed 
that PhD students and early career scientists are more important 
to public engagement than are their more senior colleagues. 
Ian Craig: But what you need are the young people, you need 
the vigorous, exciting people who are really having to make 
an impact through their science but at the same time 
communicating that enthusiasm and everything else to the 
public or to students or whoever, and it’s an important part of 
being an academic. 
For instance, Ian Craig suggested that young scientists are 
perhaps more vigorous, exciting and enthusiastic than their senior 
colleagues and that these are highly valuable characteristics in 
public engagement as well as ‘an important part of being an 
academic’. For her part, Caroline Pennington, in an attempt to 
address the negative ‘boffin’ stereotypes of themselves that 
scientists attribute to the public, stressed that the participation of 
young scientists in public engagement with schools is essential. 
This is important, Pennington suggests, because it portrays 
science as a youthful and (like Stephen Minger earlier) possibly 
even a ‘trendy’ pursuit that would be attractive to school children 
and older students. 
Caroline Pennington: So I’ve been asked to go to a school 
and talk about how girls go into science, and how to 
encourage girls to go into science. So, I’ve been trying to get 
some of the younger people here to come along, because I 
think I’m a bit old really, and it would be nice for them to see 
younger people. And we’ve got some very trendy young 
people here, so, you know, yes, I would encourage, and I do 
encourage them to, to get involved in it too. And they were all 
very happy to. 
As Pennington notes in her reference to encouraging more girls to 
go into science, public engagement activities such as school visits 
may play an important role not only in recruiting the next 
generation of scientists but also in changing the demographic 
profile of this group. While involving younger and early career 
scientists in public engagement is seen to have numerous 
benefits, other interviewees added a concern that the multiple 
imperatives and intense time pressures of a scientific career are 
even more acute with respect to junior scientists. 
Julia Polak: The challenge is horrid, because young 
scientists are at the bench and they haven’t got time, they are 
busy writing papers and grants. They reject the grants, they 
turn the paper down, and they have to go and do more 
experiments, and then you tell them to spend a whole evening 
in entertaining the public. 
For Professor Dame Julia Polak, a specialist in tissue engineering 
and regenerative medicine, the whole gamut of scientific activities 
– from running experiments to writing successful papers and grant 
proposals – is much more time-consuming for early career 
scientists, who may thus be particularly ill-suited for time-
consuming public engagement activities. Once again, the sense 
that public engagement is something that has to be undertaken in 
addition to the ‘day job’ or the ‘80-hour week’ is reflected in Polak’s 
comment that junior scientists’ scientific tribulations are then to be 
followed by a ‘whole evening’ doing public engagement. As Kay 
Davies reflects in the following extract, these are issues that junior 
scientists themselves think about and bring to the attention of the 
senior colleagues from whom they seek advice. 
Kay Davies: We had a unit retreat last week and we had a 
discussion on public understanding of science. One of the 
post docs said, well what are we supposed to do, what is the 
priority because if we do too much public understanding of 
science we get no credit for it whereas if we just concentrate 
on the science we do. So what do you advise us as young 
scientists to do? That’s a difficult thing. I said you have to do 
what you feel comfortable with, but you have to say really, 
since their future depends on the scientific output, they can’t 
spend very much time doing public understanding of science. 
Davies makes a similar point to Polak, while also drawing out her 
post doctoral researcher’s cognisance of the lack of reward for 
public engagement in scientific reward and career structures. She 
recognises the challenge that public engagement poses for both 
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junior researchers and their more senior supervisors. In her 
response to her advisee’s question, Davies once again invokes the 
autonomy that scientists have with respect to public engagement 
activities, and the sense that it is a matter of individual choice and 
preference how much, or how little, he or she wants to take part in 
them. In her role as advisor, she confirms this is her official line (‘I 
said you have to do what you feel comfortable with’), adding the 
typically ambivalent counter-advice that she thinks privately (‘but 
you have to say really, since their future depends on the scientific 
output, they can’t spend very much time doing public 
understanding of science’). 
In addition, a common theme in the interview data was a gradualist 
model that associated greater responsibility for public engagement 
with the expertise and experience that comes with progression 
through a scientific career to a more senior level. 
David Porteous: When I was a young scientist and I was first 
making discoveries that were getting into press release format 
and so on, I did come away from pretty much every 
experience feeling tainted in some way because I can’t think 
of a single occasion when what I said was correctly quoted or 
put in a context where it was balanced in the way that I felt it 
should be. Now, I may have been naïve and maybe I’d got the 
balance wrong, but that was a pretty painful process. And now 
I go into it saying, right, the probability is that I will be 
misquoted and misinterpreted, let’s try to minimise the 
probability of that happening; and you do that in a number of 
different ways. 
Echoing earlier discussions of the media, David Porteous here 
reflects that, as he gained more experience of working with the 
media, he learned that, although it is impossible to eliminate the 
risk of being misrepresented, it is possible to minimise this risk in a 
number of ways. He also describes a changing set of expectations 
and a more pragmatic managerial approach to media interviews, 
an approach that he contrasts with his earlier negative feelings of 
being misinterpreted (‘feeling tainted’) in a ‘painful process’ about 
which he ‘may have been naïve’. 
The importance of experience was also manifest in the comments 
of more junior interviewees. Within the context of the Meeting of 
Minds deliberative event in which she participated, Catriona 
Morrison ‘felt okay’ and that she was ‘able to make a useful 
contribution’, but nonetheless expressed doubts about her own 
expertise or her ability to communicate effectively, deferring to 
other more senior panellists, in particular Professor Andy Young 
and a woman from Leeds Metropolitan University. 
Catriona Morrison: I felt very much the most junior, so Andy 
Young has so much more experience than me and he knows 
a lot more about how the education system works, how 
psychology works, how the health service works, and I was 
sitting there going, oh, I don’t know that much really. But he 
had a lot of that kind of professional knowledge, but this 
woman, she was fantastic and the panel really liked her, but 
she kept talking about, well, when my mother had Alzheimer’s 
disease and this kind of thing. … So I was to be part of an 
expert panel and that I didn’t need to do any preparation, but 
they were just going to be tapping on my psychology 
knowledge. So I kind of felt okay about that. You know, as I 
say, when I turned up and I knew Andy was… I know Andy 
well, and I knew that he was going to be there, and I didn’t 
know the woman from Leeds Met, but I did kind of feel on the 
day that they knew so much more than I did. I did feel very 
junior in it. But I did feel I was able to make a useful 
contribution. And I think probably for the members of the 
public as well, to have a range of people was quite nice. We 
all had different perspectives on things. 
In her comments, Morrison twice refers to being the junior expert, 
or the expert with the least experience or professional knowledge, 
confirming a perception shared by other interviewees that long-
standing professional scientific experience brings with it the 
breadth and depth of expertise and general knowledge, as well as 
speaking skills, that are useful in public engagement. 
 
Summary 
Public engagement emerges as an anomalous activity in 
interviewees’ accounts of their professional working lives. This is 
because, although most interviewees readily confirm that public 
engagement is – by now – an important aspect of their 
professional careers, it is not as well-integrated into their working 
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lives – including the systems of incentive and reward to which 
they are subject – as other scientific, teaching and clinical 
activities are. Such activities are both daunting and time-
consuming. Within the context of already overburdened working 
lives, this means that – though important – public engagement is 
an ambiguous priority for scientists and is undertaken in addition 
to – and possibly to the detriment of – core scientific activities. 
Public engagement emerges as an activity that is characterised 
by a high level of volunteerism, implying a range of characteristics 
that are highly valued by interviewees (including autonomy, 
goodwill, passion, sincerity and a sense of duty). Interviewees 
also revealed that participation in public engagement can render 
them subject to professional stigma and can expose them to 
unfamiliar and challenging social situations. As scientists who are 
committed to public engagement, many interviewees saw value in 
the development of more meaningful institutional mechanisms for 
the incentivisation, assessment and reward of public 
engagement; for instance within scientific institutions as well in 
core- and project-funding bodies. However, such mechanisms 
were also readily associated with targets, compulsion and 
problems of measurement that might produce unforeseen 
consequences, might compromise the highly valued 
characteristics of public engagement activities mentioned above, 
and might be unfair to scientists working in areas that do not have 
an obvious public interest or dimension. Thus, they too were 
viewed with ambivalence. 
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CHAPTER 7 SCIENTISTS ON:  
PUBLIC DIALOGUE 
 
This chapter focuses on the nine interviews conducted with 
scientists who had participated in the Royal Society 
pharmacogenetics public dialogue project and the Meeting of 
Minds deliberative project on brain science. These two projects 
have the characteristics of public dialogue in the more narrow, 
technical sense in which it is institutionally understood. For 
instance, they not only emphasise dialogue and deliberation 
between public participants and experts of various kinds, but are 
conceived with the explicit objective of contributing to a policy 
process in some way and thus are designed according to 
predefined criteria (they are closed, by-invitation-only events).19 
We focus on this subsection of public engagement events in this 
final data chapter for three reasons. First, public dialogue events 
are the outcome of a lengthy process of evolution in the public 
engagement sector and, to some, represent its cutting edge. 
Second, these events are arguably more institutionalised and thus 
reflect this aspect of the public engagement sector as a whole. 
Finally, public dialogue can also be seen as an experimental 
sector in which new approaches to science and its publics coincide 
with other, broader, changes to definitions of the public sphere and 
its significance for contemporary society.20 
 
‘Bridging the gap’, enabling ‘conversations’ 
As this study found for public engagement events in general, 
scientists’ views of public dialogue events were largely positive, 
with praise often focusing on their two-way, reciprocal nature. Dr 
Jolanta Opacka-Juffry, for example, discusses her experience of 
one of the Meeting of Minds deliberative events in terms of 
breaking down barriers between scientists and their publics and 
‘bridging the gap’ between them. 
                                                 
 
 
19
 For further details about these projects, see the Royal Society website 
(http://royalsociety.org/page.asp?id=3779) and the Meeting of Minds website 
(http://www.meetingmindseurope.org/uk_site.aspx?SGREF=207). 
20
 The public sphere is a key concept in sociology referring to the semi-
formalised sectors of public debate through which participatory democracy is 
strengthened (or tested). Sociologist Nancy Fraser, for example, defines the 
public sphere as ‘a theater in modern societies in which political participation 
is enacted through the medium of talk’ (Fraser 1990). 
Interviewer: How would you characterise, if it’s possible to 
generalise, your interactions with the public participants, the 
citizens? Did you feel distanced from them? 
Jolanta Opacka-Juffry: No. 
Interviewer: Did you feel consensual in a way with them? 
Jolanta Opacka-Juffry: Very much so. 
Interviewer: Were you talking on the same wavelength? 
Jolanta Opacka-Juffry: Very much so. I thought we were 
separated on the floor and I said the arrangement was not 
terribly helpful because we were just separate, a group of 
them and a group of us, and they could think them and us. 
But, in fact, there were no barriers. I didn’t feel that at all. Just 
because of the competence of their questions and the topical 
issues they tackled, it just bridged the gap. 
In the final phrase of her comment, Opacka-Juffry speaks of a pre-
existing ‘gap’ between the scientist and public participants. This is 
perhaps a merely physical gap, caused by the ‘not terribly helpful’ 
physical arrangement of the room in which the event took place. 
However, this is possibly also a reference to the broader cultural 
gap in relationships between science and society that some 
interviewees identified (as discussed in Chapter 4). For Opacka-
Juffry, the practice of public dialogue transformed this relationship 
by ‘bridging the gap’ or removing the ‘barriers’ between the 
scientist and public participants. Significantly, she asserts that it 
was the public participants themselves who achieved this 
transformation through the ‘competence of their questions’ and the 
‘topical issues they tackled’ (this issue is discussed in more detail 
below). As a result of ‘bridging the gap’, Opacka-Juffry confirms 
that the event had a positive consensual character that enabled 
scientists and public participants to talk on the same wavelength. 
Dr Bill Newman – who participated in the Royal Society 
pharmacogenetics public dialogue – discusses his positive 
experience of public dialogue in a manner that reinforces Opacka-
Juffry’s comment. 
Interviewer 1: And did you feel comfortable? 
Bill Newman: Yes, I did. I think so. And after myself and my 
colleague maybe interjected at times or were asked to just 
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contribute, there wasn’t any point that that suddenly stopped 
the conversation so you felt there was a pregnant pause. 
Actually, then things flowed or people picked up on that and 
then sort of moved things forward again. …. 
Interviewer 1: Yes, it sounds like it was a very positive… 
Bill Newman: …experience, yeah, I think it was, it was. 
Interviewer 2: And enjoyable, did you have fun? 
Bill Newman: Yes, it was quite fun actually, yes. I mean, I’d 
be quite happy to do it again, I didn’t come away from it 
thinking it was a waste of time. 
Newman confirms that public dialogue was ‘comfortable’, ‘positive’ 
and ‘fun’ for scientists and that he would happily repeat the 
experience. His comments are also significant because they reveal 
his pre-existing concern that dialogue with the public might not be 
straightforward, that it might be awkward, punctuated by ‘pregnant 
pauses’ or halts in the ‘conversation’. Instead, as Newman puts it, 
the dialogue, or what he calls ‘the conversation’, ‘flowed’. Taken 
together, Opacka-Juffry’s and Newman’s comments suggest that, 
for the scientists involved, public dialogue can remove ‘barriers’ 
and ‘bridge gaps’ between scientists and public participants, with 
the result that consensual ‘conversations’ take place easily and 
without uncomfortable ‘pregnant pauses’ or ‘gaps’. 
 
‘Respect’: transformed understandings  
of publics 
A transformed, more positive impression of non-scientific 
participants in public dialogue processes was an almost universal 
feature of interviewees’ reflections on these events and was a 
significant component of their overall enthusiasm for them. 
Andy Young: They seemed highly articulate, very intelligent, 
very motivated to get to the bottom of these matters, and very 
absorbed in what they were doing. … I remember being 
extremely impressed at how quickly they grasped what the 
points were. 
In common with many interviewees, Andy Young lists several ways 
in which the public participants impressed him, including that they 
are ‘very intelligent’ and able to understand or ‘grasp’ the science 
‘quickly’. In addition, they are ‘highly articulate’ and ‘very 
motivated’ by and ‘absorbed in’ the work that they were required to 
do as part of the Meeting of Minds project. The impression given 
by this quotation of pleasant surprise at this outcome was a further 
consistent finding in the interviews. 
Jolanta Opacka-Juffry: Oh boy, they were so well-informed. 
Interviewer: Did that surprise you? 
Jolanta Opacka-Juffry: Yes. And I think I wasn’t the only one 
that was surprised. I was impressed. I was very impressed 
because those people worked so hard and they learnt so 
much and they used their knowledge so intelligently and they 
taught us so much. … I learnt, I think, to respect the public in 
this kind of dispute. Please don’t get me wrong. It’s not that I 
ever disrespected. … They can make a serious partner in a 
serious, focused, academic discussion. Serious dialogue. 
Opacka-Juffry reinforces Young’s view concerning the intelligence, 
ability to learn and commitment that is shown by public participants 
in public dialogue. Her comment also suggests gratitude, as well 
as a certain self-consciousness about being seen to have 
previously held a less confident view of the public (a view that she 
is quick to correct). In suggesting that the public participants 
‘taught [the scientists] so much’, members of the public emerge not 
only as individuals who are themselves able to contribute as ‘a 
serious partner’ to a ‘serious discussion’, even to an ‘academic 
discussion’, through their contributions in public dialogue, but also 
as concerned citizens whose efforts offer a corrective to doubts 
about the value of time-consuming engagement with non-experts. 
Consequently, in her confirmation that these public capabilities 
‘surprised’ her, Opacka-Juffry confirms that her experience of 
public dialogue transformed her understanding of public 
capabilities with respect to scientific matters, leading her to 
reconsider the role that the public might usefully play in debates 
concerning science, and enhancing her ‘respect’ for such events 
and for the lay public. These themes are also central to Dr 
Catriona Morrison’s reflections on the public participants at the 
Meeting of Minds event. 
Catriona Morrison: It told me how little they know. I think it 
makes you respect the public more as well. 
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Interviewer: Why is that? 
Catriona Morrison: Because they are interested. … And they 
all have opinions and questions. So when you say, well 
science is rational and objective and so on, we know best, we 
should be involved in the policy making; you have to rethink 
that when you actually encounter the public. 
Interviewer: Yes. So you felt that when you met them that 
they didn’t know very much about psychology or 
neuroscience, perhaps. Did you feel that they learnt a great 
deal about it during the course of the event? 
Catriona Morrison: Yes. 
Interviewer: And were you surprised at the capability to learn 
in that way? 
Catriona Morrison: Yes, definitely. Because I’m so used to 
dealing with undergraduate students, who have difficulty 
coping with half of what I say, so I think you just work on this 
assumption that if these students can’t understand me I can’t 
possibly explain this to the public. 
Morrison here reiterates Opacka-Juffry’s observation that her 
respect for the public was enhanced through experience of public 
dialogue, in Morrison’s case because the public participants were 
‘interested in’, had ‘opinions and questions’ about and had the 
capability to learn a great deal about neuroscience. Through this 
last comment, Morrison evokes a group of public participants that 
is itself transformed – that is, is made knowledgeable and capable 
– through public dialogue. Like Opacka-Juffry, her comments also 
suggest a sense of appreciation for having been given the 
opportunity to rethink some of her previous views. Here, as in 
much of the data for the project, first-hand experience is once 
again not only transformative but inspiring – as in the effect of a 
conversion experience or epiphany. Here Morrison notes that her 
pre-existing assessments of public capabilities were based upon 
the assumption that the general public would be less capable than 
undergraduate students and that, since these students ‘have 
difficulty coping’ with neuroscience, it would be all but impossible 
to explain her field to members of the general public – an 
assumption she realises was both inappropriate and incorrect. 
Professor Chris Frith, a neuroscientist who participated in another 
of the Meeting of Minds events, similarly praises the ‘sensible’ 
public participants – using this adjective twice. 
Chris Frith: As I say, I was very impressed with them [the 
public participants]. They seemed genuinely interested, they 
asked sensible questions. And usually, if I give a talk, there's 
always at least three people in the audience who are 
completely mad and this was not the case. … They didn't 
have bees in their bonnets as they were asking perfectly 
sensible questions. … I guess I think my worry [is] that the 
sort of people who volunteer for this will be the strange ones, 
whereas I've now got the impression that actually people do 
volunteer for good reasons. 
Frith’s comment also highlights the interviewees’ general 
impression that ‘closed’ public dialogue events and ‘open’ public 
lectures produce very different dynamics. This is particularly 
evident in his contrast between the self-selected publics of ‘open’ 
public lectures (who might have ‘bees in their bonnets’ or even be 
‘completely mad’) and the recruited publics in ‘closed’ public 
dialogue (who are ‘genuinely interested’ and ‘perfectly sensible’). It 
is also notable here that Frith, reflecting the sense of exchange 
that has been previously noted, goes on to extend the positive 
sense of volunteerism – which characterises interviewees’ 
understandings of the current context for scientists’ participation in 
public engagement – to the public participants in public dialogue. 
 
Understandings of scientists’ roles  
in public dialogue 
In contrast to the clarity with which many scientists interviewed for 
this section of the study revealed their thoughts concerning the 
overall value of public dialogue events, their perceptions of their 
roles in these processes were more ambivalent. Here, arguably, 
implicit criticism of public dialogue processes emerges, and, again, 
scientists’ relationships with their expertise appear as sources of 
mixed feelings and confusion, as do the implications of their 
authority as experts in an event modelled on polite conversation. 
When describing the roles that they were either pre-assigned by 
the organisers or that they actually performed in public dialogue 
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processes, all of the interviewees emphasised the importance of 
their identities as experts, although this was viewed equivocally, as 
both a positive and potentially negative asset. Thus, interviewees 
typically reflected on the roles they might or might not assume in 
public dialogue in terms of how best to fit in with, rather than 
‘drive’, the proceedings. 
Bill Newman: They certainly didn’t want me to drive the 
agenda. They felt that my role, and I was quite happy with 
that, was basically to provide what they call expert opinion. 
But really it was so that if people started talking about things 
that were clearly not feasible, or if they had slightly 
misconstrued conceptions as to what pharmacogenetics really 
was, or had to offer, or the actual process of it, then I was 
able to inform further on that. 
For Bill Newman, the expert role that was ascribed to him by the 
organisers of one of the Royal Society pharmacogenetics public 
dialogue events was defined in terms of providing ‘expert opinion’ 
in order to correct ‘misconstrued conceptions’ concerning the facts 
of what pharmacogenetics is and how it works. Thus, according to 
this definition or assignment of roles, public dialogue again 
becomes a site for putting the record straight through correcting 
misapprehensions about science. Newman’s comment is also 
notable since he states that it was not his role to ‘drive the agenda’ 
of the event. Instead, his role was essentially responsive in 
character: while he was to respond to misconceptions, he was not 
asked to determine the course of the discussions. Thus, although 
‘happy’, his role was also constrained. Professor Geraint Rees 
makes a similar point based upon his understanding of his role in 
one of the Meeting of Minds events, namely that he was ‘not there 
to preach’. 
Geraint Rees: You’re not there to preach or provide 
information that you think is important, you’re there to answer 
questions and interact. … It didn’t seem like a dialogue role, it 
seemed like I was a reservoir of information to be probed, so 
the citizens could form their views. 
Here, again, Rees evokes the role of a responsive expert. He 
states that he was not there to provide the information that he 
thinks is important, but rather to respond to or answer questions; 
he suggests that his role was to be an expert ‘reservoir of 
information’ that could be tapped or ‘probed’ by the public 
participants so that they could form their own views. However, in 
defining himself as a resource or a ‘reservoir’ to be drawn upon, he 
also sets himself apart – a point he makes explicit by noting that 
he did not recognise himself as having ‘a dialogue role’. 
The role of providing ‘balance’ and ‘steering’ while not being 
‘overbearing’ is similarly described by Professor Walter Bodmer, 
who, like Newman, participated in one of the Royal Society 
pharmacogenetics public dialogue events. 
Walter Bodmer: My role was largely to act as a sort of 
advisor on the science and to do it in a way that hopefully was 
not overbearing in any way, but try to explain things when the 
questions arose, try to steer the discussion into ways that one 
thought were more relevant. 
In common with all of the interviewees who had participated in 
public dialogue processes, Bodmer identifies his primary role as 
that of a scientific expert, or an ‘advisor on the science’, as he puts 
it. His understanding of the responsive nature of this role coincides 
with Newman’s and Rees’s to the extent that he sees himself as ‘a 
sort of advisor’ who is there to ‘explain things when the questions 
arose’. His use of the prefacing expression ‘hopefully’ 
acknowledges his awareness that the best intentions may not 
override the force of habit and, thus, that his role involves a 
combination of restraint and provision. In her discussions of her 
experiences at one of the Meeting of Minds events, Dr Catriona 
Morrison raises further perspectives on this issue. 
Catriona Morrison: So I was to be part of an expert panel 
and I didn’t need to do any preparation, but they were just 
going to be tapping into my psychology knowledge. … We 
were asked about access to diagnosis and memory clinics 
and [another ‘panel’ member] spoke a lot about her mother, or 
whoever had been diagnosed in her family, and I didn’t go on 
personal experience but I did draw on my experience from my 
own research. 
Interviewer: Did you feel that it was a role that was ascribed 
to you, or was it a role that you yourself wanted to take on, to 
advocate neuroscience and to, perhaps, answer some of the 
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objections that people might raise on developments in 
neuroscience? 
Catriona Morrison: Oh yes, in that sense definitely yes. Yes, 
so people have a big issue with things like animal testing, and 
I think that came up on the day. … I don’t do animal research, 
but I’m fiercely defensive about animal research and its value 
and its help in understanding things like dementia. And as I 
remember, we did have that opportunity on the day to talk 
about some of these methodologies. So certainly if I ever get 
the chance then, yes, I’m very keen to advocate neuroscience 
in that way. 
At the outset of these comments, Morrison reinforces the 
understanding of a responsive, or perhaps even passive, expert 
role in public dialogue that is universal among the interviewees: 
she is an ‘expert’, ready equipped with ‘psychology knowledge’ 
that can be ‘tapped’ and did not need to prepare for the event. 
However, in contrast to Rees’s understanding that he was not to 
‘preach’, Morrison reports that – perhaps regardless of the role that 
she was ascribed – she is ‘very keen’, both in the specific context 
of the Meeting of Minds event and more generally, to perform an 
advocatory role, in this case with respect to animal research. Here, 
then, the responsive expert role for scientists, a role within which 
personal normative commitments might be downplayed, is 
complemented by an advocatory role in which normative 
commitments are foregrounded. 
In response to a question about whether he assumed any other 
roles in addition to that of an expert at one of the Royal Society 
pharmacogenetics events, Bill Newman reflects upon the place of 
personal experience in his role as an expert, within the contexts of 
both public dialogue and the clinic. 
Bill Newman: No, I didn’t. I sort of tried as much as possible I 
think to just keep completely to that remit. I certainly didn’t 
mention anything at all about any personal experience I’ve 
had of medication. I think in my professional experience very 
rarely would I draw, I mean clearly the way you engage with 
people and all sorts, in conversation and how you have a 
consultation with somebody is completely embedded in who 
you are and what your experiences are whatever. But, 
actually vocalising that and saying to a person, well, in your 
situation I would do so and so, I can’t think I ever do that, 
because I see myself very much in a role of providing 
information and a context for that information and trying as 
much as possible, allowing the person to make their own 
independent decision based on that information and not trying 
to draw on, in any overt way, my own attitudes and 
experiences onto their decision making process. … I think that 
I brought that very much to the forum, that I decided very 
much that my role there was just to help to keep people on 
track, factually. 
Newman closely models his neutral and distanced approach to the 
pharmacogenetics public dialogue on his experience as a 
consultant clinician, noting that it is his clinical training and 
experience that enables him to approach public dialogue in a 
particular way. On this basis he understands his role in both public 
dialogue and the clinic as ‘provid[ing] information’ and ‘keep[ing] 
people on track, factually’, thus allowing other people to ‘make 
their own independent decision’ within the context provided by a 
facilitator or counsellor. Thus he is reluctant to mention personal 
experiences (for example, of ‘medication’) and personal opinions 
(‘in your situation, I would do so and so’) in both clinical 
consultations and the pharmacogenetics public dialogue. Here, as 
above, Newman’s contribution is asymmetrical: he seeks to 
engage with the public in a non-directive fashion, but in doing so 
he must largely exclude himself by maintaining a strict sense of 
professional distance. 
 
Two areas of concern: ‘representation’  
and ‘expertise’ 
On the basis of their experience of public dialogue, interviewees 
raised two key areas of concern about the practice of public 
dialogue (in addition to the concerns about the notion of public 
contributions to decision- and policy-making that were discussed in 
Chapter 5). Many of the interviewees were intrigued about the 
sampling processes that had been employed in the Royal Society 
pharmacogenetics public dialogue project and the Meeting of 
Minds project, and they expressed concerns about the extent to 
which the public participants in public dialogue were representative 
of the broader population. This concern took a number of forms. 
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Drawing on his statistical expertise, Professor Walter Bodmer 
reflected on these issues at several points in his discussions of the 
pharmacogenetics public dialogue project. 
Walter Bodmer: I distinguish between arbitrary and random, 
if you know any statistics. They were picked arbitrarily but 
whether that was a random, proper random sampling is 
another matter. They were picked off the street arbitrarily, 
whether you can really say that’s a proper random sample is 
not true, perhaps. But, nevertheless, there were a range of 
different views represented. 
In this first comment, Bodmer distinguishes between ‘arbitrary’ and 
‘proper random sampling’, as he calls it, which implies that all 
members of a population have an equal chance of being selected. 
Bodmer assumes (correctly) that the purposive sampling 
processes employed in the Royal Society project were not strictly 
‘random’. 
Walter Bodmer: I think the general impression I had [of the 
public participants] was one of more intelligence and 
awareness than would often be ascribed to so-called Joe 
Public, and these were not people who were picked because 
of that, no, and I think that’s good. Now where they went, they 
probably didn’t find the yobs that were drinking themselves 
sick in the pub. How you get a representative group is quite 
difficult. 
Bodmer here affirms the positive impression that he gained of the 
‘intelligence and awareness’ of the public participants, while 
acknowledging that the participants were not specifically selected 
on that basis. His concern lies with other sections of the public that 
might not have been represented among the public participants, 
such as ‘the yobs that were drinking themselves sick in the pub’. 
Bill Newman makes this point in a slightly different way. 
Bill Newman: I think it’s difficult with a relatively small number 
[of public participants]. I think there was a forum in London, 
maybe something in Manchester, and that was about it over a 
couple of days. So you’re looking at a relatively small amount 
of opinion and I think you can interrogate that information, in 
terms of developing some themes, … but in terms of getting 
to an absolute answer, I don’t know if you’ve got enough 
information there, you can’t do anything quantitative, certainly. 
And I don’t know if doing that small number of groups in two 
big urban centres would be fully reflective, 40 or 60 people or 
whatever of a population of 50, 60 million is difficult. 
Here again, Newman’s concern is that the public views as they are 
understood through public dialogue may not be representative of 
broader public views, in this case owing to the relatively small 
number of participants in public dialogue events. It is notable here 
that both Bodmer’s and Newman’s reflections are embedded 
within their expertise as quantitative, scientific statisticians. They 
reflect a yearning for the ‘proper random sampling’, statistical 
representation, large sample sizes, quantification and ‘absolute 
answers’ upon which the authority and legitimacy of such 
approaches, as well as their scientific status, rest. Their comments 
reflect the profound philosophical and methodological distinctions 
between such approaches and the more qualitative and 
interpretative approaches that are associated with public dialogue 
(some of which were discussed in Chapter 3 within the context of 
the methodology of the ScoPE project). 
Professor Geraint Rees, who participated in one of the Meeting of 
Minds events, also raised concerns about the ‘asymmetric’ 
procedure that was employed in the selection of experts in these 
public dialogue projects. In doing so, he raises the broader issue of 
the nature of expertise in public dialogue. 
Geraint Rees: I suspected the [expert] panellists were 
chosen by a random selection of who [the organiser] could 
find in his address book at short notice to come. …it seemed 
to be a highly asymmetric selection procedure in which the 
members of the [public] panels were chosen by a highly 
inclusive public canvassing and selection procedure that was 
very elaborate and involved a number of selection stages to 
get the socio-demographics perfectly right. …[whereas] the 
scientists on the panel seemed to be a completely random 
selection of who was available in somebody’s Rolodex at the 
time, and could be contacted by phone. 
Rees’s contrast between the ‘elaborate’ sampling or ‘selection’ 
procedure through which the public participants were recruited and 
the relatively unsophisticated selection process used to recruit the 
expert participants, which he describes as a rather last-minute and 
  
 
 
 
73 
‘completely random’ procedure based upon existing contacts in an 
‘address book’ or ‘Rolodex’, once again underscores the role of 
asymmetry characterising public dialogue events. As in the above 
cases, his observations are rooted in his expertise as a scientist 
and clinician familiar with the sampling principles employed within 
scientific and medical research. He is more specific about this 
issue in this later comment on the Meeting of Minds event. 
Geraint Rees: While I have plenty of opinions about big 
pharma, I can’t claim to have any practical information about 
pharmaceutical lobbying and so on. So, I do remember sitting 
there thinking, oh my gosh, how can I say something that’s 
relevant to these questions they’re interested in, when really 
they’re very peripheral [to my expertise]. …I’m taught to be 
cautious in my generalisations, to not go beyond the data, not 
to speculate unduly, and certainly not to make wild 
pronouncements scientifically on things I know nothing about, 
and consequently my domain of knowledge is, sort of, rich in 
the area I colonise which is quite broad, consciousness, it’s 
quite a lot of stuff. But it doesn’t, for example, include 
attention-deficit hyperactivity disorder. But I think the public 
often have an impression of domains that are much wider 
than scientists have, that somehow I can comment on 
anything to do with the brain. So, they don’t realise how 
narrow, relatively speaking, people’s expertise is. …People 
expect you to know stuff you really don’t. 
In this passage describing different types of knowledge and how 
they are perceived, Rees recounts his struggle to contribute to 
some aspects of the discussions while maintaining his expert role. 
From a scientific perspective, Rees suggests that his expertise 
with respect to ‘consciousness’ is ‘quite broad’ and covers ‘quite a 
lot of stuff’. However, on the basis of his experience in public 
dialogue and perhaps elsewhere, it might, conversely, appear 
quite narrow, leading to Rees’s concern that, as a scientific expert, 
‘people expect you to know stuff you really don’t’. For instance, 
Rees notes his impression that the public participants expected 
him to be able to provide expertise on ‘anything to do with the 
brain’, including ‘big pharma’ and ‘attention-deficit hyperactivity 
disorder’. On the basis of her experience in another of the Meeting 
of Minds events, Dr Catriona Morrison reflects on this issue in 
terms of what she feels ‘comfortable’ with: 
Catriona Morrison: So as far as psychology is concerned, 
I’m comfortable. I was comfortable with everything that was 
asked. And it was great to be able to say, I can tell you about 
this. And you could really get your teeth into it. So that was 
really good. When people start talking about policy-making 
and medical research and things like that, which I do a little bit 
of, and Andy [Professor Andy Young] knows a lot about. So 
that was fine. But there were certain bits where you just think, 
it’s like the psychologist going on the radio and talking about 
whatever they don’t know about. You just kind of feel, should I 
comment on this or should I maybe not say something, 
because I’m really not representing an expert view on some of 
these things. 
Here, Morrison describes how her sense of comfort diminished as 
discussions moved away from her area of expertise. She opens 
her comments by reporting that she was ‘comfortable’ and ‘it was 
really good’ when she was discussing ‘psychology’, her area of 
expertise; she then identifies two issues – policy-making and 
medical research – that she felt ‘fine’ discussing because she has 
‘a little bit’ and her more senior colleague ‘a lot’ of experience in 
those areas. However, she then describes uncomfortable feelings 
of uncertainty at moments when the discussion moved outside 
areas on which she felt she could ‘represent an expert view’. In 
these circumstances, she felt unsure whether to comment or not. 
She worries about being out of her depth and resembling the 
popular ‘psychologist going on the radio and talking about 
whatever they don’t know about’ (see further discussions of the 
relationships between public engagement and professional 
opprobrium in Chapter 6). She thus demonstrates again the 
difficulty that scientific expertise is not a homogeneous, firmly 
bounded phenomena. Instead, scientists’ scientific expertise 
emerges as a more heterogeneous, gradated and fluid 
phenomena with core areas featuring high levels of expert 
knowledge and peripheral areas featuring lower levels of expert 
knowledge. 
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Summary 
Interviewees discussed their experiences of policy-oriented public 
dialogue events in generally positive terms, reporting that public 
dialogue brings scientists and publics closer together in ways that 
enable them to have conversations with each other and in ways 
that differ from other forms of public engagement. A particularly 
notable aspect of interviewees’ discussions is the extent to which 
participation in public dialogue can transform scientists’ 
perceptions of public capabilities to assimilate and work with 
complex scientific and technical matters, thus prompting respect 
for the public among scientists. 
Interviewees’ misgivings concerning public participation in 
decision-making with respect to matters of science, technology 
and medicine were discussed in Chapter 5. In addition, in the 
present chapter, interviewees raised three further uncertainties or 
difficulties regarding their participation in public dialogue. First, 
while all agreed that their primary role in public dialogue is that of a 
relatively passive scientific expert who responds to public 
participants’ questions, a range of views emerged about the 
potential for scientists to act as advocates, to more deliberately 
direct the course of the dialogues, and to draw on their own 
personal experiences. Second, interviewees expressed a range of 
concerns regarding the rigour of the qualitative, small-group 
approach that is commonly employed in public dialogue. In 
particular, some interviewees revealed their concern that such 
approaches cannot claim to be representative and do not provide 
any guide as to where the weight of public opinion lies. Finally, 
interviewees expressed concerns about what they saw as the 
unrealistic public expectations of the breadth of their expertise. 
These issues are discussed in more detail in the following chapter. 
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CHAPTER 8 DISCUSSION 
 
Public culture as professional science 
The findings from this project confirm the ‘sea change’ affecting 
scientific culture in the UK, in which public engagement activities 
have become an increasingly important part of the scientific 
profession for individuals and institutions alike. These findings 
suggest that the vision of the 2000 Jenkin report, of a shift from 
deficit to dialogue, has been at least partially realised as a shift 
from deficit to dialogue models. The findings also provide a 
snapshot of an evolving public culture of engagement activities in 
which scientists currently participate more out of a positive sense 
of voluntarism and vocation than as a result of managerial or 
bureaucratic drivers. A finding that is reinforced by the qualitative 
data presented here is the extent to which the two-way, reciprocal 
model of engagement activities as exchanges has become a 
dominant paradigm, or ‘ideal type’, of engagement activity. As the 
data presented here confirms, public engagement and dialogue 
activities are seen to be desirable and necessary because science 
and the public are increasingly understood as interdependent and 
mutually beneficial: science presents social challenges and is 
dependent on public funding and consent; in turn, science benefits 
patients and the public, while the public can benefit science, in a 
series of interactions most optimistically conceived as a ‘virtuous 
circle’ or ‘win-win’ situation. Tellingly, in the accounts presented 
here, images of scientific isolation or academic ivory towers are 
limited to interviewees’ perceptions of how the public perceives the 
interviewees. More firmly than in the past, public engagement 
emerges from the interviewees’ discussions as an established 
component of professional commitment, part of the everyday 
practice of professional science. Thus, public lectures, media 
interviews, science festival debates, visits to schools and a variety 
of other activities under the broad remit of public engagement take 
their legitimate place alongside other professional or academic 
activities. This development within professional scientific culture is 
consistent with external policy developments that have located 
public engagement at the centre of all scientists’ – and, indeed, all 
academics’ – future concerns. 
The second broad area of findings from the ScoPE study is that 
public engagement emerges from the interview data and 
workshops as an anomalous aspect of professional science. Public 
engagement is an increasingly important aspect of the scientific 
profession worthy of time and commitment; at the same time, it is 
an activity that is under-rewarded and potentially professionally 
distracting and stigmatising. It is thus, confusingly for some 
scientists, seen to represent both the best and the worst features 
of scientific professionalism – at best an expression of the chief 
ideal of science as a vocation (to further scientific progress), and at 
worse a symptom of professional failure. The strong finding that 
public engagement work can be stigmatising and, in this and other 
ways, potentially detrimental to a professional scientific career is a 
reminder that the ‘sea change’ has also produced an undertow of 
tension. A similar tension surrounds the third major finding of the 
study – that although interviewees show strong support for the 
principle of robust and meaningful institutional structures for the 
incentivisation, evaluation and reward of public engagement, a 
range of potential problems associated with measurement, 
compulsion and targets are equally a source of concern. 
 
Sophisticated and embedded accounts 
Interviewees’ accounts of relationships between science, the 
public and public engagement were thoughtful, layered and 
nuanced. Public engagement activities emerged as a topic about 
which they care and think critically. The descriptions given by 
scientists of public engagement were in many cases highly 
sophisticated, including perceptive sociological and psychological 
insights. These descriptions contained many distinctions and 
qualifications in characterisations of the public, or publics. A basic 
equation that, if the public were treated reasonably and 
respectfully – in a word, sensibly – they would reciprocate in kind, 
appeared to enjoy general consensus. Lapses in public support 
tended to be seen to be located among specific groups or oriented 
toward specific applications of science and, to some degree, due 
to errors of judgement by the scientific community. Fewer 
distinctions are observable in interviewees’ discussions of the 
media, and activist or ‘opposition’ groups – such as animal rights 
protesters or religious groups – were rarely distinguished from one 
another. 
The importance of first-hand experience of public engagement and 
dialogue activities would be hard to overstate on the basis of the 
interview data. Interviewees’ descriptions and analyses can be 
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best understood as embedded or rooted in specific professional 
and personal contexts and experiences. In many instances, 
interviewees drew upon their direct experiences of the public – in 
the clinic or in public engagement – and they contrasted these with 
representations of the public they experience indirectly, perhaps in 
the talk of colleagues. Moreover, in many cases, scientists working 
on particular conditions emphasised the direct value to their 
science of their public engagement work with medical research 
charities and patient groups. Interviewees with clinical experience 
often provided instances of conversational translation, which, if 
generalised, could be seen to represent the two-way exchange 
models informing the public engagement paradigm of reintegrating 
science and its publics through talk. Other interviewees 
encountered potential obstacles to their research, describing 
contexts in which public engagement activities became crucial to 
public debate and parliamentary lobbying. 
 
Publics and public engagement 
From the perspective of most of the interviewees, then, and in 
contrast to some representations of science and society policy 
debates, the context for public engagement emerged from this 
study as a generally positive relationship between science and the 
public. For instance, most of the interviewees identified a general 
and broad-based public support for developments in science, 
technology and medicine. Some – particularly those with clinical 
responsibilities – identified ongoing improvements in public 
understandings of science. However, interviewees were quick to 
identify familiar instances in which this broad-based support lapses 
and scientific developments are compromised (GM crops, the 
MMR vaccine and (hybrid embryo) stem cell research were often 
mentioned in this regard). These lapses in support were most often 
attributed to misconceptions of science and scientists among 
sections of the public and to the negative influence of other malign 
social actors (most prominently the news media, but also civil 
society groups and corporations) as well as aspects of scientific 
culture itself. Notably, interviewees sometimes shared, or 
expressed empathy with, negative public responses to scientific 
developments, particularly within the specific contexts in which 
they emerge. 
Public engagement emerged as an activity with multiple objectives 
for the interviewees, including instrumental objectives for 
promoting scientific work. Most often, this takes the form of 
proactively or reactively putting the record straight in the face of 
public misconceptions and the malign actions of other social 
actors. These objectives were complemented by others. As well as 
highlighting the questions that scientific researchers might 
address, interviewees emphasised the importance of public 
engagement as a means of democratising science and improving 
the ways in which scientific research and clinical activities are 
undertaken. In some cases, aspirations toward democratic 
inclusion and citations of intelligent and objective publics were 
often in strong tension with concerns about the misguided choices 
and decisions that the public might make in practice. Public 
engagement was frequently cited as a reciprocal imperative or 
obligation to repay public funding (most often that obtained from 
medical research charities and patient groups, but also from the 
taxpayer). 
Interviewees with experience of policy-oriented public dialogue 
events had largely positive experiences to report, particularly with 
respect to their transformed perceptions of the capabilities of non-
scientists to understand and discuss complex scientific matters. 
Some interviewees expressed concern about the methods used in 
the design of public dialogue events, their roles as scientific 
‘experts’ and public overestimations of the breadth of their 
knowledge. 
 
Conversations with policy 
As indicated earlier in this report, the core of the contemporary 
Science and Society policy trajectory – that public engagement 
implies a deeper or two-way engagement modelled on dialogue 
with the public – was strongly reinforced in the ways that 
interviewees discussed both public engagement and public 
dialogue activities. In common with policy trajectories, interviewees 
discussed public engagement in terms of a contemporary move 
from communication alone to a combination of both 
communication and deliberation. However, while many policy 
actors and practitioners might draw strong distinctions between the 
practices and objectives of public engagement and those of public 
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dialogue, this distinction was not noticeably present in 
interviewees’ accounts. Instead, multiple objectives seem to be in 
play at all times and across the broad categories of ‘public 
engagement’ and ‘public dialogue’ events. These comments point 
to the importance of indirect and informal ‘conversations’ or 
connections between public engagement policy developments and 
the understandings of public engagement by scientists. As 
governmental plans to institutionalise public engagement to 
greater extents than heretofore become clearer, these 
conversations may become more direct. 
 
Institutionalising public engagement 
The ScoPE project provides an opportunity for scientists to 
address policy and practitioner communities with respect to two 
particularly prescient elements of the Science and Society and 
broader public engagement agendas. As mentioned in Chapter 1, 
public engagement by scientists has been increasingly 
encouraged and promoted over the past decade. More recently, 
under the auspices of the National Co-ordinating Centre for Public 
Engagement and the six pilot Beacons for Public Engagement 
(NCCPE/BPE 2009), public engagement is beginning to be 
encouraged and supported throughout the UK higher education 
sector. At the same time, it appears highly likely that the new 
Research Excellence Framework will somehow evaluate and 
reward, alongside the policy and scholarly impact of academics, 
the public engagement activities that they undertake (Drayson 
2009). 
Importantly, within this context, although the objectives that they 
ascribe to public engagement may differ to some extent from those 
espoused by NCCPE/BPE, the ScoPE interviewees gave every 
indication of sharing the commitment to public engagement that is 
evident in these policy developments. In addition, as is the case in 
the NCCPE/BPE and in the recent comments of Lord Drayson 
(2009), most of the ScoPE interviewees argued that public 
engagement should be more meaningfully and sincerely 
incentivised and rewarded by scientific/academic institutions and 
the providers of both core and project funding. However, the 
interviewees also gave compelling accounts of the positive aspects 
of the current professional culture within which they voluntarily 
undertake public engagement, and which institutional actors now 
seek to change. Notably, the interviewees observe that they have 
a great deal of autonomy with respect to their public engagement 
activities; that teams and groups of scientists can manage their 
public engagement commitments in informal ways according to 
their individual strengths and weaknesses (thus, public 
engagement is often done well); and that public engagement is 
infused with a sincerity, commitment and goodwill that can be 
associated with the current voluntary and vocational nature of 
public engagement. 
In common with the NCCPE/BPE, the ScoPE interviewees often 
noted the challenge of developing metrics for the evaluation of 
public engagement. More fundamentally, however, some 
expressed the concern that more formal systems of incentives and 
rewards also create systems of obligation and compulsion, of 
targets and quotas, which may well serve to undermine the 
positive characteristics described above (in a sense, possibly 
‘killing the goose that laid the golden egg’) and produce other 
unforeseen consequences. Indeed, many interviewees expressed 
uncertainty about the extent to which the existing rather informal 
incentives for public engagement, such as the inclusion of public 
engagement statements in funding bids, might be prompting an 
insincere, tick-box mentality among scientists. In addition, the 
interviewees all spoke of science as an already overloaded 
profession, characterised by the motif of the ‘80-hour week’. In this 
context, some interviewees reflected upon the extent to which 
institutions might wish leading international scientists to be 
undertaking public engagement activities in the time that they 
might otherwise commit to leading internationally recognised 
scientific teams in contributing to the competitive knowledge 
economy of bioscience and biomedicine. 
 
Practising public dialogue 
Interviewees also provided detailed and revealing accounts of their 
experiences in policy-oriented public dialogue that are of value to 
those working within the Sciencewise-Expert Resource Centre 
(2009) and at other sites of policy-oriented public dialogue. 
Typically, these were positive experiences; in particular, 
interviewees spoke of the ways in which such processes 
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transformed their understandings of public capabilities to discuss 
complex scientific, technical and medical issues. At the same time, 
interviewees raised specific concerns. In particular, some 
interviewees expressed concerns about the potential pitfalls and 
appropriate limits associated with public involvement in decisions 
concerning science, technology and medicine. Does this mean, 
they imply, that such decisions will become subject to the 
perceived subjectivities, prejudices, ignorances, vagaries and 
fickleness of public opinion? From the perspective of public 
dialogue, the key point here would seem to be that public dialogue 
is specifically designed to obviate these often-cited negative 
characteristics of public opinion, and instead to deliver public views 
and perspectives hewn from the in-depth knowledge and 
understanding of multiple perspectives that should result from 
iterative and well-facilitated dialogue and deliberation. 
Interviewees also expressed concerns relating to an assumed lack 
of rigour associated with the reliance on small public groups and 
qualitative data that characterises public dialogue. How, they 
appear to ask, can such small ‘samples’ be legitimate, 
representative or amenable to generalisation? And how can 
qualitative data tell us something meaningful about the weight of 
public opinion? In this instance, interviewees based their concerns 
on the contrasts between the unfamiliar methods of public dialogue 
and the familiar large-scale, quantitative methods in which they are 
trained as scientists and which they see employed within the 
context of public opinion surveys. Of course, ‘experts’ of many 
stripes are utilised in public dialogue processes, and many will be 
more familiar with qualitative approaches than the ScoPE 
interviewees are. However, the challenge would appear to be to 
emphasise the variety of ways in which the approaches that are 
typically employed in public dialogue can yield distinctive and 
valuable insights into complex issues, as well as countering the 
well-known shortcomings of quantitative approaches that may 
oversimplify known factors while failing altogether to identify less 
well-known influences, obstacles and drivers (‘factors’).21 
 
Benchmarking scientists on public 
engagement 
The closing stages of the ScoPE project and the period during 
which this report has been written have coincided with the 
announcement of the potentially highly significant ministerial 
commitment to evaluate scientists’ (and other academics’) public 
engagement activities (as ‘impact’ measures) alongside scholarly 
indications of quality in the 2015 Research Excellence Framework, 
(Drayson 2009). Of course, this commitment may yet be reversed 
or become less meaningful than Lord Drayson’s recent comments 
imply. However, it appears likely that this incentive – the 
implementation of which was both supported by many of the 
interviewees for this project and the subject of some concern – will 
become a reality over the coming years. With this in mind, it is to 
be hoped that the ScoPE project provides a meaningful 
benchmark for understanding scientists’ own perspectives, critical 
reflections and experiences with respect to public engagement in 
the period immediately prior to the implementation of any such 
changes. 
From the perspective of scientists, social scientists and policy-
makers alike, the proposal to measure and evaluate public 
engagement activities prompts a range of questions. Not least, this 
proposal demands the future revisiting of the questions that were 
posed in the ScoPE project. For instance, how might meaningfully 
incentivised public engagement influence the relationships 
between science and the public, the objectives of public 
engagement (to meet institutional targets, perhaps?) and the place 
of public engagement within the lives of professional scientists? 
More broadly, how might such developments influence existing 
and nascent professional strategies, practices and relationships 
among and between individual scientists, formal and informal 
                                                 
 
 
21
 These issues, and many others related to the employment of ‘experts’ in 
public dialogue, are being productively investigated within the Sciencewise-
Expert Resource Centre (Lansdell 2009). 
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teams or groups of scientists, academic departments, institutional 
public engagement professionals, academic institutions 
themselves, the funders of scientific research and so on? Indeed, 
how might novel imperatives to conduct public engagement alter 
the nature of a science already widely said to be increasingly 
required to orient itself around its contribution to innovation, 
problem-solving and policy (for instance, see Nowotny et al 2001), 
and how might widespread public engagement influence the 
science that gets done and the ways in which it is done? 
More broadly, the prospect of larger-scale embedding of public 
engagement and public dialogue activities has implications for 
definitions of knowledge (how to achieve more interdisciplinary 
expertise while preserving specialist knowledge), translation 
(whether a version of public engagement can serve as a valuable 
feedback system for innovation) and the public sphere (whether a 
democratisation of scientific decision-making can serve as a model 
for new forms of active citizenship). The role of the UK, which is in 
many respects increasingly distinctive as a site of public 
engagement innovation, will also attract continuing appraisal 
internationally. To the extent that this report confirms the value of 
close readings of situated data drawn from within the professional 
communities most directly affected by the ‘public engagement 
revolution’ in UK science over the past decade, it too represents a 
contribution to both a more publicly engaged science and a more 
scientifically engaged public. 
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